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Abstract 
Introduction: Obesity is a major risk factor for cardiac related morbidity and 
mortality particularly in women. Excess body fat induces detrimental LV 
structural and functional alterations that can potentially be reversed by 
aerobic exercise training, however the optimal exercise type has not been 
determined. Firstly the assessment of the impact of excess body fat, on LV 
structure and function in healthy overweight/obese women was undertaken. 
Next, the acute LV systolic and diastolic functional responses to heavy-
intensity exercise were compared between healthy obese and non-obese 
women. Finally, the long-term effects of interval and continuous heavy-
intensity training on LV structure and function in overweight/obese women 
were assessed. 
Methods: In chapter 4, 85 females were assessed for anthropometric 
characteristics and LV structure and function then divided into 3 groups; 
normal weight, overweight and obese. The allometric relationships between 
each pair of anthropometric and cardiac variables were assessed and the 3 
groups were compared for absolute and allometrically scaled LV structural 
and functional data. In chapter 5, 16 females (8 obese and 8 non-obese) 
completed a 10-min heavy-intensity exercise session. LV systolic and 
diastolic function were assessed at rest, 8 min into exercise and 5 min post-
exercise and compared between both groups. In chapter 6, 20 
overweight/obese females were assessed for  LV structure and function 
before and after completing 12 weeks of either interval or continuous heavy-
intensity training. All measures of LV structure and function were assessed 
by echocardiography. 
Results: In chapter 4, excess visceral fat was associated with LV concentric 
hypertrophy as well as reduced LV diastolic filling velocity, diastolic 
myocardial velocity and systolic and diastolic myocardial deformation. Fat-
free mass (FFM) was identified as the most appropriate scaling variable to 
normalise for body size without masking the impact of excess fat. In chapter 
5, obese woman displayed greater exercise-induced systolic deformation 
and diastolic filling compared to non-obese women. In chapter 6, both 
continuous and interval heavy-intensity training resulted in improvement in 
LV structure, diastolic myocardial velocity and systolic and diastolic 
myocardial deformation with no difference between both training 
interventions. 
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Conclusion: Excess visceral fat is associated with LV concentric 
hypertrophy and reduced systolic and diastolic function in healthy 
overweight and obese women. Heavy-intensity exercise enhances LV 
systolic and diastolic functional response to exercise in overweight/obese 
women and results in long-term improvements in LV function regardless of 
exercise type provided it is performed at the heavy-intensity domain. 
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Chapter 1 Introduction 
 
Obesity is defined by the WHO as an abnormal or excessive accumulation 
of fat that may impair health and is commonly classified using the body 
mass index (BMI) which is the person’s weight in kilograms divided by the 
square of his height in meters (kg/m
2
); A BMI ≥ 25 is considered overweight 
and  ≥  30 obesity (WHO, 2014). Overweight and obesity are major public 
health concerns and leading causes of global morbidity and mortality. 
Around 3.4 million adults each year die because of obesity (WHO, 2014, 
Flegal et al., 2013). The World Health Organisation (WHO) has reported a 
10-40% increase in the prevalence of obesity in the majority of European 
countries over the period between 1990 and 2000. This increase was most 
drastic in England, where the prevalence of obesity had more than doubled 
during this period (WHO, 2000).1 In 2002, national health surveys reported a 
three-fold increase in the prevalence of obesity in Great Britain since 1980 
(Rennie and Jebb, 2005). According to the National Health And Nutrition 
Examination Survey (NHANES), the prevalence of overweight and obesity in 
the United States has also been significantly increasing over the past three 
decades (Flegal et al., 1998) . In 2011, more than two thirds of the American 
population was reported to be either overweight or obese (Ogden et al., 
2014).  
Obesity is strongly associated with heart disease. Indeed, obesity is a major 
risk factor for the development of heart failure (HF) both independently and 
through its association with co-morbidities such as atherosclerosis, 
hypertension, dyslipidemia, impaired glucose tolerance and metabolic 
syndrome (Eckel and Krauss, 1998). Women are particularly at risk of 
developing cardiovascular disease and approximately 2.4 million women 
have HF (Jensen et al., 2014). Women present with diastolic HF twice as 
frequently as men (Jessup, 2003). In 2009, 58.2% of heart failure deaths 
were women (Jensen et al., 2014). In the Framingham Heart Study 
population, body mass index (BMI) was shown to increase the population 
attributable risk of heart failure (HF), with a 7% increase in women and 5% 
in men for each increment of 1 in BMI (Kenchaiah et al., 2002). 
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Furthermore, obese women were shown to have double the risk of 
developing HF compared to non-obese women, whereas obese men only 
had a 20% increase in the risk compared to non-obese men (Kenchaiah et 
al., 2002). Furthermore, in a population of 8802 men and women (Dagenais 
et al., 2005) showed that obesity, and particularly  abdominal adiposity, is an 
independent predictor of all types HF in women but not in men. Indeed, it 
was shown that for every 0.01 increase in waist-to-hip ratio (WHR) above 
0.83, the risk of developing HF increases by 5% in women, whereas in men 
there was no association between WHR and HF risk (Dagenais et al., 2005). 
Earlier autopsy and invasive studies suggested that obesity is associated 
with eccentric left ventricular hypertrophy, secondary to chronic volume 
overload, accompanied by diastolic dysfunction which eventually progresses 
to systolic dysfunction and heart failure (Kaltman and Goldring, 1976, 
Alexander, 1985). This remained the predominant notion for decades until 
the development of non-invasive techniques such as echocardiography 
which enabled researchers to assess LV structure and function in mildly 
obese normotensive subjects and reporting contradicting findings 
challenging this classic notion. It was observed by several researchers that 
mild to moderately obesity is associated with concentric LV remodelling and 
hypertrophy accompanied by subclinical reduction in both LV systolic and 
diastolic function. (Alpert, 2001, Alpert and Hashimi, 1993, Danias et al., 
2003, Di Bello et al., 2006, Wong and Marwick, 2007b). These structural 
and functional changes can take years before manifesting themselves 
clinically, and can eventually result in cardiac failure. In the past, the 
occurrence of congestive cardiac failure caused entirely by obesity was 
classically defined as obesity cardiomyopathy. However, with the 
development of reliable non-invasive techniques capable of detecting subtle 
myocardial structural and functional deterioration in mild to moderate 
obesity, Wong et al. (2007) suggested that the definition of obesity 
cardiomyopathy should be extended to include any myocardial disease in 
obese individuals that cannot be explained by other aetiologies (Wong and 
Marwick, 2007b).  
There has been a lot of disparity with regards to the type of LV morphology 
and degree of systolic and diastolic dysfunction reported by different studies 
in association with overweight and obesity. This is partly due to the 
individual differences between different study populations in the degree of 
obesity, body composition and fat distribution. Indeed, obesity, defined as a 
body mass index (BMI > 30 mg.kg
-1
) does not take into account individual 
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differences in fat and muscle content. Furthermore, several studies have 
shown that fat distribution, notably abdominal/visceral fat accumulation is a 
strong determinant of the adverse cardiac outcomes related to obesity. 
Therefore, a clear distinction between the normal physiological influence of 
body size and composition and the pathological influence of adipose tissue, 
taking into account the different fat distribution in the subjects studied, is 
paramount in the definition of the impact of obesity on LV size, morphology 
and function. This can only be achieved by normalising cardiac structural 
and functional variables to body size and composition using allometric 
scaling procedures (Batterham et al. 1999). Amongst studies comparing 
cardiac structure and function in obese to non-obese individuals, some 
researchers normalised cardiac structural and functional variables to body 
size using ratio-scaling, which assumes a linear relationship between 
cardiac size and body size resulting in over-correction and errors in the 
results. Others normalised cardiac variables to body size or composition 
variables using allometric scaling by raising the body size variable to the 
power of an allometric exponent. This method was shown to be more 
accurate, however the exact exponent for each body size or composition 
variable has also been a point of debate and not clearly defined. Batterham 
et al. (1999) suggested that in each study, a population specific power 
exponent offers the most accurate scaling for comparison between 
individuals. Finally, the choice of body size variable has also been 
inconsistent in the literature as some studies scaled cardiac size to body 
mass while others have scaled to body surface area or fat-free mass. Fat-
free mass has been identified as the best scaling body size variable. All 
these inconsistencies would be expected to result in completely different 
and even at times contradictory findings. Nevertheless, it is generally agree 
that obesity is associated with an increase in cardiac size and a reduction in 
systolic and diastolic function. While several studies have explored the 
allometric relationship between body size and composition and LV size and 
morphology, the relationship between body size and composition and LV 
function and whether there is a need to scale functional variables to 
individual differences in body size and composition has not been clearly 
defined. Therefore, the first aim of this thesis is to explore the relationship 
between body size, and composition, notably fat-free mass, on LV size, 
morphology and systolic and diastolic function using allometric scaling in a 
population of healthy women.   
Several cross-sectional and longitudinal studies have demonstrated that 
aerobic exercise training is an effective intervention in restoring cardiac 
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function in obese subjects and reversing the pathological changes induced 
by obesity (Gondoni et al., 2007, Eriksson et al., 2010, Kosmala et al., 
2009). A large number of these studies aimed primarily at reducing weight 
and therefore designed interventions combining dietary modification with 
exercise training. While these studies have shown that exercise does indeed 
maximise weight loss when combined to hypo-caloric diet resulting in 
improvement in cardiovascular health, it was not clear if these benefits were 
secondary to a reduction in body fat or the influence of exercise or both. 
Recent evidence suggests that aerobic exercise training alone improves 
cardiac structure and function in obese subjects free of comorbid conditions 
(Morrison et al., 1986, Vogelsang et al., 2008, Ingul et al., 2010, Schuster et 
al., 2012). Hence, it may be possible to reverse obesity-cardiomyopathy via 
aerobic exercise training alone without caloric restriction, restoring normal 
cardiac function and preventing the development of heart failure in obese 
subjects. This can be particularly of benefit for obese individuals struggling 
to reduce their weight by caloric restriction.  
The exact mode, intensity, and duration of exercise training that achieves 
the best cardiac outcome in healthy obese subjects is not yet established. 
Studies that have explored the cardiac benefits of aerobic training on 
healthy obese subjects, free of cardiovascular morbidities, have used 
different combinations of intensity, duration and training types. Durations 
have ranged from as low as 3 weeks to as long as 8 months programmes. 
While most studies used moderate intensity continuous training 
programmes (Humphries et al., 2002, Vogelsang et al., 2008, Schrauwen-
Hinderling et al., 2010, Sijie et al., 2012) others used high intensity interval 
training (Sijie et al., 2012, Ingul et al., 2010) and others used a combined 
resistance and endurance training programme of moderate intensity 
(Schrauwen-Hinderling et al., 2010, Schuster et al., 2012).  
Furthermore, several studies have used different methods for defining the 
training intensity. While most studies defined it as a percentage of HRmax 
(Ingul et al., 2010, Schrauwen-Hinderling et al., 2010, Schuster et al., 2012, 
Vogelsang et al., 2008) others used a percentage of VO2max (Mitchell et al., 
2002, Baynard et al., 2008, Millen et al., 2014). Shuster et al. designed a 
training programme aiming at achieving a HR corresponding to the rate of 
maximal lipid oxidation (Schuster et al., 2012). Finally, some studies did not 
define a particular intensity and simply encouraged participants to be more 
active and cycle/walk to and from work (Eriksson et al., 2010). To the best of 
our knowledge, none of the studies exploring the training-induced cardiac 
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structural and functional changes have defined training intensity based on 
lactate threshold (LT). 
High-intensity interval training has recently been a topic of increasing 
interest. Exercise intensity has been shown to be a strong determinant 
factor in the cardiovascular outcome of aerobic training. According to Wisloff 
(2007) high-intensity interval training is superior to moderate-intensity 
continuous training in improving cardiac structure and function in heart 
failure patients (Mahdiabadi et al., 2013, Wisloff et al., 2007). Very few 
studies have explored the effects of aerobic interval training on cardiac 
structure and function in healthy obese subjects. In fact, to our knowledge, 
only two studies have done so (Ingul et al., 2010, Sijie et al., 2012). Ingul et 
al. demonstrated that, after 13 weeks of interval training, obese adolescents 
restored impaired systolic and diastolic cardiac function compared to lean 
counterparts. Sijie et al. on the other hand, compared both training modes in 
healthy obese young women and reported a greater increase in SV and EF 
after high intensity interval training. This study, to our knowledge, is the only 
study comparing the cardiac effects of interval and continuous training in 
healthy obese subjects. However, Sijie et al. reported a significant reduction 
in body fat in both groups after training, which was significantly greater in the 
interval training group. This, therefore, does not exclude the possibility of 
weight reduction being a factor in the better cardiac outcome with the 
interval training group. It is believed that interval training is superior to 
continuous training in improving cardiac function because of the higher 
intensities achieved via this training mode. To date, it is not yet known if the 
repetitive nature of interval training has any additional benefit over 
continuous training in restoring cardiac structure and function in 
overweight/obese subjects provided both training modes are in the high 
intensity domain. The comparison between the influence of work- and 
intensity-matched interval and continuous training on cardiac structure and 
function in healthy obese females has not yet been explored. Therefore, the 
second aim of this thesis is to compare the effects of work-matched heavy-
intensity interval and continuous training on LV structure and function in 
overweight and obese women using novel highly sensitive 
echocardiographic techniques. 
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Chapter 2 Literature review 
2.1  Evidence on the relationship between obesity and heart 
disease 
Obesity is strongly associated with conditions that affect cardiac structure 
and function such as diabetes mellitus, hypertension, hyperlipidemia, 
obstructive sleep apnea and coronary atherosclerosis (Poirier 2006, 
Caterson 2004), making the independent influence of obesity on the heart 
difficult to distinguish. Nevertheless, a large body of evidence confirms the 
independent relationship between obesity and heart disease (Hubert et al., 
1983, Chen and Garg, 1999, Dagenais et al., 2005, Kenchaiah et al., 2002). 
Hubert et al. examined the cohort of the original Framingham Heart Study 
population for the development of cardiovascular disease (CVD) over a 26-
year follow up period (Hubert et al., 1983). The cohort consisted of 5,209 
overweight men and women ranging between 28–62 years of age and free 
of clinically evident CVD at the beginning of the study. Their results showed 
that heaviest subjects had a 2-3 fold greater relative risk of developing 
ischemic heart disease and congestive heart failure after 26 years compared 
to the leanest ones. This relationship did not change after adjusting for 
coexisting risk factors including age, systolic BP, serum cholesterol, 
smoking, glucose tolerance and electrocardiographic left ventricular 
hypertrophy, indicating an independent association between obesity and 
heart disease development. Furthermore, the degree of obesity was 
significantly and positively related to the risk of CVD development. 
Several longitudinal follow-up studies showed, later on, similar significant 
independent relationships between obesity and heart failure development. In 
the New Haven, Connecticut cohort of the Established Population for 
Epidemiological Studies of the Elderly Program, consisting of 1749 elderly 
subjects free of heart disease at baseline, Chen and Garg (1999) reported 
that, over a 10-year follow-up period, oberweight (BMI ≥ 28 Kg.m
-2
) was 
found to be an independent predictor of heart failure with a risk ratio of 1.6 
(P = 0.04)(Chen and Garg, 1999). Similar findings were reported by He et al. 
(2001) after conducting the First National Health and Nutrition Examination 
Survey (NHANS I) Epidemiologic Follow-up Study (He et al., 2001). In this 
study, He et al. examined the incidence of developing congestive heart 
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failure (CHF) over an average of 19 years in 13,643 men and women from 
the NHANES I original cohort, free of overt heart disease at baseline. It was 
revealed that overweight (BMI ≥ 27.8 or ≥ 27.3 Kg.m
-2
 for men and women 
respectively) was an independent risk factor for CHF development, with a 
relative risk of 1.35 (P < 0.001).  
In the Framingham Heart Study, Kenchaiah et al. (2002) demonstrated that 
obesity is not only an independent risk factor for the development of heart 
failure as a continuous variable but also as a categorical variable (normal, 
18.5 – 24.9; overweight, 25 – 29.9; obese ≥ 30.0). Indeed, after a follow-up 
period of 14 years in average, it was shown that the hazard ratios for the 
development of heart failure for obese women and men were 2.12 and 1.9 
respectively compared their non-obese counterparts. Additionally, a graded 
increase in the risk of heart failure development was shown across the 
categories of BMI whereby a 7 and 5 percent increase in the risk of heart 
failure was detected for every increment of 1 kg.m
-2
 in BMI for women and 
men respectively (Kenchaiah et al., 2002).  
Finally, Dagenais et al. (2005) have reported some very interesting findings 
following their 4.5 year follow-up Heart Outcomes Prevention Evaluation 
(HOPE) Study. They have demonstrated that people with BMI > 29.8 at 
baseline had a significant 28% increase in the relative risk of developing 
CHF when compared with those with BMI < 25.6, a relationship that was no 
longer significant after waist circumference (WC) or waist to hip ratio (WHR) 
was added as a covariate. However, different findings were found with 
abdominal obesity as subjects with WHR > 0.90 had double the risk of 
developing CHF compared to subjects with WHR < 0.83, with a relative risk 
of 2.3 (P < 0.01), even after including BMI as a covariate. These findings, 
however were only seen in women (Dagenais et al., 2005). Hence, a large 
body of evidence suggests that obesity, notably visceral adiposity, is an 
independent risk factor for the development of heart disease. 
2.2 Nature of the relationship between obesity and LV 
structure and function 
Obesity induces structural and functional changes to the heart. Of particular 
importance, are the structural, morphological and functional changes 
induced by excess adipose tissue on the left ventricle. The following section 
will review what is known about the left ventricular structural and functional 
alterations associated with obesity in the absence of cardiovascular 
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comorbidities. Firstly, the impact of excess adipose tissue on LV size and 
morphology will be reviewed, with a particular focus the difference between 
the physiological impact of body size and composition vs. the pathological 
influence of excess body fat on LV structure. Next, the impact of 
uncomplicated obesity on LV systolic and diastolic function  will be reviewed. 
Subsequently, an extensive review of the mechanisms involved  in the LV 
structural and functional alterations in obesity will be carried out.  
2.2.1 Obesity and LV structure 
Obesity generally induces structural changes to the anatomy of the heart, 
notably the left ventricle (LV), by causing abnormalities in LV dimension, wall 
thickness and the geometric pattern resulting from the proportional changes 
in thickness vs. diameter. It is generally agreed that obesity is associated 
with LV  enlargement, also known a LV hypertrophy (LVH), however there 
are divergent views regarding the degree of hypertrophy as well as the 
morphological pattern associated with obesity. This will be reviewed in the 
below by considering the existing literature on the impact of obesity on LV 
structure which will be divided into size and morphology and each will be 
discussed separately starting with LV size. In order to establish the 
independent impact of excess body fat on LV size, it is imperative to 
partition out the normal physiological influence of body size and composition 
using proper scaling techniques. This will be discussed in the following 
section. This thesis will focus on the left ventricle, and the term LV size will 
be employed to designate LV mass (LVM) and internal diastolic diameter 
(LVIDd), whereas the term LV morphology will be employed to designate 
LVM and relative wall thickness (RWT) 
2.2.1.1 The physiological impact of body size on LV size 
Regardless of obesity, body size has a natural influence on the size and 
dimensions of the left ventricle ie. an increase in body size will be 
accompanied by a physiological increase in LV size. Therefore, for 
comparisons between subjects to be meaningful, it is imperative to 
normalise LV mass and dimension for individual differences in body size. In 
the past, cardiac studies have used ratio scaling ie. simply dividing the 
cardiac size variable, notably LVM, by a body size variable such as body 
mass (BM), body surface area (BSA) or height (HT). This method has been 
shown to introduce artefacts and errors in estimating the impact of 
overweight as it assumes a linear relationship between LVM and body size 
which was shown not to be the case. Hence, ratio scaling results in 
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overcorrection for body size in heavy individuals leading to the under-
estimation of their LV size.  
Allometric scaling is a more accurate method of normalisation for body size 
and avoids the errors of ratio scaling (Batterham et al., 1999). It consists of 
dividing the cardiac size variable by the body size variable raised to the 
power of a scaling exponent. Theoretically, the allometric exponent of each 
body size variable should follow the theory of geometric similarity ie. LVM (3-
dimensional) should relate to BM (3-dimensional) and fat-free mass (FFM, 
3-dimensional) to the first power, to BSA (2-dimensional) to the 1.5 power 
and to HT (one-dimensional) to the 3
rd
 power. Similarly, Left ventricular 
internal diameter (LVID, one-dimensional) should relate to BM (3-
dimensional) and FFM (3-dimensional) to the 0.33 power, to BSA (2-
dimensional) to the 0.5 power and to height (one-dimensional) to the first 
power (Batterham et al., 1999). Multiple scaling studies have explored the 
allometric relationships between LV size (LVM and LVID) and body size 
variables in large population samples in order to derive the most powerful 
associations as well as the specific power exponents for each body size 
variable (Batterham et al., 1997, Hense et al., 1998, Chantler et al., 2005, 
Simone et al., 1994, Savage et al., 2008, De Simone et al., 2011). Results 
from most studies have generally followed closely the theory of geometric 
similarity in healthy non-obese subjects.  
In the context of obesity, in order to properly determine the impact of excess 
body fat on LV size, it is essential to normalise LVM and LVID for a body 
size variable that does not incorporate adipose tissue, ie. fat-free mass 
(FFM) or height (HT). Some studies have suggested that FFM is the most 
appropriate scaling variable for LVM and LVID and that it should be used 
rather than height. The FFM allometric exponents for LVM and LVID have 
been shown to follow the dimensionality theory, ie. not significantly different 
from 1 and 0.33 respectively and was shown to eliminate gender differences 
(Daniels et al., 1995, Hense et al., 1998) and give the most accurate results 
compared with other body size variables (Batterham et al., 1997, Batterham 
and George, 1998, Hense et al., 1998, Iacobellis et al., 2002). Other studies 
have recommended indexing LVM for height after showing that it eliminates 
gender differences and best detects LVH in obese subjects (de Simone et 
al., 1992, Daniels et al., 1995, Chirinos et al., 2010, De Simone et al., 2011). 
However, there has been a large disparity in the height exponents reported 
for LVM by different studies; 2.7 by De Simone, 3 by Daniels and 1.7 by 
Chirinos (de Simone et al., 1992, Daniels et al., 1995, Chirinos et al., 2010). 
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De Simone showed that indexing LVM for BSA, BSA
1.5
 or BM erroneously 
identified LVM as reduced in obese adults whereas this was not the case 
with HT
2.7 
which reduced the variability in LVM between subjects and best 
predicted the presence of LVH in overweight/obese subjects. In a study 
comparing obese men and women, De Simone et al. showed that, although 
women had significantly lower absolute LVM values than men, after indexing 
for either FFM and HT
2.7
 this difference was reversed and women had 
significantly higher indexed LVM than men. This reversal was more 
pronounced with HT
2.7
. De Simone attributed these results to obesity as 
women had significantly higher FM than men (De Simone et al., 2011). From 
these findings, it appears that both FFM and HT are appropriate scaling 
body size variables in order to remove individual differences in body size 
without removing the impact of excess adipose tissue as both measures do 
not incorporate fat unlike BSA and BM. LVM indexed for HT
2.7 
is the most 
widely used measure of LV size amongst researchers and clinicians as 
height is easy and simple to measure in comparison to FFM.  
With regards to LVIDd, it has not been conventionally indexed to body size 
and is usually reported as an absolute value. Batterham and Georges 
(1998) recommended indexing LVIDd for FFM
0.33
 or BSA
0.5
 and advised 
against indexing it for height as it was associated with the greatest errors 
(Batterham and George, 1998). 
2.2.1.2 The impact of obesity on left ventricular size 
Left ventricular (LV) size consists of LV mass (LVM) and internal diastolic 
diameter (LVIDd). It is well recognised that obesity is associated with a 
bigger LV size. Autopsy studies have shown that obese individuals have 
significantly higher LVM and LVIDd than non-obese ones, a phenomenon 
known as LV hypertrophy (LVH; Smith HL, 1933). This study included 
morbidly obese subjects that had hypertension, congestive heart failure 
(CHF) and/or coronary heart disease (CHD).  
Echocardiography has enabled researchers to non-invasively assess LV 
size and morphology in healthy obese subjects free of cardiovascular co-
morbidities and establish the independent relationship between obesity and 
LV size. Left ventricular mass (LVM), as estimated from 2D 
echocardiography, has been shown to be a powerful predictor of 
cardiovascular morbidity and mortality (Liao et al., 1997, Stevens et al., 
2013). 
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With regards to the impact of obesity on LV size, the vast majority of 
cardiology literature has reported significantly higher values for LVM in 
obese subjects compared to lean controls, including both absolute and 
indexed LVM. Nevertheless, some studies have reported significantly higher 
absolute but similar indexed LVM between obese and lean controls 
(Iacobellis et al., 2002, Saltijeral et al., 2011, Abdelazez, 2014). The 
reported values for LVM and LVM/HT
2.7
 in overweight/obese subjects in the 
literature varied from as low as 132.6 ± 30.3 g and 37.5 ± 9 g/m
2.7 
respectively 
 
(Chinali et al., 2004) to as high as 234 ± 65 g (Avelar et al., 
2007) and 58.85 ± 14.27 g/m
2.7
 respectively (Di Bello et al. 2006). The upper 
limit of normal for LVM and LVMI as recommended by the American Society 
of Cardiologist (ASC) is 162 g/m
2.7
 and 44 g/m
2.7
 respectively for women and 
224 g/m
2.7 
and 48 g/m
2.7 
respectively for men (Lang et al., 2005). 
With regards to LVIDd, older studies reported significantly higher LVID 
values in obese subjects compared to non-obese controls (Alexander, 1985, 
Alpert et al., 1995a). These studies included morbidly obese subjects with 
multiple co-morbidities. More recent echocardiographic studies assessing 
mild-moderate obesity in subjects free of co-morbodities, have reported 
disparate findings. While some found significantly higher LVIDd in proportion 
to LVM in obese compared to lean subjects (Koopman et al., 2012, Saltijeral 
et al., 2011, Yaseen, 2014), others reported slightly higher LVID in 
overweight and obese subjects though to a lesser extent than LVM 
(Peterson et al., 2004, Avelar et al., 2007). Interestingly, others studies 
reported no significant difference in LVID between obese and controls 
(Wong et al., 2004, Di Bello et al., 2006, Deng et al., 2010). This 
discrepancy may be related to the differences in subjects’ characteristics in 
each study in terms of age, degree and duration of obesity, body 
composition and fat distribution. 
2.2.1.3 Obesity and left ventricular morphology 
There are two types of LV morphologies: eccentric, indicating an increase in 
LVIDd in proportion to LV wall thickness with no change in relative wall 
thickness (RWT), and concentric, indicating an increase in wall thickness 
that is not paralleled with an increase in LVIDd with a consequent increase 
in RWT. Relative wall thickness equals the sum of the inter-ventricular 
septal thickness (IVST) and posterior wall thickness (PWT) divided by 
LVIDs. A RWT < 0.42 indicates eccentric LV remodelling or hypertrophy, 
whereas a RWT > 0.42 is concentric. The term remodelling is applied when 
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LVMI < 51 g/m
2.7
 whereas hypertrophy is when LVMI > 51 g/m
2.7 
(Woodiwiss 
et al., 2008).  
The LV geometric pattern associated with obesity has recently been a topic 
of debate. The classic description of LV morphology associated with obesity 
has predominantly been eccentric as demonstrated by earlier studies 
((Smith HL, 1933, Nakajima et al., 1985, Messerli, 1982, Lauer et al., 1992, 
Kono et al., 1994) and supported by recent studies on subjects with isolated 
obesity (Pascual et al., 2003, Chinali et al., 2006, Tumuklu et al., 2007, 
Wierzbowska-Drabik et al., 2013, Koopman et al., 2012, Barbosa et al., 
2013). This is believed to occur as an adaptation to the large intravascular 
volume resulting from excess adipose tissue as will be explained later in this 
chapter. A growing number of studies have challenged this observation by 
reporting a concentric LV morphology in healthy normotensive obese 
children and adults (Gutin et al., 1998, Peterson et al., 2004, Mitchell et al., 
2002, Wong et al., 2004, Avelar et al., 2007, Woodiwiss et al., 2008, De 
Simone et al., 2011). The duration and degree of obesity, the body fat 
content and distribution as well as haemodynamic, hormonal, metabolic and 
inflammatory factors are believed to be key determinants of LV morphology 
in uncomplicated obesity as will be discussed later in this chapter. 
2.2.2 Obesity and LV systolic function 
LV systolic function, or systole, refers to the contraction of the myocardium 
with subsequent ejection of blood out of the ventricle. It is influenced by 
preload, afterload and myocardial contractility. Preload refers to ventricular 
filling and is usually represented by LV end-diastolic volume (EDV) or 
diameter (LVIDd). LV filling pressure is measured by its surrogate E/Em, 
where E is early mitral inflow velocity and Em is early myocardial tissue 
velocity (Ommen et al., 2000). Stretching of the myocardium during diastolic 
filling results in stronger systolic contraction through the Frank-Starling 
mechanism. Afterload refers to the tension or stress that develops in the wall 
of the ventricle during contraction and is measured by its surrogate, end-
systolic wall stress (Norton, 2001, Colan et al., 1984). Myocardial 
contractility refers to excitation-contraction coupling and Ca
2+
 handling within 
the cardiac myocyte. The echocardiographic assessment of LV systolic 
function comprises standard echocardiographic parameters, tissue-Doppler 
imaging (TDI) and two-dimensional speckle tracking (2DST). 
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2.2.2.1 Standard echocardiography 
Ejection fraction (EF) is the most widely used measure of LV systolic 
function despite having low sensitivity and being strongly affected by HR, 
preload and afterload (Carabello, 2003). Nevertheless, it remains a popular 
and reliable indicator of general LV systolic performance. Obesity is 
associated with an increased intravascular volume and higher CO, in order 
to meet the high metabolic demands of excess adipose tissue. Higher CO is 
caused by a higher stroke volume (SV) as HR is usually unchanged in 
obese subjects. Studies have reported different findings in relation to EF in 
uncomplicated obesity. The majority of studies reported normal EF and/or 
FS in healthy obese adults and children, non-significantly different form non-
obese controls (Messerli, 1982, Nakajima et al., 1985, Koehler et al., 1989, 
Stoddard et al., 1992, Veille and Hanson, 1994, Peterson et al., 2004, 
Tumuklu et al., 2007, Wong et al., 2004, Lorch and Sharkey, 2007, Deng et 
al., 2010, Orhan et al., 2010, Barbosa et al., 2013, Koopman et al., 2012, 
Saltijeral et al., 2011, Yaseen, 2014). Nonetheless, a number of studies 
reported a reduced EF in otherwise healthy moderately obese adults; 
however two of these studies used radionuclide ventriculography, rather 
than echocardiography, which may explain the disparity from the 
echocardiographic studies given the difference in sensitivities in the two 
methods (Scaglione et al., 1992, Merlino et al., 1994). Karason et al. (1998) 
showed a reduced EF in healthy obese subjects compared to lean controls, 
however these subjects were morbidly obese referred for weight-reducing 
gastroplasty (BMI up to 47 kg.m
-2
) and were shown to have significantly 
higher systolic BP than controls (Karason et al., 1998). Finally, two studies 
reported reduced EF in moderately obese otherwise healthy adolescents 
(Chinali et al., 2006, Ingul et al., 2010). Interestingly, a supernormal EF was 
observed in obese adults and children by other studies (Di Salvo et al., 
2006, Iacobellis et al., 2002, Pascual et al., 2003, Di Bello et al., 2006). This 
disparity in findings may be related to differences in preload and/or afterload 
between study groups or differences in subject characteristics such as 
degree and duration of obesity, body composition and fat content and 
distribution. Finally, the presence of “hidden” undiagnosed comorbidities 
such as glucose intolerance, subclinical coronary disease, hypertension and 
metabolic disorders can sometimes not be excluded by simple history taking 
and even though these studies reported normal systolic blood pressure 
(SBP) in their studied subjects, hypertension still may be present as it 
cannot be excluded by a single reading.  
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2.2.2.2 Tissue-Doppler imaging (TDI) and two-dimensional 
speckle tracking (2DST) 
Tissue Doppler imaging (TDI) is an echocardiographic technique allowing 
the quantitative measurement of LV myocardial velocity, deformation and 
dyssynchrony (Yu et al., 2007). TDI is a relatively more sensitive and less 
load-dependent measure of LV contractility compared to EF in detecting 
subclinical global myocardial contractile dysfunction in uncomplicated 
obesity (Di Bello et al., 2006). 
Several studies have reported lower peak systolic myocardial velocity (Sm), 
both global and regional, in individuals with uncomplicated obesity 
compared to lean controls, despite both groups displaying similar EF (Di 
Bello et al., 2006, Peterson et al., 2004, Tumuklu et al., 2007, Wong et al., 
2004). Furthermore, Peterson et al. (2004) and Tumuklu et al. (2007) both 
reported significant inverse correlations between BMI and both global and 
regional Sm. Studies on obese children reported similar observations of 
reduced peak Sm only in the LV lateral wall with no change in the septum 
(Barbosa et al., 2013, Koopman et al., 2012, Saltijeral et al., 2011). This can 
be due to the tethering effect of the right ventricular overload which is one of 
the limitations of TDI as it does not distinguish between active and passive 
movements of the myocardium (Gulati et al., 1996). Two studies reported 
normal systolic myocardial velocity in obese children (Di Salvo et al., 2006) 
and adults (Orhan et al., 2010), however they displayed lower myocardial 
systolic strain and strain rate compared to controls.  
Myocardial performance index (MPI), also known as Tei index, is a TDI-
derived index of both systolic and diastolic function (Arnlov et al., 2004). It 
has the advantages of being easy to measure, reproducible, independent of 
preload, HR and ventricular morphology (Karatzis et al., 2009). Darbik et al. 
(2010) reported significantly higher Tei index in morbidly obese adults 
compared to controls denoting systolic and diastolic dysfunction 
(Wierzbowska-Drabik et al., 2013). 
Myocardial deformation, also know as “strain”, is a novel echocardiographic 
measure of myocardial systolic and diastolic function that can be measured 
using TDI or 2DST. Strain is defined as the change in length of a segment of 
the myocardium relative to its resting length (Dandel et al., 2009). Measures 
of systolic myocardial deformation include strain (S) expressed as a 
percentage and systolic strain rate (SRs) which is the rate of the 
deformation (Dandel et al., 2009). Myocardial deformation occurs in three 
directions during systole: longitudinal shortening, circumferential shortening 
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and radial thickening. Strain and SRs are novel echocardiographic 
measurements that allow the assessment of regional as well as global 
myocardial systolic and diastolic function. They are believed to be less load-
dependent and more sensitive than EF and myocardial velocity in detecting 
subclinical myocardial regional and global dysfunction (Shah and Solomon, 
2012). Myocardial deformation can be measured by TDI or 2D speckle 
tracking (2DST), the latter being more accurate and angle-independent. The 
TDI-derived S and SRs reported are in the longitudinal direction only due to 
the angle dependence of this technique (Dandel et al., 2009, Shah and 
Solomon, 2012). Several studies reported significant impairments in regional 
and/or global TDI-derived LV longitudinal S and SRs in obese healthy adults 
and children with preserved EF, FS and occasionally Sm (Di Salvo et al., 
2006, Koopman et al., 2012, Orhan et al., 2010, Tumuklu et al., 2007, Wong 
et al., 2004). Di Salvo argued that the reduced longitudinal deformation in 
the presence of increased preload is indicative of myocardial contractile 
dysfunction as longitudinal strain was previously shown to increase with 
increased preload (Herbots et al., 2004). 
Despite the advantages of TDI over conventional echocardiography, it still 
has its technical limitations. It is angle dependent, does not discriminate 
between active and passive ventricular motion and may be affected by 
translational motion of the whole heart (Barbosa et al., 2013, Orhan et al., 
2010). Also, TDI-derived myocardial velocity only examines one dimension, 
namely the long axis of the LV though it has been validated as an index of 
global LV function. 
2.2.2.3 Two-dimensional speckle tracking (2DST) 
Two-dimensional Speckle tracking (2DST) is more accurate, sensitive and 
superior to TDI in assessing myocardial deformation. It is angle 
independent, has low signal-to-noise ratio, measures deformation in the 3 
planes (longitudinal, circumferential and radial), can assess every region of 
the LV myocardium as well as myocardial twist during systole (Dandel et al., 
2009). Studies that used 2DST reported reduced global and regional 
myocardial deformation in obese subjects with preserved EF, however the 
directions in which impairment was reported have not been consistent. 
Some studies reported reduced systolic deformation in the longitudinal and 
circumferential but not radial directions (Binnetoglu, 2014, Yaseen, 2014) 
whereas others also reported reduced longitudinal and circumferential 
together with increased radial systolic strain and strain rate in obese 
subjects (Saltijeral et al., 2011). Others reported reduced systolic 
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deformation in the longitudinal and radial but not circumferential directions 
(Koopman et al., 2012) while others reported reduced circumferential and 
radial but not longitudinal systolic deformation in obese subjects compared 
to lean controls (Wierzbowska-Drabik et al., 2013). In a study by Kuznetsova 
et al. (2008) exploring the distributional characteristics of LV myocardial 
deformation in a random population, global longitudinal S and global radial 
SR were found to negatively correlate with WHR and body weight 
respectively (Kuznetsova et al., 2008).  
Left ventricular systolic torsion as well as the rotation of the base (B-rot) and 
apex (A-rot) can be measured by 2DST giving novel insight LV myocardial 
contractility. During systole, the LV base rotates clockwise whereas the apex 
rotates counter-clockwise, resulting from the opposite orientation of the 
subendocardial and subpericardial fibres and creating a twisting deformation 
called twist from which torsion is derived (twist normalised to LV length) 
(Notomi et al., 2005). Few studies have assessed LV rotation and torsion in 
healthy obese subjects. Deng et al. (2010) reported significantly lower apical 
and basal rotation, twist and torsion in obese compared to non-obese 
individuals (Deng et al., 2010). Interestingly, Saltijeral et al. (2012) reported 
significantly higher LV twist and torsion in obese children compared to 
controls (Saltijeral et al., 2011). 
Two-dimensional speckle tracking has some limitations which may partly 
explain this discrepancy. It depends on the quality of the 2D image and 
frame rates which can be challenging especially in obese subjects. Also, it 
measures the motion of the speckles in the image plane and hence 
misalignment between the speckles and the ultrasonic plane can lead to out 
of plane motion (Amundsen et al., 2006). Furthermore, the longitudinal 
displacement of the base can affect the speckle data obtained in the short-
axis view (Geyer et al., 2010). Longitudinal strain measurement has 
generally been shown to have better reproducibility than radial strain which 
may also explain the discrepancy in radial data (Geyer et al., 2010). 
2.2.3 Obesity and LV diastolic function 
LV diastolic function refers to the filling of blood from the left atrium (LA) to 
the LV across the mitral valve and is dependent on ventricular relaxation, 
which is an active energy-dependent process, and ventricular compliance, 
which is a passive process (Nishimura and Tajik, 1997). Diastole consists of 
4 phases; (1) isovolumic relaxation which is the short interval between aortic 
valve closure and mitral valve opening with no change in LV volume, (2) 
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early diastolic filling phase, which starts by the opening of the mitral valve 
and is dependent on the pressure differences between the LA and LV, (3) 
diastasis, which is a short period of little or no filling when the LA and LV 
pressures become equal, (3) late diastolic filling phase, during which LA 
contracts to expel the remaining blood into the LV (Little and Downes, 
1990). Echocardiographic measures of diastolic function include 
conventional pulse wave Doppler- (PWD-) derived diastolic transmitral filling 
patterns, TDI-derived diastolic myocardial velocities and deformation and 
2DST-derived diastolic myocardial deformation. The gold standard method 
for the assessment of LV diastolic function is the measurement of 
intracardiac pressures as an increase in diastolic filling pressure reflects a 
reduction in the distensibility of the ventricle. This is an invasive method and 
therefore has not been frequently employed in healthy obese subjects. 
E/Em is a validated echocardiographic index  of LV filling pressure as will be 
explained below. 
2.2.3.1 Pulse wave Doppler (PWD) echocardiography 
Conventional diastolic transmitral LV filling velocities, measured by PWD, 
include isovolumetric relaxation time (IVRT), early mitral inflow velocity (E), 
late mitral inflow velocity (A), E/A ratio and deceleration time of early mitral 
inflow wave (DCT). The patterns of transmitral diastolic filling associated 
with isolated obesity has been variable in the literature. While some studies 
reported a reduced E wave and increased A wave (Alpert et al., 1995b, 
Iacobellis et al., 2002), others reported a reduced E wave and unchanged A 
wave (Wong et al., 2004, Yaseen, 2014). Several studies, however, reported 
an increased A wave with an unchanged E wave (Barbosa et al., 2013, Di 
Bello et al., 2006, Koopman et al., 2012, Orhan et al., 2010, Wierzbowska-
Drabik et al., 2013). All these patterns, however, resulted in a reduction in 
E/A ratio which indicates a degree of diastolic dysfunction in healthy obese 
subjects. Nonetheless, several studies did not detect any change in neither 
E nor A waves in individuals with isolated obesity (Abdelazez, 2014, 
Binnetoglu, 2014, Chinali et al., 2006, Lorch and Sharkey, 2007, Pascual et 
al., 2003, Peterson et al., 2004, Saltijeral et al., 2011, Di Salvo et al., 2006). 
Interestingly, one study detected both higher E and A waves in mildly obese 
adults with no change in E/A ratio (Stoddard et al., 1992). With regards to 
DCT and IVRT, several studies reported a prolongation in both variables in 
healthy obese subjects (Alpert et al., 1995a, Binnetoglu, 2014, Di Bello et 
al., 2006, Di Salvo et al., 2006, Iacobellis et al., 2002, Koopman et al., 2012, 
Orhan et al., 2010, Karason et al., 1998, Wong et al., 2004) while a few 
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reported a unchanged DCT and IVRT (Chinali et al., 2006, Lorch and 
Sharkey, 2007). Despite being reliable and commonly used measures of 
diastolic function, PWD-derived transmitral filling  velocities are influenced 
by HR, preload and afterload and therefore TDI-derived myocardial diastolic 
velocities provide less-load dependent and more sensitive option for the 
detection of subtle diastolic dysfunction (Nishimura and Tajik, 1997, Garcia 
et al., 1998).  
2.2.3.2 Tissue Doppler Imaging 
TDI-derived diastolic myocardial velocity include early phase diastolic 
velocity (Em), late diastolic velocity (Am) and Em/Am ratio. The ratio of 
E/Em is a recognised surrogate for LV filling pressure and is usually 
reported as a measure of LV diastolic function. Patterns of diastolic 
myocardial velocities associated with isolated obesity have been variable in 
the literature. Some studies reported decreased Em and unchanged 
(Peterson et al., 2004, Wong et al., 2004, Orhan et al., 2010, Wierzbowska-
Drabik et al., 2013) or increased (Di Bello et al., 2006) Am while others 
reported unchanged Em and increased Am (Barbosa et al., 2013, Koopman 
et al., 2012, Lorch and Sharkey, 2007). Finally, some reports indicated no 
change in neither Em nor Am in obese children compared to controls 
(Binnetoglu, 2014, Saltijeral et al., 2011). The ratio of early transmitral 
diastolic velocity to early diastolic myocardial velocity (E/Em) is a validated 
index of LV filling pressure and has been shown to be increased in healthy 
obese adults and children by several studies (Di Bello et al., 2006, Di Salvo 
et al., 2006, Wierzbowska-Drabik et al., 2013, Wong et al., 2004, Koopman 
et al., 2012) however it was reported unchanged by others (Barbosa et al., 
2013, Saltijeral et al., 2011). 
TDI-derived diastolic deformation include early diastolic strain rate (SRe) 
and late diastolic strain rate (SRa). These variables are believed to reflect 
slowing of the rate of relaxation of the LV wall. Fewer studies have assessed 
TDI-derived diastolic longitudinal deformation in healthy obese subjects. Di 
Bello et al. (2006) and Koopman et al (2012) reported reduced longitudinal 
SRe in obese adults and children respectively (Di Bello et al., 2006, 
Koopman et al., 2012) whereas Lorch and Sharkey (2007) found it similar to 
controls (Lorch and Sharkey, 2007).  
2.2.3.3 Two-dimensional speckle tracking (2DST) 
Two-dimensional speckle tracking-derived myocardial diastolic deformation 
has not been thoroughly investigated in healthy obese subjects. One study 
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reported reduced circumferential and unchanged longitudinal and radial SRe 
in morbidly obese subjects (Wierzbowska-Drabik et al., 2013) whereas 
another study found reduced circumferential and longitudinal but preserved 
radial SRe in obese subjects compared to controls. This same study 
reported similar longitudinal, circumferential and radial SRa in both groups 
(Yaseen, 2014).  
From these studies reviewed above, it is evident that isolated obesity is 
associated with subtle but unfavourable changes in LV structure as well as 
systolic and diastolic function. The discrepancy between many of these 
studies could be related to the differences in the characteristics of the 
subjects enrolled including age, gender, degree and duration of obesity, 
degree of body fat content, body composition and fat distribution. Obesity is 
still defined according to BMI which does not separate adipose from muscle 
tissue, and hence individuals with similar BMIs may not necessarily have the 
degree of excess adipose tissue vs. muscle tissue. 
2.3 Pathophysiology of LV structural and functional changes 
in obesity 
Obesity mediates its detrimental impact on LV structure and function 
through several mechanisms, as seen above. The abnormal haemodynamic 
changes associated with obesity are well-established mediators of LV 
structural remodelling and functional disturbance in obese individuals. 
Several other factors have been identified and shown to play important roles 
in the process of obesity-related LV remodelling and systolic and diastolic 
dysfunction including  metabolic, hormonal and inflammatory factors 
secondary to lipotoxicity and myocardial fibrosis. The following section will 
review the evidence and theoretical basis of these mechanisms.  
2.3.1 Haemodynamic changes 
Obesity is associated with an expansion of the intravascular blood volume, 
due to the high metabolic demands of excessive adipose tissue, rich in 
vascular network, as well as non-adipose tissue including muscle and skin 
(Alexander, 1985). This expanded circulatory volume occurs in response to 
peripheral vasodilatation of capillary and arteriolar network within the 
adipose tissue and the reduction in peripheral vascular resistance. A 
subsequent increase in preload on the heart results in increasing LV 
diastolic filling and stretching of the myocardium resulting in a greater stroke 
volume via the Frank-Starling mechanism, with no change in HR (Alexander, 
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1985). It was suggested that renal sodium and water retention also 
contributes to the high blood volume associated with obesity (Abel et al., 
2008). The increased preload and excessive stretching of the myocardium 
results in LV dilatation and eccentric hypertrophy, ie. chamber dilatation with 
no change in wall thickness (Alpert et al., 1995a, Abel et al., 2008) which is 
initially compensatory and not accompanied by functional disturbance. 
Prolonged exposure to chronic volume overload,  LV wall stress increases 
secondary to chamber dilatation, according to Laplace’s law, exerting an 
increased afterload on the LV and resulting in compensatory thickening of 
the myocardium, pathological remodelling and eventual concentric 
hypertrophy with subsequent systolic and diastolic dysfunction and heart 
failure (Lavie and Messerli, 1986). It is believed that diastolic dysfunction 
precedes systolic dysfunction in the form of myocardial stiffness and 
impaired relaxation (Alpert et al., 1995a). Indeed, Di Divitis et al. (1985) 
reported increased pulmonary vascular resistance, pulmonary capillary 
wedge pressure, pulmonary artery pressure, right ventricular end-diastolic 
pressure in morbidly obese subjects. This sequence of pathological events 
has been the predominant notion for decades before several studies 
reported concentric LVH in healthy obese subjects which contradicts this 
notion. Several authors suggested that eccentric LV hypertrophy is in fact a 
late outcome in the course of obesity secondary to prolonged exposure to 
volume expansion. It was suggested that early in obesity, in addition to 
increased preload, an increased afterload is also present secondary to 
arterial stiffness in the peripheral arterial network with subsequent increased 
peripheral vascular resistance leading to compensatory LV concentric 
hypertrophy with subclinical systolic and diastolic dysfunction (Peterson et 
al., 2004, Binnetoglu, 2014, Di Bello et al., 2006). This was supported by 
reports of an enlarged aortic diameter and arterial stiffness in the absence of 
hypertension in obese subjects (Nemes et al., 2008). Iacobellis et al. (1992) 
however, reported normal LV size and morphology, enlarged aortic root and 
supernormal ejection fraction in normotensive obese subjects suggesting 
that the hyperkinetic systole and enlarged aorta are both a result of 
increased preload rather than afterload  and that the earliest impairment in 
LV function that results from LV hypertrophy is myocardial stiffness which is 
manifested by impairment of the late phase of diastolic filling (Iacobellis et 
al., 2002).  
Finally, it is now recognise that the haemodynamic changes alone cannot 
explain the detrimental LV morphological and functional changes associated 
with obesity and that a combination of several factors such including fatty 
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infiltration, myocardial fibrosis and hormonal, metabolic and inflammatory 
changes all play important roles alongside haemodynamic changes (Abel et 
al., 2008, Alpert, 2001, Wong et al., 2004, Wong and Marwick, 2007a). 
2.3.2 Lipotoxicity or myocardial steatosis 
Obesity is associated with a high fatty acid (FA) uptake and conversion into 
triglyceride (TG) droplets that accumulate in the cytosol of cardiac myocytes. 
This  accumulation of fat in cardiac myocytes, is termed lipotoxicity or 
myocardial steatosis (Sacks and Fain, 2007, Wong and Marwick, 2007a). 
The high fatty acid uptake is secondary to high circulating free FAs as well 
as direct fatty infiltration from the epicardial adipose tissue (EAT) after 
excessive fat accumulation (Sacks and Fain, 2007). EAT is the visceral fat 
depot of the heart. It is normally located along the atrio-ventricular and inter-
ventricular grooves and as adipose tissue accumulates with obesity it 
spreads to cover the surface of the ventricles (Figure 2.1). It is characterised 
by having a strong capacity to freely uptake and release free FAs. In the 
absence of obesity, it is believed to protect the heart against exposure to 
high levels of free FAs and provide the heart with energy needs. However, 
as obesity progresses and accumulation of fat in the EAT increases it 
releases FAs directly into the myocardium which, together with the vascular 
delivery of free FAs, causes decrease in the FA oxidative capacity of cardiac 
myocytes which can no longer cope with the FA delivery, leading to cellular 
lipid accumulation, lipotoxicity and myocardial steatosis (Sacks and Fain, 
2007). In a study by Kankaanpaa et al. (2006) an increase in myocardial 
triglyceride content, detected by spectroscopy, was strongly associated with 
EAT mass, WHR free, FA levels and LVM (Kankaanpaa et al., 2006). 
Myocardial steatosis and lipotoxicity results in metabolic disturbances within 
the cardiac myocytes, notably mitochondrial disturbance and alterations in 
substrate utilization as well as release of pro-inflammatory cytokines, 
myocardial fibrosis and apoptosis with subsequent contractile disfunction, as 
will be explained below. 
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Figure 2. 1 Macroscopic appearance of epicardial adipose tissue. 
Epicardial adipose tissue tends to be distributed along the atrio-
ventricular and inter-ventricular grooves (black arrows), extending to 
cover the ventricular surface as adipose tissue accumulates. 
2.3.3 Cellular metabolic disturbance 
Obesity is associated with metabolic disturbances within the cardiac 
myocytes. Animal studies have shown detrimental alterations in substrate 
utilization in in cardiac myocytes isolated from obese mice models. This 
consisted of an increase in FA oxidation and a reciprocal decrease in 
glucose oxidation and this was observed prior to detectable changes in 
cardiac function on isolated hearts (Buchanan et al., 2005). These changes 
are believed to result from increased FA delivery to cardiac myocytes, 
impaired insulin signaling and activation of transcriptional pathways resulting 
in increased expression of genes involved in FA import (Abel et al., 2008).. 
Additionally, obesity is associated with mitochondrial dysfunction whereby 
an increase in mitochondrial oxygen consumption is accompanied by a 
decrease in ATP production, a condition termed mitochondrial uncoupling. 
This further increases FA utilization and subsequent release of pro-
inflammatory cytokines, fibrosis, apoptosis and myocardial contractile 
dysfunction (Abel et al., 2008).  
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2.3.4 Inflammation 
Myocardial steatosis and lipotoxicity result in intracellular accumulation of 
toxic byproducts of FA oxidation, increased oxidative stress within cardiac 
myocytes with resultant increased production of reactive oxygen species 
(ROS) and pro-inflammatory cytokines including interleukin-6 (IL-6), atrial 
natriuretic peptide (ANP) and tumour necrosis factor (TNF). This results in 
subsequent cellular damage, myocardial fibrosis and dysfunction (Abel et 
al., 2008, Wong and Marwick, 2007b). Furthermore, EAT accumulation 
results in paracrine release of pro-inflammatory adipokines including TNF-
alpha, MCP-1, IL-1β, IL-6, IL-8 and others resulting in inflammation, fibrosis, 
apoptosis, disturbance in signalling pathways and subsequent contractile 
dysfunction (Sacks and Fain, 2007).  
2.3.5 Hormonal alterations 
Obesity is associated with several hormonal alterations including insulin 
resistance, leptin insensitivity and reduced adiponectin expression (Wong 
and Marwick, 2007b). Excess adipose tissue causes impaired intracellular 
insulin signaling in the heart as shown by animal studies. Insulin resistance 
is believed to be responsible for detrimental outcomes in cardiac myocytes 
via several mechanisms. Insulin resistance reduces glucose uptake and 
increase FA oxidation, change cardiac myocyte gene expression, promote 
cellular apoptosis and dysfunction and increase myocardial susceptibility to 
injury when exposed to pressure overload or chronic adrenergic stimulation 
(Abel et al., 2008, Wong and Marwick, 2007b). Furthermore, insulin 
resistance can result in compensatory hyperinsulinema and binding of 
insulin to insulin-like growth factor-1 receptors on cardiac myocytes resulting 
in their proliferation and differentiation which could explain the strong 
association between insulin resistance and LV hypertrophy (Abel et al., 
2008). Furthermore, hyperinsulinema leads to an increase in 
angiotensinogen level and subsequently angiotensin II which is a potent 
growth factor for cardiac myocytes promoting cell proliferation, hypertrophy, 
apoptosis and fibrosis and leading to myocardial dysfunction (Wong and 
Marwick, 2007b). Several studies reported a strong association between 
fasting insulin level and diastolic dysfunction suggesting an action of insulin 
on LV relaxation (Iacobellis et al., 2002, Wong et al., 2004, Mureddu et al., 
1998). Moreddu suggested that insulin resistance can cause impairment of 
myocardial actin-myosin cross-links due to lack of Ca
2+
 re-uptake from the 
sarcoplasmic reticulum (Mureddu et al., 1998). Furthermore, there is a 
strong association between hyperinsulinema, insulin growth factor-1 (IGF-1) 
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and left ventricular hypertrophy in obese subjects (Ohya et al., 1996) and 
concentric remodelling suggesting that insulin resistance plays a role in LV 
concentric hypertrophy. Additionally, Di Bello et al. (2006) showed a strong 
correlation between insulin resistance, LVMI and myocardial systolic and 
diastolic deformation and velocity, further supporting that insulin resistance 
plays a role in LV hypertrophy and dysfunction and increased myocardial 
collagen content in obesity. Kosmala et al. (2012) showed significant inverse 
correlations between insulin resistance and systolic and diastolic 
deformation and velocity further suggesting an impact of insulin resistance 
on LV dysfunction (Kosmala et al., 2009). Indeed, Di Bello et al. (2006) 
reported a strong association between insulin resistance and altered 
myocardial reflectivity seen on integrated backscatter indicating increased 
myocardial fibrosis and/or steatosis and lipoapoptosis in severly obese 
subjects (Di Bello et al., 2006). Obesity is also associated with leptin-
resistance and reduced adiponectin expression which induces apoptosis 
and results in LV contractile dysfunction. 
2.4 Impact of aerobic exercise training on LV structure and 
function in obesity 
The benefits of aerobic training on cardiovascular function are well-
established (Blomqvist and Saltin, 1983). A large body of evidence show 
that aerobic training induces favourable cardiac structural and functional 
adaptations resulting in improvement of cardiac performance in healthy 
individuals as well as cardiac patients (Blomqvist and Saltin, 1983, Erbs et 
al., 2003, Giannuzzi et al., 2003, Levy et al., 1993, Shapiro and Smith, 1983, 
Smart et al., 2006, Smart et al., 2007, Spina et al., 1992a, Spina et al., 
1992b). Of particular importance, are the LV structural and functional 
adaptations to aerobic training in obese individuals. Recent evidence 
suggest that aerobic training alone can reverse obesity-mediated LV 
pathological remodelling and restore normal systolic and diastolic function in 
otherwise healthy obese individuals without the need to reduce body weight 
through caloric restriction (Morrison et al., 1986, Vogelsang et al., 2008, 
Ingul et al., 2010, Schuster et al., 2012). This can be of particular benefit in 
obese individuals who struggle or are unable to reduce their body weights, 
protecting them from the detrimental outcomes of obesity on the heart, 
slowing down or reversing the pathological development of obesity 
cardiomyopathy and eventual heart failure. The following section will review 
what is known about LV structural and functional adaptations to aerobic 
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exercise in healthy obese individuals. First, the systolic and diastolic 
functional response to exercise in obese individuals will be reviewed. Next, 
the structural, morphological and functional adaptations to long term aerobic 
training in healthy obese individuals will be reviewed. Finally, the impact of 
exercise intensity and benefits of aerobic interval training will be outlined. 
2.4.1 LV functional response to exercise in obesity 
Physical exercise subjects the heart to a form of physiological and metabolic 
stress and therefore, in obese individuals, extra effort is required from the 
heart to meet the high metabolic demands of the working muscles in 
addition to the excess adipose tissue. The normal physiological 
cardiovascular response to aerobic exercise consists of haemodynamic 
changes paralleled by LV functional alterations in order to meet the oxygen 
demands of the working muscles. During aerobic exercise, peripheral 
vasodilatation and the pumping action of the working skeletal muscles result 
in expansion of central blood volume with a resultant increase in LV venous 
return. Despite the increased venous return, the LV diastolic filling volume 
and end-diastolic diameter remain constant, as a protective mechanism 
against stretch-induced rise in LV wall stress according to Laplace’s law 
(Rowland, 2008). A decrease in LV end-systolic diameter and volume, 
together with a rise in heart rate can result in increased stroke volume and 
cardiac output. The reduced LV end-systolic diameter is achieved by an 
enhanced LV systolic contractile performance, represented as a greater 
speed, force and acceleration of contraction in a shorter time. (Rowland, 
2008). This is manifested on echocardiography as decreased ejection time, 
increased ejection fraction, fractional shortening, systolic blood flow velocity 
and systolic myocardial velocity, circumferential and longitudinal shortening 
and torsion (Rowland, 2008). With regards to LV diastolic function during 
exercise, it parallels the systolic functional response with shortening of 
diastolic time intervals and increased diastolic filling rates, myocardial 
relaxation, circumferential and longitudinal elongation and LV diastolic 
untwisting (Rowland, 2008). All these changes progressively increase with 
increasing exercise intensity, with the exception of stroke volume that only 
rises initially then remains stable. 
Within the context of obesity, studying the LV response to exercise in obese 
individuals can be viewed, on one hand, as an additional diagnostic tool to 
detect subtle reductions in LV systolic and diastolic contractile performance 
that are only detectable under the additional stress of exercise on the heart. 
On the other hand,  it allows the understanding of the long-term exercise-
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induced LV structural and functional adaptations in obese subjects and 
whether their response to exercise differs from non-obese individuals. The 
following section will review what is known about the LV systolic and 
diastolic functional response to aerobic exercise in healthy obese 
individuals.. 
2.4.1.1 LV systolic function during exercise in obesity 
Studies that have explored cardiac response to exercise in healthy obese 
subjects are very limited and have reported somewhat disparate findings. In 
one of the earliest studies, Alpert et al. (1989) assessed the EF response to 
maximal exercise in 23 morbidly obese (≥ twice Ideal Body Weight; IBW) 
otherwise healthy men and women, using radionuclide ventriculography at 
the end of an incremental supine cycling session (Alpert et al., 1989). The 
cohort was divided into 2 groups according to the presence or absence of 
LVH. It was found that, despite both groups having similar resting EF, a 
significant (11 ± 10%) increase in EF at peak exercise was detected in the 
group with normal LVM whereas no significant change was seen in the LVH 
group. Both groups had similar magnitudes of change in HR and mean BP 
(MBP) from rest to peak exercise. Additionally, a strong significant 
correlation was reported between %IBW and LVM which inversely 
correlated with exercise-delta EF. Alpert concluded that the degree of 
obesity determines the degree of LVH and consequently the EF response to 
exercise (Alpert et al., 1989). Licata (Licata et al., 1992) confirmed and 
extended these observations by assessing the impact of both the degree 
and duration of obesity on the EF response to maximal exercise in 29 
overweight and moderately obese adults using radionuclide 
ventriculography. A significant ( >5%) increase in EF at maximal exercise 
was shown only in the overweight group with no significant change in the 
moderately obese group. On subdividing the groups according to the 
duration of obesity, only the overweight subjects that had been overweight 
for less than 10 years showed a significant increase in EF at maximal 
exercise whereas the moderately obese group did not show any significant 
change in EF regardless of the duration of obesity. Both groups, however 
had non-significantly different LVM and LVMI. Exercise-delta EF significantly 
and negatively correlated with the duration of obesity but not BMI or resting 
EF (Licata et al., 1992). Licata concluded that the degree and duration of 
obesity are useful predictors of LV systolic functional reserve in subjects 
with normal LVM. These two studies that early in obesity and before the 
development of LVH, overweight/obese individuals display enhanced LV 
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systolic function during exercise, a response that is lost as obesity 
progresses further. Reports from Ferraro et al. (1996) also showed poor LV 
systolic response to exercise in severely obese adults as, in addition to 
having significantly lower EF at rest, they showed no change in EF during 
submaximal supine cycling whereas a significant (~5%) increase was 
detected in the control group (Ferraro et al., 1996). Sasso et al. (2005) 
extended these findings by showing that, despite having a significantly 
higher EF at rest, overweight and moderately obese adults displayed 
significantly lower exercise-induced increase in EF during supine cycling at 
75 W load compared to lean controls (Sasso et al., 2005). Furthermore, the 
exercise-induced increase in EF was significantly higher during insulin 
infusion in both groups. Sasso concluded that, even though 
overweight/obese subjects displayed higher resting EF than lean controls, 
possibly reflecting an initial compensatory increase in systolic function, 
exercise revealed a reduction in systolic function which is likely related to 
insulin resistance (Sasso et al., 2005). This conclusion, however needs to 
be validated by more sensitive, less load-dependent measures of systolic 
function such as TDI and 2DST-derived myocardial velocity, deformation 
and torsion, as EF despite being a reliable indicator of LV general systolic 
performance, it does not assess myocardial contractility and is highly 
influenced on changes in HR, preload and afterload. 
Other studies have compared obese and lean subjects with regards to their 
cardiac output (CO), cardiac index (CI; CO/BSA), stroke volume (SV) and 
stroke volume index (SVI) responses to exercise. Salvadori et al. (1999) 
compared cardiac performance of moderately to severely obese subjects at 
rest and during upright cycling at 40 W and 70 W to non-obese controls 
(Salvadori et al., 1999). Obese subjects had similar resting but higher 
exercise CO compared to lean controls, however they had similar resting but 
lower exercise CI at 40 W and 70 W compared to lean counterparts. A 
significant inverse correlation was found between CI and work rates in both 
groups with a significantly lower slope in the obese group than controls. 
Salvadori concluded that cardiac performance in obese subjects, although 
similar to non-obese subjects at rest, is less efficient during progressive 
exercise. Giordano et al. (2003) also reported significantly reduced peak CI 
in obese children, compared to controls despite both groups displaying 
similar resting CI (Giordano et al., 2003).  
These findings were challenged by (Rowland et al., 2003) who reported 
higher resting and exercise SV and CO throughout an incremental upright 
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cycling session until maximal exercise in moderately obese young girls 
compared to lean counterparts, and maximal CI  was not significantly 
different. Rowland concluded that excess body fat does not reduce cardiac 
functional capacity in moderately obese adolescent females and that on the 
contrary significantly greater SV and CO were manifested at peak exercise 
(Rowland et al., 2003). Interestingly, Vella et al. (2009) showed significantly 
higher resting and exercise absolute CO and SV as well as EF in overweight 
and moderately obese adults during upright cycling at 50, 75 and 100 W 
compared to controls (Vella et al., 2009). In fact significantly higher exercise-
induced change in SV and EF were detected in the obese group compared 
to controls. In another study, Vella et al. (2011) assessed cardiac 
performance throughout an incremental upright cycling session until 
exhaustion and reported that, in moderately obese adults resting and 
maximal CI and SVI were non-significantly different from controls, however 
they were significantly higher throughout the incremental exercise session. 
With regards to EF, it was significantly lower in the obese group at rest and 
throughout the incremental exercise but reached similar values to the control 
group at submaximal and maximal exercise.  
Ingul et al. (2010) were the first to assess TDI-derived LV myocardial 
velocity and deformation in addition to haemodynamic parameters during 
exercise in obese subjects (Ingul et al., 2010). This was carried out before 
and after a 3 months heavy-intensity interval training programme. In 
comparison to lean controls, the obese group displayed significantly lower 
systolic function both at rest and during upright cycling at 100 W compared 
to lean controls, represented as lower mitral annulus excursion (MAE), 
velocity time integral of the LV outflow tract (VTILVOT), maximum velocity of 
LVOT (VmaxLVOT), peak systolic myocardial velocity (Sm), global strain and 
systolic strain rate. After the 3-months exercise intervention, with the 
exception of VmaxLVOT  and Sm, systolic function increased in the obese 
group to similar values as the lean controls both at rest and during exercise 
without any weight reduction. At rest, VmaxLVOT was similar in both groups, 
however it was significantly lower in the obese group during exercise 
compared to controls. The opposite was true with regards to Sm as it was 
significantly lower at rest but increased to become similar to the control 
group during exercise. This study, however did not compare the exercise-
deltas of systolic function between both groups. 
A recent study by Shuster et al. (2012) assessed global and regional LV 
systolic performance using TDI echocardiography in first and second degree 
46 
 
obese young boys throughout an incremental supine cycling session until 
exhaustion. It was shown that the obese group had significantly higher 
absolute SV and CO at rest, throughout the incremental exercise and at 
maximal exercise compared to controls. However, CI and SVI were non-
significantly different in both groups neither at rest nor throughout exercise. 
As for FS and Sm, both mild and moderately obese children displayed non-
significantly different values at rest and throughout the incremental exercise, 
In moderately obese children both measures levelled off at submaximal and 
maximal exercise to significantly lower levels compared to both lean and 
mildly obese children. This further confirms the presence of subtle systolic 
dysfunction in obese individuals that could only be detected during near 
maximal exercise. 
In conclusion, it appears that in early, mild/moderate obesity, before 
pathological LVH, LV systolic functional response to exercise is similar, if not 
superior, to non-obese individuals with some evidence of reduced functional 
capacity at maximal exercise only. More severely obese individuals appear 
to  display reduced cardiac systolic capacity during exercise. The existing 
evidence is still not conclusive enough as very few studies assessed LV 
functional response to exercise using novel techniques that give a more 
sensitive and load-independent indication of systolic function. Furthermore, 
the discrepancy between studies could be related to the different imaging 
techniques employed, mode of exercise (supine, semi-supine or upright) 
and intensity used. Also, the assessment of the pattern of change in LV 
performance throughout an entire incremental exercise session gives more 
information than the assessments at fixed time points. For instance, Vella et 
al. (2009) showed that SV was similar in both obese and non-obese groups 
at rest and maximal exercise, however it was significantly higher in the 
obese group throughout the incremental exercise session (Vella et al., 
2009). Finally, metabolic and hormonal factors might also play an important 
role such as insulin resistance was shown by (Sasso et al., 2005). This is of 
particular relevance when defining the type of obesity ie. peripheral vs. 
visceral fat distribution. 
2.4.1.2 LV diastolic function during exercise in obesity 
Fewer studies have assessed LV diastolic performance during exercise in 
healthy obese individuals. In an early study, Alexander and Peterson (1972) 
reported abnormally elevated LV end diastolic pressure (LVEDP) during 
supine cycling, measured by intracardiac catheterization, in nine morbidly 
obese adults (> twice IBW) (Alexander and Peterson, 1972). This persisted 
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even after profound weight loss. The authors attributed this high LVEDP to 
LV diastolic dysfunction secondary to decreased compliance associated with 
myocardial hypertrophy. Consistent with these results, Ingul et al. (2010) 
reported significantly higher E/Em ratio, an well-validated echocardiographic 
surrogate marker of LVEDP, and lower Em, both at rest and during upright 
cycling at 100 W, in moderately obese compared to lean adolescents (Ingul 
et al., 2010). Interestingly, after the obese group completed a 3 months 
heavy-intensity interval training programme, both E/Em ratio and Em 
decreased to similar values as non-obese controls both at rest and during 
exercise without any accompanying weight reduction. Sasso et al. (2005) 
compared peak flow rate (PFR), a measure of LV diastolic function, using 
angioscinthigraphy, in overweight and obese adults compared to lean 
controls at rest and during supine cycling at 75 W  (Sasso et al., 2005). 
Obese subjects had significantly lower resting and exercise PFR, which did 
not change during insulin infusion suggesting that LV diastolic dysfunction in 
obesity is unlikely related to insulin resistance. Schuster et al. (2012) 
compared LV performance during an incremental exercise session in the 
semi-supine position in mild and moderately obese children and non-obese 
controls on  (Schuster et al., 2012). All 3 groups showed similar E velocity at 
rest, incremental and maximal exercise. At all stages of assessment, the 
mildly obese children showed significantly higher Em than controls whereas 
the moderately obese children showed significantly lower Em than controls. 
Shuster suggested that early in lower degrees of obesity, a compensatory 
increase in diastolic function is seen during exercise in order to optimise 
increased diastolic filling, however, with more severe degrees of obesity, 
eventual diastolic dysfunction occurs. This study also reiterates the 
importance of using sensitive and relatively load-independent techniques 
such as TDI  in order to detect subtle changes in function not detected by 
standard PWD.  
As shown by the above studies, obese subjects do manifest a reduced LV 
diastolic function both at rest and during exercise compared to non-obese 
counterparts, however no comparison has been made with regards to the 
amount of change during exercise. Mild to moderate degrees of obesity 
appear to have compensatory increase in diastolic function both at rest and 
during aerobic exercise, however, more studies are required for this 
conclusion to be validated. 
In conclusion, to date an accurate comparison LV response to exercise in 
obese and non-obese healthy individuals using sensitive, load-independent 
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echocardiographic techniques are lacking. More importantly, the proper 
matching of participants for exercise intensity domain is crucial. None of the 
previous studies reviewed above have  accounted for individual differences 
in lactate threshold (LT) and VO2max, alternatively participants exercised at 
fixed work rates and would have been exercising at different intensities from 
each other. This can potentially result in errors in the conclusion as the heart 
would be subjected to different intensities within participants of the same 
study or participants in-between studies. 
2.4.2 LV structural adaptation to aerobic exercise training in 
obesity 
Generally, long-term aerobic exercise training is known to result in 
significant alterations in LV structure, consisting of eccentric hypertrophy ie. 
increase in chamber diameter and wall thickness, accompanied by systolic 
and diastolic adaptations. This process is called exercise-induced cardiac 
remodelling (Weiner and Baggish, 2012). In addition to the type of exercise 
and the duration and intensity of training, the extent of exercise-induced 
cardiac remodelling is also determined by gender, race and genetic factors 
(Weiner and Baggish, 2012). In this section, the structural and functional LV 
adaptations to long-term aerobic exercise training in obese individuals will 
be reviewed. It should be noted that the following review will only include 
longitudinal studies involving healthy overweight and/or obese individuals 
free of any cardiovascular co-morbidities. Additionally, only studies involving 
aerobic endurance training in the form of walking, running, cycling or rowing 
will be considered and studies including dietary interventions will be 
excluded. 
2.4.2.1 Impact of aerobic training on LV structure in obesity 
Reports from longitudinal studies exploring the influence of aerobic training 
on measures of LV size and morphology in healthy normotensive obese 
subjects have been somewhat inconsistent. Several studies showed no 
significant change in either LV size or morphology following aerobic training 
(Baynard et al., 2008, Eriksson et al., 2010, Millen et al., 2014, Mitchell et al., 
2002, Stewart et al., 2006). These studies involved overweight and/or 
moderately obese adults and used a variety of training durations and 
intensities including 6 months low-intensity training (Eriksson et al., 2010), 6 
months mixed moderate-intensity continuous endurance and strength 
training (Stewart et al., 2006, 6 weeks moderate-intensity continuous or 
heavy-intensity interval training (Millen et al., 2014) and 10 days heavy-
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intensity interval training. Mitchell et al. (2002) reported a slight increase in 
diastolic LV posterior wall thickness (PWTd), diastolic interventricular 
septum thickness (IVSTd) and diastolic LV internal diameter (LVIDd) after 8 
months moderate-intensity training in obese adolescents but no change in 
LVM or LVMI was observed (Mitchell et al., 2002). Two studies reported a 
post-training increase in LVM following aerobic training. Humphries et al. 
(2002) reported an increase in absolute LVM, but not LVMI, with no change 
in RWT in children after 4 months of aerobic training at a HR > 150 bpm 
(Humphries et al., 2002). Furthermore, an association between the training-
induced increase in LVM and decrease in heart rate reactivity was reported, 
indicating that those that improve the most in fitness are more likely to 
increase LVM. It was noted that a significant decrease in fat mass and 
increase in fat-free mass was reported post-training. Vogelsang et al. (2008) 
reported a post-training increase in LVM and LV EDV in 10 moderately 
obese adults after 8 weeks of moderate intensity rowing, attributing these 
changes to the Frank-Starling mechanism (Vogelsang et al., 2008). 
Vogelsang argued that increased EDV indicates an increased preload in 
response to training that has possibly increased the chamber diameter, 
stretching its walls and causing reflex eccentric hypertrophy to diminish wall 
stress (Vogelsang et al., 2008). It should be noted that this study used MRI 
which is more sensitive than echocardiography. Finally, only one study 
reported a reduction in LVM with no change in RWT or EDV following 8 
weeks of low-intensity aerobic training in 10 moderately obese adults 
(Schuster et al., 2012). It was noted that the subjects involved had severe 
concentric LVH (average LVM = 234.6 ± 16.9 g) before training which may 
explain the exercise-induced reverse remodelling via reduction in LVM as 
opposed to the increase or no change in LVM in the previously mentioned 
studies in which LVM values were all within normal range before 
interventions. The training intensities and durations varied greatly among 
these studies which may partly explain the discrepant results. Also, changes 
in body composition could play a role as some of these studies reported a 
reduction in fat percentage following training whereas others reported an 
increase in muscle mass. 
2.4.2.2 Impact of aerobic training on LV systolic function in 
obesity 
With regards to standrard echocardiographic measures of systolic function, 
reports have been disparate. Vogelsang et al. (2008) reported a post-
training increase in EDV and SV with no change in EF, measured by MRI, in 
50 
 
10 moderately obese adults after 8 weeks of moderate intensity training and 
(Vogelsang et al., 2008) whereas Sijie et al. (2012) reported an increase in 
EF and a reduction in resting HR in overweight women after 12 weeks of 
either heavy-intensity interval training or moderate intensity continuous 
training (Sijie et al., 2012). Two studies (Ingul et al., 2010, Schrauwen-
Hinderling et al., 2010) reported a post-training increase in both SV and EF 
following 13 weeks of heavy intensity interval training and 12 weeks of 
combined moderate intensity endurance and resistance training 
respectively. Eriksson et al. (2010) reported a slight increase in mitral 
annular excursion (MAE) by standard M-mode echocardiography with no 
change in FS following 6 months low-intensity training in moderately obese 
women, whereas Ingul et al. (2010) reported an increase in both these 
measures following 13 weeks heavy-intensity interval training in obese 
adolescents.  
With regards to LV myocardial velocity and deformation, one study reported 
an increase in systolic TDI-derived myocardial velocity (Sm), longitudinal 
strain (LongS) and longitudinal systolic strain rate (LongSRs) in addition to 
standard measures of LV systolic function including SV, EF, MAE and 
LVOTVTI following 13 weeks of heavy-intensity interval training in obese 
adolescents (Ingul et al. 2010), whereas another study reported a post-
training increase in TDI-derived LongS and LongSRs with no change in EF, 
SV, CO or Sm after 8 weeks of low-intensity aerobing training in moderately 
obese adult men (Schuster et al., 2011). Schuster also reported a decrease 
in systolic intraventricular dysynchrony following training. Both these studies 
also reported a post-training reduction in body fat content, in particular 
visceral fat.  
Finally, some studies failed to detect any changes in LV systolic function 
following aerobic training in healthy obese normotensive subjects. Mitchell et 
al. (2002) reported no change in either LV structure or mid-wall fractional 
shortening (MFS) in obese adolescents following 8 months of moderate or 
heavy-intensity aerobic training (Mitchell et al., 2002). Similarly, Humphries 
et al. (2002) showed no training-induced change in CO or MFS despite an 
increase in LVM following 4 months of aerobic training at a HR > 150 bpm in 
obese children (Humphries et al., 2002). Baynard et al. (2008) showed that 
10 days of heavy-intensity aerobic training did not result in any change in LV 
structure of MFS in obese adults with or without metabolic syndrome 
(Baynard et al., 2008). Finally, Millen et al. (2014) reported no training-
induced change in EF, MFS or Sm in overweight and obese adults after 6 
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weeks of either moderate intensity continuous or heavy-intensity interval 
training (Millen et al., 2014).  
2.4.2.3 Impact of aerobic training on LV diastolic function in 
obesity 
Most studies that have used standard pulse wave Doppler echocardiography 
to assess LV diastolic filling velocities (E, A and E/A ratio) in healthy obese 
subjects following aerobic training found no significant change after training. 
Two studies reported significant reductions in DCT and IVRT following 13 
weeks of heavy-intensity interval training in obese adolescents (Ingul et al., 
2010) and 8 weeks of low-intensity training in 10 obese adults (Schuster et 
al., 2011). With regards to diastolic myocardial velocity, they reported an 
increase in TDI-derived Em post-training whereas Millen et al. (2014) 
reported no change in either LV diastolic filling velocities or Em after 6 
weeks of either moderate or heavy-intensity training in overweight and 
obese adults (Millen et al., 2014). One study assessed diastolic LV 
dyssynchrony using TDI and diastolic myocardial deformation using 2D 
speckle tracking echocardiography and reported a significant increase in 
both diastolic dyssynchrony and SRe in healthy obese adults after 8 weeks 
of low-intensity aerobic training (Schuster et al., 2011). Despite a lack of 
training effect on diastolic function, Stewart et al. (2005) showed a negative 
correlation between the training-induced increase in both E wave and E/A 
ratio and the decrease in abdominal fat and insulin level (Stewart et al., 
2005). Additionally, in a stepwise regression model, the reductions in 
abdominal fat and insulin accounted for 7% and 5% respectively of the 
variance of E wave. Subjects in this study were 51 overweight to mildly 
obese men and women (mean age 63.6 ± 5.7 years) and training involved 
26 weeks of 15 min resistance training followed by 45 min of moderate-
intensity aerobic training. Finally, Eriksson et al. (2010) reported no 
significant change in diastolic function following 6 months low intensity 
training in mildly obese adults, neither did Millen et al. (2014) following 6 
weeks of either moderate intensity continuous or heavy-intensity interval 
training. 
2.4.3 Factors determining aerobic training effects on LV structure 
and function in obese subjects 
The disparity between studies with regards to LV structural and functional 
adaptation to aerobic exercise training can likely be attributed to a number of 
factors that will be discussed below. These include factors related to the 
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subjects enrolled in each study in terms of age, gender, degree and duration 
of obesity, degree of visceral adiposity and baseline LV structure and 
function. the technique used in the assessment of LV structure and function 
can also explain this variability including its sensitivity, accuracy and degree 
of load-dependence. Finally, the exercise training intervention employed, its 
intensity, session duration, number of sessions per week and total duration 
of intervention, training intensity and mode of training ie. continuous versus 
interval.  
2.4.3.1 Subject characteristics 
Subjects enrolled in the studies discussed above included a wide range of 
age groups. This included children (Humphries et al., 2002), adolescents 
(Mitchell et al., 2002, Ingul et al., 2010), young to middle aged adults 
(Vogelsang et al., 2008, Baynard et al., 2008, Schuster et al., 2011, Millen et 
al., 2014) and older adults (Stewart et al., 2005, Eriksson et al., 2010). 
These differences make comparison between studies difficult. De Simone et 
al. (1995) showed that the variability of LVM in relation to height increases 
during human growth and that the allometric power exponent of LVM versus 
height in adults and children is lower that that derived for the entire age 
spectrum (de Simone et al., 1995). Hence, LVM/height
2.7
, which is the most 
widely used scaling method in cardiac research, may not be appropriate 
when comparing studies involving different age groups. Furthermore, studies 
have used different scaling methods to normalise for body size differences, 
which would be expected to make comparisons between studies difficult. 
2.4.3.2 Degree, duration and pattern of obesity 
The discrepancy in the effects of training on LV structure and function in the 
literature could also be explained by the different degrees of obesity in the 
subjects enrolled. While most studies included obese subjects with BMIs 
between 30 and 35 kg.m
-2
, some included overweight subjects with BMIs < 
30 kg.m
-2 
(Millen et al. 2004, Eriksson et al. 2010) and others included 
subjects with BMIs > 35 kg.m
-2
(Stewart et al. 2005 and Millen et al. 2014). 
No information was given in most of these studies on the duration of obesity 
in the subjects enrolled which might possibly have an influence on the effect 
of training. Indeed, Licata et al. (1992) showed that overweight individuals 
that had been overweight for less than 10 years had a significant increase in 
EF during exercise compared to those that had been overweight for more 
than 10 years, and a negative correlation was reported between the duration 
of obesity and the exercise-induced increase in EF (Licata et al., 1992). 
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More importantly, obesity is generally defined using BMI which incorporate 
both adipose tissue and muscle tissue and hence it does not account for 
individual differences in body composition and fat distribution. Individual 
differences in fat content and distribution is likely a relevant factor in the 
comparison between obese subjects. Some of the above mentioned studies 
measured fat content, and included subjects with ~30% fat (Humphries et 
al., 2002, Schuster et al., 2011) while others had ~ 38% fat (Stewart et al., 
2005, Baynard et al., 2008) and ~ 44% fat (Mitchell et al,. 2002). 
Furthermore, the differences in fat distribution and the degree of visceral 
adiposity likely explain at least partly the disparity in the results. Schuster et 
al. (2011) showed that the greatest degree of improvement in LV structure 
and function following exercise was seen in the subjects with the greatest 
degree of visceral adiposity at baseline (Schuster et al., 2011). Two studies 
accurately measured visceral adipose tissue using MRI, one of which 
reported ~146 cm
3
 (Stewart et al., 2005) while the other two were more than 
double this value; ~300 cm
3
 (Mitchell et al., 2002) and ~350 cm
3
 (Humphries 
et al., 2002). Other studies used waist circumference as a surrogate marker 
of visceral adiposity and were roughly within the same range. Additionally, 
some of these studies reported a significant reduction in %fat and/or visceral 
fat post-training (Humphries et al., 2002, Mitchell et al., 2002, Stewart et al., 
2005, Ingul et al., 2010, Eriksson et al. 2010., Schuster et al., 2011, Sijie et 
al., 2012) and the majority of these studies reported some training effect on 
LV structure and/or function. Some authors attributed the lack of training 
effect on LV structure and function to insufficient loss of adipose tissue 
(Mitchell et al. 2002., Stewart et al., 2005 and Baynard et al., 2008). 
Additionally, Stewart et al. (2005) found a negative correlation between 
abdominal fat change and LVM change over time. This argument can be 
challenged by the fact that Eriksson et al. (2010) failed to detect any change 
in LVM after training either, though a significant reduction in WC and total 
body fat content were reported. Hence, other factors must be involved such 
as training intensity and duration. 
2.4.3.3 Training intensity and duration 
It is generally well-established that training type, intensity, duration and 
frequency are important determinants of the training-induced benefits of 
exercise (Shephard, 1968). In particular, heavy-intensity training was shown 
to induce superior cardiac benefits to moderate-intensity training (Wisloff et 
al., 2007) where heavy-intensity interval training induced LV structural and 
functional adaptations not achieved by moderate intensity training (Wisloff et 
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al., 2007). Heavy intensity training was shown to reduce cardiovascular 
mortality (Wisloff et al., 2006). Studies that have explored the impact of 
aerobic training on cardiac structure and function have used a variety of 
training durations and intensities ranging from short heavy-intensity 
programmes such as 10 days (Baynard et al., 2008) and 6 weeks (Millen et 
al. 2014), both of which did not result in any training-induced change in LV 
structure and function, to longer moderate or low intensity programmes 
including 6 months (Stewart et al., 2005) and 8 months (Eriksson et al., 
2010). The majority of studies that have reported improvements in LV 
structure and/or function have used heavy-intensity programmes (Mitchell et 
al., 2002, Vogelsang et al., 2008, Sijie et al. 2012, Ingul et al., 2010.) for 
durations as short as 8 weeks to as long as 6 months.  
2.4.4 Cardiac benefits of heavy-intensity interval training 
Interval training generally consists of brief repetitive bouts of exercise at high 
intensities (~95% VO2max) followed by periods of exercise at lower 
intensities. Interval training has the advantage of having rest periods that 
enable subjects to complete short bouts at higher intensity, which 
challenges the pumping ability of the heart (Wisloff et al., 2007). 
Furthermore, despite being an aerobic type of exercise, it includes periodic 
excursions into “anaerobic” energy pathways resulting in greater 
improvements in cellular signalling pathways involved in energy metabolism 
including mitochondrial biogenesis and the up-regulation of enzymes 
involved in glycolysis (Earnest, 2008). Wisloff et al. (2007) demonstrated 
that 12 weeks of heavy-intensity exercise training induced reverse LV 
remodelling and improvement in systolic function in cardiac patients, 
outcomes that were not achieved by moderate intensity continuous training 
(Wisloff et al., 2007). Furthermore, it was shown that heavy-intensity interval 
training attenuates post-myocardial infarction myocardial hypertrophy, 
increases cardiac myocyte contractile function and increases SERCA-2 
expression and Ca
2+
-sensitivity of the myofilaments (Wisloff et al., 2002). 
Additionally, high-intensity interval training was shown to significantly 
increase insulin-sensitivity (Hood et al., 2011) and improves skeletal muscle 
mitochondrial capacity (Little et al., 2010). In the context of obesity, heavy-
intensity interval training was shown to improve LV systolic and diastolic 
function, however studies exploring the impact of heavy-intensity interval 
training on cardiac structure and function in healthy obese individuals are 
limited. Ingul et al. (2010) showed that 13 weeks of high-intensity interval 
training restored an impaired LV systolic and diastolic function in obese 
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healthy adolescents (Ingul et al., 2010). Sijie et al. (2012) showed that 12 
weeks of both heavy-intensity interval training and moderate intensity 
continuous training resulted in significant improvement in LV systolic 
function, though greater with interval training, and significant reduction in 
%fat and waist to hip ratio in overweight adults (Sijie et al., 2012). To date, 
evidence suggest that the superior benefits provided by interval training 
result from the higher intensities used in this type of training. It is not known, 
however, if the repetitive pattern of exercise has any additional impact on 
cardiac structure and function in obesity. Studies comparing the impact of 
work and intensity-matched continuous and heavy intensity exercise training 
on LV structure and function in healthy obese individuals have not been 
carried out. 
2.5 Summary and thesis aims 
Overweight and obese women are particularly at risk of heart disease. 
Obesity induces unfavourable alterations in LV structure, morphology and 
function that increase in severity with increasing degrees of obesity, in 
particular, abdominal adiposity. It is not clear, however whether obesity 
induces concentric or eccentric LV remodelling. Extensive evidence exists 
suggesting that body size and composition are physiologically related to LV 
size and morphology in a non-linear fashion, calling for a need to normalise 
cardiac structural variables for individual differences in body size and 
composition using allometric scaling procedures. The physiological impact of 
body size and composition on LV functional variables, notably novel 
echocardiographic measures of LV systolic and diastolic function including 
myocardial velocity, deformation and torsion, and whether there is a need to 
normalise these variables for body size and/or composition has not been 
previously investigated in healthy obese women.  
Exercise training improves LV structure and function in obese individuals. It 
was shown that aerobic exercise training induces LV reverse remodelling 
and restores normal LV systolic and diastolic function in obese individuals 
without the need to restrict caloric intake or reduce weight. The optimum 
exercise type for improving LV structure and systolic and diastolic function, 
notably myocardial velocity, deformation and torsion has not yet been 
established. The benefits of aerobic training on cardiac structure and 
function appear to be higher with higher training intensities. Little is known 
about the LV systolic and diastolic functional responses to heavy-intensity 
exercise, in particular LV myocardial velocity, deformation and torsion. 
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Heavy-intensity interval training has recently been suggested as a more 
beneficial life style intervention to improve cardiac function in obese 
individuals. However, the impact of interval training on LV structure and 
function has not been compared with continuous training in 
overweight/obese women. Additionally, it is not known, whether the 
repetitive pattern of interval training provides any additional benefit on LV 
structural and functional exercise-induced alterations, particularly in obese 
women. 
Therefore, the aims of this thesis areː 
1. To assess the impact of excess adipose tissue, particularly visceral 
adipose tissue, on LV size, morphology and function in overweight 
and obese women after normalising for body size and composition 
using study specific allometric power exponents. 
2. To establish which body size variable/composition variable best 
accounts for individual differences in body size by allometric scaling 
without masking the influence of excess adipose tissue 
3. To compare the LV systolic and diastolic functional response to 
heavy-intensity exercise in healthy obese and non-obese women 
using novel echocardiographic techniques 
4. To compare the effects of work- and intensity-matched interval and 
continuous exercise training on LV structure and function in 
overweight and obese women. 
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Chapter 3 General Methods 
3.1  Participant recruitment and screening 
Participants were recruited via local poster advertisements and e-mail 
advertisements to participants who had previously given consent to be 
contacted for future studies. Ethical approval for all studies was granted by 
the University of Leeds Faculty of Biological Sciences Ethics committee 
which followed the principles outlined in the Declaration of Helsinki. Studies 
in chapters 4 and 6  were granted ethics approval through the same ethics 
application and the study in chapter 5 was granted ethics approval through a 
separate ethics application (see Appendix 1). Participant information sheets 
were provided and full informed consent was obtained prior to all data 
collection (see Appendix 2). Participants were verbally informed of all 
procedures to be undertaken and, where appropriate, familiarisation with 
measurements and techniques was provided. At initial contact with 
participants, inclusion criteria were confirmed verbally. Individuals were 
excluded from the studies if they were smokers, utilising any form of 
prescribed medication, had known cardiovascular, pulmonary and metabolic 
disease, musculoskeletal impairment, cancer, contraindication to exercise or 
clinical, electrocardiographic or echocardiographic evidence of structural 
heart disease not directly related to obesity. Participants were given at least 
24 hours to read through the information sheets and to ask any questions. 
Finally, participants were requested to sign written consent and complete a 
physical activity readiness questionnaire which was used to further identify 
any exclusion criteria. 
3.2 Experimental protocols 
Each study’s experimental procedures are detailed in the individual 
chapters. All visits took place in temperature controlled exercise physiology 
laboratories at the University of Leeds. For the echocardiographic 
assessment and the assessment of cardio-respiratory fitness, participants 
were instructed to refrain from performing exercise activity and drinking 
alcohol and caffeine in the 12 hours prior to the test. For the measurement 
of body composition, participants were instructed to arrive at the laboratory 
following an overnight fast of at least 12 hours. 
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3.3 Assessment of body size and composition 
3.3.1 Body mass index (BMI) and body surface area (BSA) 
Participants’ height (HT) and body mass (BM) were measured using a 
stadiometer and manual calibrated scales to the nearest 0.5 cm and 0.1 kg 
respectively. BMI was determined using the following equation: 
BMI (kg/m
2
) = BM (kg)/ Ht
2
 (m) 
Body surface area (BSA) was calculated from the following equation 
developed by Dubois and Dubois (1916): 
BSA (m
2
) = BM
0.425
 x HT
0.725
 
3.3.2 Waist-hip ratio (WHR) 
Waist circumference was measured, as an index of visceral adiposity, by 
placing a tape measure around the abdomen at a position midway between 
the uppermost border of the iliac crest and the lower border of the costal 
margin. Hip circumference was measured as the widest part of the hip 
region. Both waist and hip circumferences were measured to the nearest 0.5 
cm. Waist to hip ratio was determined using the following equation: 
WHR = WC (cm)/ HC (cm) 
Where WC = waist circumference and HC = hip circumference 
3.3.3 Bioelectrical impedance analysis (BIA) 
Measurement of body fat, including fat mass (FM), fat-free mass (FFM) and 
fat percent (FP) was performed using a commercially available bioelectrical 
impedance analyser (Bodystat 1500, Isle of Man, UK). BIA is a safe, rapid, 
inexpensive and non-invasive technique to estimate body fat content, and 
requires minimal operator training. 
3.3.3.a Principle of BIA 
Bioelectrical impedance analysis (BIA) measures the impedance or 
resistance to the flow of an electric current through the body fluids. 
Impedance is low in fat-free tissue where intracellular and extracelllular fluid 
(ICF and ECF respectively) and electrolytes are primarily situated, whereas 
in fat tissue have a high impedance. Impedance is the product of resistance 
and reactance. Resistance is the resistance to current flow through the 
body, whereas reactance is the frequency-dependent resistance to current 
flow that happens in cell membranes, that separate the extracellular from 
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the intracellular fluid compartments, being poor electric conductors, due to 
their capacitating nature (Buchholz et al., 2004, Kushner, 1992). At a fixed 
frequency of 50 kHz, a small constant current passed between electrodes 
spanning the body flows through both the ECF and ICF (Kushner, 1992). 
The voltage drop between electrodes provides a measure of impedance that 
is subsequently converted to a corresponding estimate of TBW via 
prediction equations. Prediction equations used by Bodystat 1500 have 
been generated in populations of obese females, comparable to most 
participants in these studies. FFM is then calculated from this estimate using 
an assumed hydration fraction for lean tissue. FM and PF are then 
calculated as follows: 
FM (kg) = BM (kg) – FFM (kg) 
FP (%) = FM (kg) / BM (kg) x 100 
Where FM = fat mass, BM = body mass, FFM = fat-free mass 
3.3.3.b BIA experimental procedure 
Subjects were instructed to attend for BIA measurements following an 
overnight fast of at least 12 hours and to void their bladder 30 min prior to 
the measurement. After 10 minutes of rest in the supine position, four self-
adhesive, disposable electrodes were connected to the subject’s left side, 
two at the wrist and two at the ankle, immediately after wiping the skin with 
alcohol in order to remove skin resistance. The subject’s age, sex, weight 
and height were entered manually into the analyser before a small constant 
current of 400 uA at a fixed frequency of 50 kHz was passed between 
electrodes. FFM, FM and FP are then displayed on the BIA analyser screen. 
FM (kg) = BM (kg) – FFM (kg) 
FP (%) = FM (kg) / BM (kg) x 100 
Where FM = fat mass, BM = body mass, FFM = fat-free mass 
3.3.3.c Validity and reliability of BIA 
The validity and reliability of this method has been confirmed by previous 
studies (Lukaski et al., 1985, Buchholz et al., 2004) 
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3.4 Echocardiographic assessment of LV structure and 
function 
Left ventricular structure and function were assessed using 
echocardiography, which is a non-invasive imaging technique that utilises 
ultrasound waves to provide images of the heart. Several approaches can 
be adopted using echocardiography depending on the site from which the 
heart is visualised. Transthoracic echocardiographic, which is the approach 
used used for this work, is the standard approach and consists of acquiring 
ultrasonic images of the heart from the anterior aspect of the subject’s chest 
wall. Several echocardiographic modalities have been employed in this work 
for the quantitative assessment of LV structure and function. These include 
standard two-dimensional (2D) imaging, motion-mode (M-mode), pulse 
wave Doppler (PWD), tissue Doppler imaging (TDI) and two-dimensional 
speckle tracking (2DST). 
Echocardiographic image acquisition was carried out using a commercially 
available ultrasound system (Vivid 7, GE Medical Systems, Horten, Norway) 
and a 1.6 - 4 MHz phased array transducer with the subject lying in the left 
lateral decubitus position. Subjects were instructed to breath hold during 
image recording and at least three cardiac cycles were stored digitally in raw 
DICOM format to CD/DVD or USB archive. Off-line analysis was carried out 
using commercially available software (Echo-pac, GE Medical Systems, 
Horten, Norway, version 7.0.0) and the average of at least 3 consecutive 
cardiac cycles was taken for all measurements. 
3.4.1 Standard 2D and M-mode Echocardiography 
Two-dimensional images were acquired in accordance with the American 
Society of Echocardiography (ASE) (Henry et al., 1980). Harmonic imaging 
was used and images were optimised to maximise spatial and temporal 
resolution by adjusting gain, dynamic range, depth, angle width, frame rate 
and frequency.  
Initially, a 2D parasternal long-axis (PLAX) view was obtained (Figure 3.1). 
An M-mode axis passing beyond the tip of the mitral valve at mid-chordal 
level, perpendicular to the LV long axis was acquired for the measurement 
of the diastolic and systolic interventricular septum thickness (IVSTd and 
IVSTs), LV posterior wall thickness (PWTd and PWTs) and LV internal 
diameter (LVIDd and LVIDs) performed from leading edge to leading edge. 
Systolic measurements were taken at end systole identified as the point of 
narrowest LV internal dimension whereas diastolic measurements were 
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taken at end diastole identified as the point of widest diameter (Sahn et al., 
1978). The subsequent calculation of LV mass (LVM) was carried out using 
the equation developed and validated by Devereux (Devereux et al., 1986) 
showing a significant correlation (r = 0.92) with post-mortem findings: 
LVM (g) = 0.8 x (1.04 [(LVIDd + PWTd + IVSTd)
3
 – (LVIDd)
3
] + 0.6 g 
The relative wall thickness (RWT), an index of LV concentric morphology 
(Grossman et al., 1977) was also calculated as follows: 
RWT = (IVSTd + PWTd) / LVIDd 
Fractional shortening (FS), a 2D measure of systolic contractile function was 
calculated as follows: 
FS (%) = (LVIDd – LVIDs) / LVIDd x 10
-2
 
 
 
Figure 3. 1 LV Standard Parasternal Long Axis view. IVST: 
interventricular septal thickness, LVID: left ventricular internal diameter, 
PWT: posterior wall thickness, LAD: left atrial diameter 
 
In the same view, an M-mode axis through the left atrium across the aortic 
annulus was carried out for the measurement of its anterior-posterior 
diameter (LAD) in end systole. 
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Epicardial fat thickness was measured as proposed by (Iacobellis and 
Willens, 2009) as the echo-free space between the outer wall of the right 
ventricular myocardium and the visceral pericardium in three different 
cardiac cycles at end-systole (Figure 3.2). The average of three 
measurements at both parasternal long-axis (PLAX) and short-axis (PSAX) 
views was calculated. For the PLAX view, maximum EFT was measured 
along the midline of the ultrasound beam, perpendicular to the aortic 
annulus, used as an anatomical landmark. Whereas, for the PSSX view, 
maximum EFT was measured along the midline of the ultrasound beam, 
perpendicular to the interventricular septum at mid-chordal and tip of 
papillary muscles levels. We have recorded intra and interobserver 
intraclass correlation coefficients of x and y, respectively for this 
assessment. 
 
Figure 3. 2 Epicardial fat thickness measurement. In the parasternal 
long axis view, epicardial fat thickness (between red arrows) is 
identified as the echo-free space between the outer wall of the right 
ventricular myocardium and the visceral pericardium 
Left ventricular and atrial volumes were measured using the Simpson’s 
biplane method as recommended by the ASE (Lang et al., 2005) which 
consists of manual endocardial border tracing at end-diastole, defined as 
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the frame immediately following mitral valve closure, and end-systole, 
defined as the frame immediately prior mitral valve opening, in two 
tomographic planes; transthoracic apical four-chamber (A4C) and two-
chamber planes (A2C). The area is subsequently divided into a series of 
stacked discs and the LV and LA volumes are calculated as the sum of all 
the disks using the following equation: 
Volume = π / 4 (h) Ʃ (D1) (D2) 
where h is the height of each disk and D1 and D2 are the orthogonal minor 
and major axis of each disk. Left ventricular ejection fraction (EF) a 
commonly used measure of global LV function was calculated as follows 
(Pombo et al., 1971): 
EF (%) = (EDV – ESV) / EDV x 10
-2
 
3.4.2 Standard Pulse Wave Doppler (PWD) echocardiography 
Standard PWD echocardiography assesses the global LV diastolic function 
by measuring the velocity of flow through the mitral valve in the A4C view in 
accordance with the Canadian Consensus Recommendations (Rakowski et 
al., 1996). A 4mm sample volume was placed at the tips of the mitral valve 
parallel to mitral inflow giving rise to a spectral signal reflecting diastolic 
mitral inflow for the measurement of peak flow velocities in early (E) and late 
diastole following atrial contraction (A) and the early diastolic flow 
deceleration time (DCT; Figure 3.3). The E/A ratio was also calculated. 
Isovolumic relaxation time (IVRT) was measured at the apical 3 chamber 
(A3C) view by placing a 4 mm sample volume in both the LV inflow and 
outflow and was defined as the time interval from between aortic valve 
closure and mitral valve opening. 
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Figure 3. 3 Mitral Inflow Pulse Wave Doppler (PWD) 
echocardiography. DCT = deceleration time, E = peak early diastolic 
inflow velocity, A = peak late (atrial phase) diastolic inflow velocity. 
 
3.4.3 Tissue Doppler Imaging (TDI) echocardiography 
Whilst in the A4C view, the TDI mode was activated and a 2 mm sample 
volume was placed on the septal and lateral aspects of the mitral annulus. 
In the subsequent spectral trace, peak myocardial velocities were 
measured, including systolic myocardial velocity  (Sm), early diastolic 
myocardial velocity (Em) and late diastolic myocardial velocity following atrial 
contraction (Am; Figure 3.4). An average of the septal and lateral mitral 
annular velocities was calculated, from which E/Em was derived. E/Em is a 
validated surrogate index for LV end-diastolic filling pressure (Ommen et al., 
2000). Additionally, myocardial performance index (MPI), an index of 
combined global systolic and diastolic performance, was calculated as 
follows: [(a – b) / b] where (a) is the time interval from the end to the onset of 
diastolic myocardial velocity and (b) is the ejection time (Tei et al., 1995) 
(Figure 3.5). 
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Figure 3. 4 Tissue Doppler Imaging echocardiography at the lateral annulus. Sm = 
peak systolic myocardial velocity, Em, peak early diastolic myocardial velocity, Am = 
peak late (atrial phase) diastolic myocardial velocity. 
 
Figure 3. 5 TDI- derived Measurement of Myocardial Performance Index (MPI). a = 
time interval from end to onset of diastole, b = ejection time. 
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3.4.4 Two-Dimensional Speckle Tracking (2DST) echocardiography 
Two-dimensional speckle tracking (2DST) echocardiography was carried out 
to assess LV strain (S) and strain rate (SR) in the longitudinal, 
circumferential and radial directions. The assessment of longitudinal strain 
(LongS) and strain rate during systole (LongSRs) and early and late diastole 
(LongSRe and LongSRa respectively) was carried out on standard 2D 
images taken from the A4C and A2C views (Figure 3.6 and 3.7).  
 
 
Figure 3. 6 Longitudinal strain curves from the apical 4-chamber view 
 
Figure 3. 7 Longitudinal SR curves from the apical 4-chamber view. 
SRs = systolic SR, SRe = early diastolic SR, SRa = late diastolic SR. 
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The assessment of LV circumferencial and radial strain (CircS and RadS 
respectively) and strain rate during systole (CircSRs and RadSRs 
respectively), early diastole (CircSRe and RadSRe respectively) and late 
diastole (CircSRa and RadSRa respectively) was carried out on standard 2D 
images from the PSAX view at the basal level of the LV. This was achieved 
by placing the ultrasound beam at the level of the tips of the mitral valve 
leaflets (Park et al., 2008).  These images were also used for the 
assessment of basal rotation. As for the assessment of apical rotation and 
subsequently LV torsion (LVTor), an additional standard 2D image was 
taken at the PSAX view at apical level of the LV by placing the ultrasound 
beam just proximal to the level of obliteration of LV lumen (van Dalen et al., 
2008). Torsion was calculated as the difference between basal and apical 
rotations at the same time point. All images were taken at end expiration. In 
the apical views, the focal point was positioned at the mitral valve whereas 
in the PSAX views the focal point was positioned at the centre of the LV to 
minimise the effects of beam divergence. The sector width and depth were 
adjusted to allow frame rates between 40 and 90 frames per second (Artis 
et al., 2008). Off-line analysis of S, SR, rotation and LVTor was carried out 
by allocating a region of interest (ROI) in all views by tracing of the 
endocardial border of the entire LV followed by the adjustment of 
endocardial and epicardial alignment and continuous frame-by-frame 
tracking of “natural acoustic markers” (Figure 3.8 and 3.9) (Korinek et al., 
2005). Subsequent S and SR were calculated from the amount and rate of 
displacement of the acoustic markers. The analysis software automatically 
graded the tracking quality of each segment of the LV as either acceptable 
or unacceptable, in which case they were excluded (Figure 3.10 and 3.11). 
The average of the tracked segments of each wall of the LV in each view 
were used in the analysis. 
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Figure 3. 8 Region of interest for 2DST in the apical 4-chamber view. 
 
 
Figure 3. 9 Region of interest for 2DST in basal parasternal short axis 
view. 
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Figure 3. 10 Automatic software grading of tracking quality for 2DST in 
apical 2-chamber view 
 
 
Figure 3. 11 Automatic software grading of tracking quality for 2DST in 
parasternal basal short-axis view 
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The intra-observer variability for echocardiographic measurements was 
minimal with co-efficients of variation ranging between 4% and 13%. 
Table 3.1 shows the coefficients of variation for the echocardiographic 
measured variables. 
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Variable Coefficient of variation 
EFT 
IVSTd 
LVIDd 
LVPWd 
E 
A 
DCT 
IVRT 
EDV 
ESV 
Sm 
Em 
LongS 
LongSRs 
LongSRe 
LongSRa 
CircS 
CircSRs 
CircSRe 
CircSRa 
RadS 
RadSRs 
RadSRe 
RadSRa 
Torsion 
4.9 % 
4 % 
4.6 % 
4.4 % 
10,4 % 
9.3 % 
6.8 % 
9.7 % 
9.4 % 
10 % 
6.4 % 
6.2 % 
5.7 % 
8.3 % 
7.9 % 
8.4 % 
8 % 
10.8 % 
11.6 % 
12.3 % 
9.3 % 
11.4 % 
12 % 
11.8 % 
12.7 % 
Table 3. 1 Intra-observer variability for echocardiographic 
measurements 
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3.5 Assessment of cardio-respiratory fitness (CRF) 
Cardiorespiratory fitness was assessed by measuring the maximal aerobic 
capacity (VO2max) and lactate threshold (LT) recorded during cardio-
pulmonary exercise (CPX) tests. These variables were also used to 
determine the desired work-rate (WR) during subsequent exercise sessions. 
Furthermore, LT was used as a reference point between moderate and 
heavy-intensity domains (Rossiter, 2011). 
3.5.1 Cardio-pulmonary exercise (CPX) test 
In order to determine maximal oxygen uptake (VO2max) and LT, a CPX test 
was performed by participants. This consisted of a ramp incremental (RI) 
exercise test followed by a step exercise (SE) stage (Figure 3.12). For 
chapter 5, the CPX test was performed in the seated position on an 
electronically braked bicycle ergometer (Excalibur Sport V2.0; Lode BV, 
Groningen, The Netherlands) whereas for chapter 6 it was performed in the 
semi supine position on an echocardiography-compatible supine bicycle 
ergometer (Lode BV Medical Technology, Groningen, Netherlands). In all 
tests, a nose clip and a mouth piece were fitted. Breath by breath analysis of 
expired gas was undertaken using oxygen and carbon dioxide analysers 
(Breeze Suite software V.5.0 and V.7.2, Medgraphics D-series; 
Medgraphics, Medical Graphics Corporation, St Paul, MN, USA). 
The RI test consisted of an initial 4 min rest period, followed by 4 min of 
cycling at 20 W until gas exchange reached a steady state, defined by a 
respiratory exchange ratio (RER) between 0.75 - 0.9. At this point, the RI 
test began at a rate of 12 W/min during which participants were instructed to 
maintain a cadence of > 60 rpm and encouraged to carry on until volitional 
fatigue. The test was terminated when participants could no longer maintain 
a cadence of ≥ 50 rpm despite strong encouragement. Throughout the test, 
heart rate (HR) and blood pressure (BP) were measured every 2 minutes 
using a 12-lead ECG and a sphygmomanometer respectively. Additionally, 
the rate of perceived exertion (RPE) was measured every 2 minutes using 
the Borg’s scale of 6 – 20.  
At the end of the RI test, maximal WR was calculated as follows: 
WRpeak (W) = RI test duration x ramp rate + 20 
Where 20 is the initial WR during the 4 min cycling prior to the initiation of 
the RI test. 
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After the RI test, a step exercise (SE) was carried out. The participants 
cycled for 5-min at 20 W and then WR was increased to 105% of WRpeak 
recorded in the RI test. Participants cycled at a high cadence (> 80 rpm) 
until volitional fatigue followed by a cool-down period of 5 min of cycling at 
20 W. The SE stage was used to confirm whether VO2max was achieved at 
the end of the RI test in case a plateau was not reached (Rossiter et al., 
2006). 
 
Figure 3. 12 Schematic representation of the cardio-pulmonary 
exercise test for the assessment of cardio-respiratory fitness. A 
rest period was followed by 5 min of cycling at 20 W before the ramp 
incremental (RI) stage was initiated. This was followed by 5 min of 
cycling at 20 W before the step exercise (SE) stage was initiated. 
Finally, the test ended with a 5 min cool-down period. 
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3.5.2 Calculation of VO2max and lactate threshold (LT) 
Exported breath by breath data was analysed using OriginLab software 
(OriginPro 8, OriginLab, Northampton, MA, USA). Peak oxygen uptake 
(VO2peak) was calculated as the highest average value of 12 consecutive 
breaths from RI and SE parts of the CPX test (Bowen et al., 2012). For 
chapters 5 and 6, a paired t-test indicated that the VO2peak values from the ʀɪ 
and SE stages of the test were not significantly different, therefore VO2max 
was calculated as the average of the VO2peak values from the RI and SE. 
The relative VO2max was calculated by dividing the absolute VO2max by BM 
(kg).  Lactate threshold was estimated non-invasively using the V-slope 
method. This method consisted of identifying the point of inflection on the 
curve of VO2 plotted against VCO2 (Beaver et al., 1986). In order to confirm 
this point, further checks were performed to ensure a rise in end tidal O2 and 
a plateau in end-tidal CO2 coincided with this point (Whipp et al., 1986) 
(Figure 3.13). The estimation of LT was carried out by at least 2 researchers 
and the average was reported. 
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Figure 3. 13 Calculation of lactate threshold (LT; red shaded line) 
using the V-slope method. LT was confirmed by ensuring the 
identified point coincided with a rise in end-tidal O2 and a plateau 
in end-tidal CO2. 
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3.6 Statistical analysis 
All statistical analyses were carried out using software (SPSS v.19, IBM 
Corporation, Somers, NY, USA). Initially, all data were examined for normal 
distribution using the Kolmogorov-Smirnov test. In the event where data 
were not normally distributed, non-parametric tests were carried out. In 
chapter 4, the allometric relationship between variables was assessed using 
the equation of the general form (y = x
b
) as y = dependent variable, x = 
independent variable and b = the beta exponent of the slope of the log-linear 
plot. Pearson correlations were carried out to assess inter-variable 
relationships. In chapter 4, a one-way ANOVA was performed to compare 
between groups. In chapters 5 and 6, Student’s independent t-tests were 
performed to compare between groups’ resting values (chapter 5) and 
baseline values (chapter 6). The effects of exercise and recovery (chapter 4) 
and exercise training (chapter 5) were assessed using ANOVA with 
repeated measures. When baseline values were significantly different 
between groups, they were entered as covariates in the model. Cohen’s d 
was calculated to assess effect size as the difference between rest and 
recovery means (chapter 5) or pre and post-training means (chapter 6) 
divided by the standard deviation of the variable (Field, 2013). Significance 
was accepted as P < 0.05. 
 
 
 
 
 
77 
 
Chapter 4 The relationship between left ventricular structure 
and function, and indices of obesity in overweight and obese 
women 
Aspects of this chapter were presented at the following conferences: 
 Annual Faculty of Biological Sciences Postgraduate Symposium, 
University of Leeds, UK, March 2011 
 Europrevent 2012 - European Society of Cardiology, Dublin, May 
2012 
 The Systems Biology of Exercise: Cardio-respiratory and Metabolic 
Integration, University of Leeds, UK, August 2012 
4.1 Introduction 
Obesity is a global epidemic with a progressively increasing world-wide 
prevalence (Ogden et al., 2014, Rennie and Jebb, 2005, WHO, 2014). 
Women, have a higher risk of heart failure compared to men (Kenchaiah et 
al., 2002). Furthermore, obesity, and particularly abdominal adiposity, was 
shown to increase the risk of heart failure in women but not in men 
(Dagenais et al., 2005). 
Obesity induces unfavourable LV structural and functional alterations in 
otherwise healthy obese individuals that remain silent for years before 
progressing to overt heart failure (Chinali et al., 2006, Di Salvo et al., 2006, 
Koopman et al., 2012, Pascual et al., 2003, Peterson et al., 2004, Tumuklu 
et al., 2007, Wierzbowska-Drabik et al., 2013, Wong et al., 2004). With 
regards to LV morphology, obesity has traditionally been associated with 
eccentric LV morphology (Koopman et al., 2012, Pascual et al., 2003). An 
increasing number of studies have recently challenged this notion by 
reporting LV concentric morphology in otherwise healthy normotensive 
obese individuals (Wong et al., 2004, Woodiwiss et al., 2008, Peterson et 
al., 2004). This appears to be related to increasing excessive visceral 
adipose tissue rather than a general increase in body fat (Neeland et al., 
2013). As for LV function, depending on the echocardiographic technique 
used, results have been variable. Standard echocardiography tended to 
present a classic pattern of LV diastolic dysfunction with preserved systolic 
function (Wong et al., 2004, Peterson., 2004), or even sometimes 
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supernormal systolic function (Di Bello et al., 2006, Iacobellis et al., 2002). 
Novel techniques such as TDI and 2DST have shown subtle changes in 
both systolic and diastolic dysfunction (Barbosa et al., 2013, Shah and 
Solomon, 2012, Wierzbowska-Drabik et al., 2013, Wong et al., 2004). 
Furthermore, visceral fat, particularly epicardial fat, has recently been 
identified as the principal mediator of adverse LV structural and functional 
changes (Iacobellis and Willens, 2009). Indeed, echocardiographic 
epicardial fat thickness  is suggested as a more accurate surrogate marker 
of visceral adiposity than waist circumference and is believed to have, in 
addition to endocrine and paracrine effects, local mechanical influence on 
cardiac function (Crendal et al., 2014).   
In order to properly explore the impact of obesity on LV size, morphology 
and function, it is imperative to distinguish between the normal physiological 
impact of body size and the pathological influence of excess fat (Chantler 
and Lakatta, 2009). Large scaling studies have thoroughly explored the 
allometric relationship between body size, LV size and dimensions. These 
studies, however did not address LV function. It was shown that LV size 
(LVM and LVIDd) related to body size (BSA, BM, height and FFM) in a non-
linear fashion, indicating a need for allometric normalisation using allometric 
scaling before comparing individuals (Batterham and George, 1998, 
Batterham et al., 1997, de Simone et al., 1992, De Simone et al., 2011). Fat-
free mass has been suggested as the most appropriate body size variable to 
partition out individual differences in body size without masking the impact of 
excess adipose tissue (Batterham et al., 1997). Indeed, in the context of 
obesity, scaling LV dimensions to a body size variable that does not 
incorporate adipose tissue would be the most accurate way of establishing 
the independent impact of adipose tissue. With regards to LV function, the 
allometric relationship between body size and SV and CO has previously 
been reported (de Simone et al., 1997, Turley et al., 2006). Novel TDI- and 
2DST-derived measures of LV systolic and diastolic function, their allometric 
relationships with body size and composition, and whether or not there is a 
need to scale these measures to body size or composition have not 
received much attention. 
Therefore, the aims of this study is therefore to firstly define the allometric 
relationship of body size and composition to LV size and function, and 
establish which LV structural and/or functional variables need to be scaled 
to body size, notably FFM. Secondly, this study aims to explore the impact 
of obesity, particularly visceral adiposity and epicardial fat, on LV size, 
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morphology and function in healthy overweight and obese women using 
novel echocardiographic techniques and proper scaling techniques. 
4.2 Methods 
4.2.1 Participants 
Eighty five females (age: 35.4 ± 9.1 yrs) were recruited for the study through 
local poster and email advertisements across the University of Leeds 
campus. All participants were healthy, free of known cardiovascular disease 
and were not utilising any form of prescribed medication. The nature and 
purpose of the study was explained to each participant and written informed 
consent was provided prior to their participation. Participants represented a 
broad range of body size categories (BMI range 18.5 – 39.9 kg/m
2
). 
4.2.2 Experimental protocol 
Participants were invited to attend the exercise physiology laboratory at the 
University of Leeds on a single occasion after being instructed to refrain 
from heavy physical exercise for 8 hours and have fasted for 12 hours prior 
to attendance. All anthropometric and echocardiographic variables were 
measured/calculated at the same visit in a temperature-controlled laboratory 
following a 5 minute period of rest in the supine position. 
4.2.3 Measured variables 
The protocols for the following variables are described in detail in the 
general methods chapter. 
4.2.3.1 Anthropometric variables  
The anthropometric variables measured/calculated included body mass 
(BM), height (HT), waist circumference (WC), hip circumference (HC), waist 
to hip ratio (W:H ratio), fat mass (FM), fat percent (FP) and fat-free mass 
(FFM). 
4.2.3.2 Echocardiographic variables 
Echocardiographic techniques are explained in detail in the general methods 
chapter (section 3.4). Standard 2-D echocardiographic variables included 
epicardial fat thickness (EFT), left ventricular diastolic internal diameter 
(LVIDd), diastolic posterior wall thickness (PWTd), diastolic interventricular 
septal thickness (IVSTd), mean wall thickness (MWT), relative wall 
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thickness (RWT), left ventricular mass (LVM), ejection fraction (EF), stroke 
volume (SV). PWD echocardiographic variables included early diastolic 
inflow velocity (E), late diastolic inflow velocity (A), E:A ratio (E/A), 
isovolumetric relaxation time (IVRT) and deceleration time (DCT). TDI 
echocardiographic variables included peak systolic myocardial velocity (Sm), 
peak early diastolic myocardial velocity (Em), peak late diastolic myocardial 
velocity (Am), Em:Am and E/Em. Finally, 2DST echocardiographic variables 
included global longitudinal strain (LongS), global longitudinal systolic and 
early, late and early to late diastolic strain rates (LongSRs, LongSRe, 
LongSRa and LongSRe/a respectively), global circumferential strain (CircS), 
global circumferential systolic and early, late and early to late diastolic strain 
rates (CircSRs, CircSRe, CircSRa and CircSRe/a respectively), global radial 
strain (RadS), global radial systolic and early, late and early to late diastolic 
strain rates (RadSRs, RadSRe, RadSRa and RSRe/a respectively) and LV 
torsion (LVTor). 
4.2.4 Statistical analysis 
Statistical analysis procedures are explained in detail in the General 
Methods chapter (section 3.6). All data were normally distributed and are 
presented as mean ± SD. The relationships between each pair of 
anthropometric and echocardiographic variables were checked for linearity 
using Tanner’s “special circumstance” calculation (Tanner, 1949). This 
involves comparing the correlation coefficient (r,x,y) for each combination of 
anthropometric and echocardiographic variables with the ratio of the 
coefficients of variation (CV) for the same two variables (CVx/CVy). Linearity 
(i.e. when r,x,y is equal to cvx/cvy) was not found between any pair of 
variables, therefore they were analysed for allometric relationships from 
natural log transformations of the absolute data. The curvilinear allometric 
equation of the general form (y = xb) was examined as y = dependent 
variable, x = independent variable and b = the beta exponent of the slope of 
the log-linear plot. Comparison between the 3 BMI-divided groups was 
undertaken using a one-way ANOVA for the absolute and allometrically 
scaled (y/x
b
) data. Results of all data analysis were considered significant if 
P < 0.05. 
81 
 
4.3 Results 
4.3.1 Participants’ characteristics 
The anthropometric and blood pressure characteristics of the three groups 
are presented in Table 4.1. The total number of participants was 85, which 
was divided into three groups according to BMI; normal weight (NW, BMI 
<25 kg/m
2
, n=31), overweight (OW, BMI ≥25 and <30 kg/m
2
, n=28) and 
obese (OB, BMI ≥30 kg/m
2
, n=26). Resting blood pressure did not differ 
between the three groups (P < 0.05).  All anthropometric and body 
composition variables except FFM were larger in overweight participants 
than in their normal weight counterparts (P < 0.05), whilst obese participants 
displayed greater values than both overweight and normal weight 
participants in all variables except height and waist:hip ratio (P > 0.05). In 
these variables obese participants differed only from normal weight 
participants (P < 0.05). 
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Table 4. 1 Anthropometric, body composition and blood pressure 
characteristics for normal weight, overweight and obese participants 
 Normal (n=31) Overweight (n=28) Obese (n=26) 
Age (years) 31.1 ± 8.06 35.5 ± 10.6 40.7 ± 5.31 *† 
Weight (kg) 62.2 ± 8.38 75.1 ± 7.37 * 92.8 ± 11.1 *† 
Height (m) 1.69 ± 6.41 1.64 ± 6.55 * 164.9 ± 5.53 * 
BMI (kg/m
2
) 21.7 ± 1.9 27.7 ± 1.46 * 34.1 ± 3.11 *† 
BSA (m
2
) 1.71 ± 0.14 1.82 ± 0.12 * 1.99 ± 0.14 *† 
Fat percent (%) 21.2 ± 5.1 34.7 ± 5.8 * 43.9 ± 2.9 *† 
Fat mass (kg) 13.1 ± 3.68 26.4 ± 5.93 * 41.1 ± 6.92 *† 
Fat-free mass (kg) 48.7 ± 7.65 47.8 ± 6.26 52.1 ± 4.98 *† 
Waist (cm) 75.8 ± 7.89 90.9 ± 9.89 * 105.3 ± 8.66 *† 
Waist : Hip 0.80 ± 0.07 0.87 ± 0.07 * 0.87 ± 0.06 * 
Epicardial fat (cm) 1.87 ± 0.77 3.46 ± 0.98 * 4.05 ± 1.19 *† 
SBP (mmHg) 124 ± 11 127 ± 10 126 ± 9. 
DBP (mmHg) 80 ± 5 82 ± 7 84 ± 9 
* Significantly different from Normal (P<0.05) † significantly different from 
both Overweight and Normal (P<0.05). BMI, body mass index; BSA, body 
surface area; SBP, systolic blood pressure; DBP, diastolic blood pressure. 
4.3.2 LV size and morphology: relationship to body size and 
composition 
Firstly, Tanner’s special circumstances, to test the validity of ratio scaling of 
LV structural indices by body size indices, were not satisfied in any pair of 
LV and body size variables. Table 4.2 shows the correlation coefficients 
(r,x,y) for each combination of anthropometric and echocardiographic 
structural variables versus the ratio of the coefficients of variation (CV) for 
the same two variables (CVx/CVy). This eliminates the possibility of a linear 
relationship between LV structural variables and those of body size and 
composition. Therefore, allometric log-linear scaling was employed to 
explore the relationship between LV size and morphology and body size and 
composition and results are presented in Table 4.3. Figure 4.1 shows the 
relationship between LVM and BM before and after allometric scaling. After 
allometric scaling, the correlation coefficient for both variables changed from 
a significant value of 0.48 to a non-significant value of 0.01 (figure 4.1). 
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Figure 4. 1 Relationship between LVM and BM before and after 
allometric scaling
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Table 4. 2 Tanner’s special circumstances; the correlation coefficients (r,x,y) for each combination of anthropometric and 
echocardiographic structural variables versus the ratio of the coefficients of variation for the same two variables 
(between brackets) 
 BSA BM HT FM FFM WC EFT 
LVM 
0.46 
(0.35) 
0.48 
(0.74) 
0.10 
(0.14) 
0.39 
(1.78) 
0.43 
(0.49) 
0.48 
(0.60) 
0.40 
(1.6) 
LVIDd 
0.01 
(0.93) 
0.07 
(1.96) 
0.17 
(0.37) 
0.23 
(4.76) 
0.28 
(1.28) 
0.19 
(1.61) 
0.28 
(4.26) 
LVL 
0.27 
(0.62) 
0.27 
(0.92) 
0.10 
(1.35) 
0.26 
(1.18) 
0.17 
(0.75) 
0.30 
(0.65) 
0.33 
(0.22) 
IVSTd 
0.19 
(0.03) 
0.24 
(0.06) 
0.07 
(0.01) 
0.27 
(0.14) 
0.06 
(0.037) 
0.30 
(0.05) 
0.26 
(0.12) 
PWTd 
0.18 
(0.32) 
0.24 
(0.66) 
0.12 
(0.13) 
0.30 
(1.63) 
0.07 
(0.44) 
0.34 
(0.55) 
0.42 
(1.47) 
 
LVM, left ventricular mass; EDV, end-diastolic volume, LVIDd, left ventricular diastolic internal diameter; LVL, left ventricular length; IVSTd, diastolic interventricular 
septum thickness; PWTd, diastolic posterior wall thickness. 
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Table 4. 3 The allometric correlation (r) and allometric power exponent (b ± 95% confidence intervals) for LV morphology 
and indices of body size and composition 
 BSA BM HT FM FFM WC EFT 
LVM 
0.46 ** 
(1.3±0.58) 
0.48 ** 
(0.64±0.27) 
0.10 
(0.7±1.62) 
0.39 ** 
(0.19±0.1) 
0.43 ** 
(0.92±0.45) 
0.48 ** 
(0.75±0.31) 
0.40 ** 
(28.8±17.2) 
LVIDd 
-0.01 
(-0.02±0.25) 
- 0.07 
(-0.04±0.12) 
0.17 
(0.5±1.07) 
- 0.23 * 
(-0.05±0.04) 
0.28* 
(0.23±0.18) 
- 0.19 
(-0.12±0.15) 
-0.28 * 
(-0.26±0.21) 
LVL 
0.27 * 
(0.74±0.62) 
0.27 * 
(0.35±0.3) 
0.10 
(0.07±2.23) 
0.26 * 
(0.13±0.11) 
0.17 
(0.37±0.49) 
0.30 * 
(0.49±0.35) 
0.33 * 
(1.15±0.86) 
IVSTd 
0.19 † 
(0.28±0.24) 
0.24 * 
(0.29±0.25) 
-0.07 
(-0.99±5.05) 
0.27 * 
(0.27±0.22) 
0.06 
(0.25±0.95) 
0.30 * 
(0.92±0.7) 
0.26 * 
(0.28±0.24) 
PWTd 
0.18 † 
(0.57±0.73) 
0.24 * 
(0.37±0.34) 
-0.12 
(-0.1±2.9) 
0.30 * 
(0.16±0.12) 
-0.07 
(-0.02±0.58) 
0.34 ** 
(0.58±0.39) 
0.42 ** 
(0.26±0.13) 
MWT 
0.43 ** 
(0.98±0.47) 
0.48 ** 
(0.52±0.21) 
- 0.01 
(-0.08±1.33) 
0.49 ** 
(0.20±0.09) 
0.23 * 
(0.39±0.38) 
0.56 ** 
(0.71±0.24) 
0.53 ** 
(0.27±0.13) 
RWT 
0.34 ** 
(0.99±0.63) 
0.40 ** 
(0.56±0.29) 
- 0.08 
(-0.58±1.7) 
0.46 ** 
(0.24±0.1) 
0.07 
(0.16±0.51) 
0.50 ** 
(0.82±0.32) 
0.51 ** 
(0.13±0.06) 
 
* P < 0.05, ** < 0.005, LVM, † < 0.09. LVM, left ventricular mass; EDV, end-diastolic volume, LVIDd, left ventricular diastolic internal diameter; LVL, left ventricular length; 
IVSTd, diastolic interventricular septum thickness; PWTd, diastolic posterior wall thickness; MWT, mean wall thickness; RWT, relative wall thickness. 
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4.3.2.1 LV size  
Generally, larger body sizes were associated with bigger, heavier and longer 
left ventricles as shown by the significant correlation of both LVM and LVL 
with BSA. Height was not related to either LVM or LVL (P > 0.05). Hence the 
relationship to body size was primarily as a result of BM. Furthermore, both 
LVM and LVL significantly correlated with FM, WC and EFT, whereas only 
LVM significantly correlated with FFM (P < 0.05). There was no relationship 
between LVIDd and body size variables BM, HT and BSA. However, with 
regards to body composition, LVIDd exhibited opposite relationships with 
adipose and non-adipose tissue, showing a modest but significant positive 
correlation with FFM and negative correlation with FM, WC and EFT.  
4.3.2.2 LV morphology  
Generally, larger body sizes were associated with thicker LV walls as shown 
by the significant correlation between both LVM and mean wall thickness 
(MWT) and BM, and subsequently, BSA. Furthermore, there was a 
significant correlation between RWT and both BM and BSA, both of which 
did not correlate with LVIDd, suggesting a concentric LV morphology 
associated with bigger body sizes. Looking more closely at body 
composition, FM and FFM each were associated with different LV 
morphologies. FM significantly and positively correlated with MWT and RWT 
and negatively with LVIDd. However, FFM exhibited a significant positive 
correlation with both MWT and LVIDd with no correlation with RWT. This 
indicates a concentric LV morphology associated with higher adipose tissue 
content as opposed to an eccentric LV morphology with higher non-adipose 
tissue content. The correlations of LV morphology with FFM were modest (r 
= 0.20 to 0.30) compared to FM (r > 0.46). Furthermore, LVM, MWT, RWT 
significantly and positively correlated with WC and EFT whereas LVID 
negatively correlated with WC and EFT, though only reaching statistical 
significance with EFT. Finally, EFT exhibited the strongest correlations (r > 
0.50) with indices of LV size and morphology compared to all other indices 
of body size and composition. 
4.3.2.3 LV size and morphology vs body size and compositionː what is 
the nature of the relationship? 
Generally, the allometric power exponents generated for the indices of LV 
size and morphology scaled for body size and composition confirmed a non-
linear relationship between them, and were not always fitting with the theory 
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of geometric similarity (table 4.3). Indeed, the allometric b exponent for LVM 
(3-dimensional) scaled for BSA (2-dimensional) included 1.5 in its  95% 
confidence intervals. However, the allometric b exponent for LVM (3-
dimensional) scaled to BM (3-dimensional) was lower than and did not 
include 1.0 within its 95% confidence intervals (95%CI). As for one-
dimensional measurements of LV, when scaled to BSA (2-dimensional) and 
BM (3-dimensional), the generated power exponents did include 0.5 and 
0.33 respectively within their 95% CI. Similarly, the generated allometric b 
exponents for LVM (3-dimensional), LVID and MWT (both 1-dimensional) 
scaled to FFM (3-dimensional) included 1.0 and 0.33 respectively within 
their respective 95% CI. 
However, scaling indices of LV size and morphology to measures of adipose 
tissue (FM, WC and EFT) generated b exponents that were low, not fitting 
with the theory of geometric similarity and with broad 95% CI.  
4.3.3 Does LV size and morphology differ between normal weight, 
overweight and obese subjects? 
The absolute mean values ± SD of the echocardiographic measurements of 
LV size and morphology before and after allometric scaling for indices of 
body size and composition for the 3 groups are shown in Table 4.4.  
In absolute terms overweight and obese participants did not differ from each 
other in indices of LV size (P > 0.05). However both groups displayed 
significantly greater LVM and wall thicknesses than the normal weight 
participants (P < 0.05). The mean LVM values for all 3 groups did not 
exceed the limits of normal according the ASE guidelines (Lang et al., 
2005). Whilst the overweight and obese participants had smaller LVIDd than 
their normal weight counterparts, the diameters fell within the normal range. 
After removing the influence of BM and BSA the differences in LV size 
between the three groups disappeared. Interestingly, after scaling for FFM, 
the OB group’s LVM remained significantly greater than the NW group, 
however the difference between both groups’ mean LVM decreased from 
~30% before scaling to ~19% after scaling. Figure 4.2 represents the 
differences between the 3 groups’ LVM before and after allometric scaling 
for BSA and FFM. 
With regards to LV morphology, the NW group had normal average MWT 
and RWT as opposed to the OW and OB groups who both had significantly 
greater average MWT and RWT exceeding the limits for concentric 
remodelling. There was no significant difference between both groups. 
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Allometric scaling of  MWT and RWT for FM and WC resulted in removal of 
the differences between the 3 groups, whereas scaling for BM, BSA and 
FFM did not remove the differences between the 3 groups.  
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Table 4. 4 Difference between normal weight, overweight and obese 
subjects in LV size and morphology 
 Normal Overweight Obese 
LVM (g) 
LVM/BM
0.64 
LVM/BSA
1.3
 
LVM/FFM
0.92
 
LVM/FM
0.19
 
136.7±31.6 
9.81±2.38 
80.5±19.3 
2.85±0.69 
84.2±21.1 
158.6±42.6 * 
10±2.58 
87.2±23 
3.18±0.85 
81.4±19.9 
178.3±47.7 * 
9.81±2.48 
89.3±22.8 
3.38±0.83 * 
87.2±22.9 
LVIDd (cm) 
LVIDd/FFM
0.23 
LVIDd/FM
-0.05 
4.73±0.36 
1.95±0.15 
5.38±0.41 
4.36±0.53 * 
1.78±0.20 * 
5.12±0.61 
4.48±0.47 * 
1.82±0.16 * 
5.44±0.56 
LVL (cm) 
LVL/BM
0.35 
LVL/BSA
0.27 
LVL/FM
0.13 
LVL/WC
0.49
 
5.75±1.73 
1.35±0.39 
3.37±0.95 
4.11±1.22 
0.69±0.2 
6.83±1.86 * 
1.51±0.4 
3.74±0.97 
4.43±1.22 
0.74±0.2 
6.46±1.28 
1.34±0.3 
3.29±0.81 
3.96±0.82 
0.66±0.15 
MWT (cm) 
MWT/BM
0.52
 
MWT/BSA
0.43 
MWT/FFM
0.29 
MWT/FM
0.20 
0.84±0.13 
0.098±0.016 
0.50±0.08 
0.19±0.03 
0.51±0.09 
1.05±0.25 * 
0.110±0.025 * 
0.58±0.13 * 
0.23±0.05 * 
0.53±0.12 
1.10±0.22 * 
0.105±0.022 
0.55±0.11 * 
0.23±0.04 * 
0.51±0.09 
RWT 
RWT/BM
0.56
 
RWT/BSA
0.43 
RWT/FM
0.24 
0.36±0.07 
0.036±0.007 
0.21±0.04 
0.19±0.01 
0.49±0.16 * 
0.044±0.013 * 
0.27±0.08 * 
0.22±0.06 
0.50±0.13 * 
0.040±0.011 
0.25±0.07 * 
0.20±0.05 
* Significant difference from NW group. LVM, left ventricular mass; LVIDd = left 
ventricular diastolic internal diameter; LVL, left ventricular length; MWT, mean wall 
thickness; RWT, relative wall thickness; BM, body mass; BSA, body surface area; 
FFM, fat-free mass; FM, fat mass; WC, waist circumference. 
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Figure 4. 2 Left ventricular mass in normal weight (NW), overweight 
(OW) and obese (OB) women before and after allometric scaling 
for body size or fat-free mass. * indicates significant difference. 
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4.3.4 LV systolic function vs body size and composition  
The allometric correlations (r) and power exponents (b) of the measures of 
LV systolic function vs. body size and composition are presented in Tables 
4.5 and 4.6. Stroke volume exhibited significant positive non-linear 
correlations with BSA, BM, FFM, WC and EFT (P < 0.05), the strongest 
being with FFM (r = 0.33, b: 0.67 ± 0.45). This indicates a need to normalise 
SV for FFM in order to properly assess the impact of excess adipose tissue 
on stroke volume without the influence of non-adipose tissue. The 95% 
confidence intervals for the allometric power exponents generated for SV 
scaled for FFM included 1.0 which is consistent with the theory of geometric 
similarity as both measures are 3-dimensional.  
Longitudinal strain negatively correlated with FM, WC and EFT, the 
strongest correlation with EFT (r = -0.33, P < 0.05). Interestingly, only EFT 
correlated negatively with longitudinal SRs and positively with circumferential 
SRs. None of the remaining systolic variables correlated with body size or 
FFM. 
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Table 4. 5 The allometric correlations (r) and allometric power exponents (b ± 95% confidence intervals) for standard and 
TDI-derived LV systolic function and indices of body size and composition 
 
 
BSA BM HT FM FFM WC 
EFT 
SV 
0.28 * 
(0.75±0.6) 
0.26 * 
(0.34±0.29) 
0.14 
(0.97±1.54) 
0.21 
(0.10±0.11) 
0.33 * 
(0.67±0.45) 
0.28 * 
(0.43±0.34) 
0.29 * 
(0.15±0.12) 
EF 
0.04 
(0.05±0.33) 
0.08 
(0.06±0.16) 
0.12 
(-0.42±0.82) 
0.17 
(0.05±0.07) 
0.14 
(-0.15±0.25) 
0.19 
(0.16±0.19) 
0.20  † 
(0.05±0.06) 
FS 
0.04 
(-0.07±0.44) 
0.00 
(0.01±0.21) 
0.14 
(-0.67±1.1) 
0.00 
(0.00±0.09) 
0.01 
(0.01±0.04) 
0.06 
(0.07±0.25) 
0.13 
(0.05±0.09) 
Sm 
0.09 
(-0.19±0.44) 
0.08 
(-0.07±0.19) 
0.09 
(-0.45±1.09) 
0.02 
(-0.01±0.08) 
0.08 
(-0.11±0.34) 
0.03 
(0.03±0.26) 
-0.04 
(-0.02±0.01) 
* P < 0.05. † P < 0.09. SV, stroke volume; EF, ejection fraction; FS, fractional shortening; SWS, systolic wall stress; Sm, systolic myocardial 
velocity. 
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Table 4. 6 The allometric correlations (r) and allometric power exponents (b ± 95% confidence intervals) for 2DST-derived 
LV systolic function and indices of body size and composition 
LongS 
0.19 
(-0.32±0.47) 
0.25 
(-0.21±0.22) 
0.12 
(0.46±1.07) 
0.29 * 
(-0.09±0.08) 
0.01 
(-0.01±0.39) 
0.29 * 
(-0.27±0.26) 
- 0.33 * 
(-0.13±0.1) 
CircS 
0.02 
(-0.06±0.96) 
0.08 
(-0.12±0.45) 
0.15 
(1.1±2.07) 
0.09 
(-0.05±0.15) 
0.10 
(0.25±0.71) 
0.14 
(-0.28±0.57) 
-0.17 
(-0.12±0.18) 
RadS 
0.05 
(-1.28±2.2) 
0.09 
(-0.65±1.27) 
0.12 
(-2.74±4.76) 
0.02 
(-0.03±0.71) 
0.21 
(-0.86±1.4) 
0.05 
(0.21±1.58) 
0.24 † 
(0.33±0.35) 
LongSRs 
0.13 
(-0.17±0.35) 
0.08 
(-0.05±0.17) 
0.17 
(-0.47±0.75) 
0.02 
(-0.00±0.06) 
0.12 
(-0.11±0.26) 
0.03 
(-0.02±0.2) 
- 0.28 * 
(-0.08±0.08) 
CircSRs 
0.25 * 
(1.13±1.24) 
0.25 * 
(0.53±0.59) 
0.09 
(0.87±2.79) 
0.25 
(0.18±0.20) 
0.14 
(0.45±0.94) 
0.14 
(0.39±78) 
0.30 * 
(0.27±0.25) 
RadSRs 
0.09 
(-0.27±1.16) 
0.06 
(-0.09±0.66) 
0.15 
(-0.92±3.26) 
0.02 
(-0.03±0.82) 
0.02 
(-0.03±0.82) 
0.06 
(-0.11±0.82 
0.13 
(0.09±0.09) 
* P < 0.05. † P < 0.09. LongS, longitudinal strain; CircS, circumferential strain; RadS, radial strain; LongSRs, longitudinal systolic strain rate; 
CircSRs, circumferential systolic strain rate, RadSRs, radial systolic strain rate. 
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4.3.5 LV systolic function: is there a difference between normal 
weight, overweight and obese participants? 
Table 4.7 presents the absolute values (mean ± SD) of LV systolic function 
in the 3 groups. SV, absolute and scaled for FFM, did not differ significantly 
between the 3 groups. Longitudinal strain was significantly lower in the 
obese compared to both the normal weight and overweight subjects, and no 
difference was found between these two groups. No significant difference 
was found between the 3 groups’ systolic haemodynamic parameters, 
myocardial velocity, circumferential and radial deformation or torsion. 
 
Table 4. 7 LV systolic function in normal weight, overweight and 
obese participants 
 Normal Overweight Obese 
SV (ml) 
SV/FFM
0.67
 (ml/g
0.67
) 
EF (%) 
FS 
Sm (ms) 
LS (%) 
CS (%) 
RS (%) 
LSRs (sec
-1
) 
CSRs (sec
-1
) 
RSRs (sec
-1
) 
Torsion (%) 
50.4 ± 13.9 
3.76 ± 0.89 
61.6 ± 7.45 
0.37 ± 0.06 
6.32 ± 1.16 
22.1 ± 2.95 
18.6 ± 4.8 
45.67 ± 19.3 
1.07 ± 0.13 
0.93 ± 0.23 
2.32 ± 0.51 
19.14 ± 7.2 
54.9 ± 15 
4.07 ± 1.18 
65.4±10.8 
0.37 ± 0.07 
6.54 ± 1.55 
21 ± 2.75 
17.1 ± 4.72 
45.16 ± 21.6 
1.07 ± 0.11 
1.27 ± 0.68 
2.16 ± 0.4 
18.57 ± 7.64 
53.2 ± 10.4 
3.8 ± 0.76 
63.6 ± 7 
0.38 ± 0.08 
6.16 ± 1.02 
19 ± 2.72 *† 
16.3 ± 5.34 
44.5 ± 20.5 
1.05 ± 0.13 
1.19 ± 0.57 
2.19 ± 0.59 
15.3 ± 5.3 
* indicates significantly different from Normal (P < 0.05). † significantly different 
from Overweight (P < 0.05). SV, stroke volume; FFM, fat-free mass; EF, ejection 
fraction; FS, fractional shortening; SWS, systolic wall stress; Sm, systolic 
myocardial velocity; LongS, longitudinal strain; CircS, circumferential strain; RadS, 
radial strain; LongSRs, longitudinal systolic strain rate; CircSRs, circumferential 
systolic strain rate; RadSRs, radial systolic strain rate.  
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4.3.6 LV diastolic function vs. body size and composition 
The allometric relationships between the measures of LV diastolic function 
and body size and composition are presented in Tables 4.8, 4.9 and 4.10. 
Generally, increasing degrees of body size were associated with reductions 
in LV diastolic function. Body surface area and BM, correlated negatively 
with E/A, Em, Em/Am and LongSRe/a and positively with A, IVRT, Am and 
LongSRa. These correlations were stronger with BM than BSA and were 
mediated by the adipose tissue component of BM rather than the muscular 
component. Indeed, all of the above mentioned variables of LV diastolic 
function displayed similar correlation patterns with FM, WC and EFT and no 
significant correlations were found with FFM. Waist circumference had the 
strongest correlations with measures of LV diastolic function (r values 
ranging from ~0.50 to ~0.60) as shown in table 4.6. Interestingly, CircSRe, 
CircSRa, RadSRe and RadSRe/a all positively correlated with BSA, BM, 
FM, WC and EFT. Relationships between LV diastolic functional measures 
and FFM have generally been non-significant. Additionally, the generated 
allometric power exponents were small with very broad 95% confidence 
intervals. Circumferential SRa was the only variable to correlate modestly (r 
= 0.38) with FFM, however this was an isolated finding and does not provide 
substantial evidence as to the need to normalise LV diastolic strain rate to 
FFM. Additionally, the generated allometric power exponent very broad 95% 
confidence intervals (0.4 to 2.36) indicating an unstable and weak 
relationship. 
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Table 4. 8 The allometric correlations (r) and allometric power exponents (b ± 95% confidence intervals) for PWD-derived 
LV diastolic function and indices of body size and composition 
 BSA BM HT FM FFM WC EFT 
E 
0.04 
(-0.07±0.43) 
0.10 
(-0.09±0.20) 
0.18 
(0.86±1.06) 
0.19 
(-0.07±0.08) 
0.10 
(0.15±0.34) 
0.13 
(-0.15±0.25) 
-0.05 
(0.02±0.08) 
A 
0.43 * 
(1.29±0.61) 
0.50 * 
(0.69±0.27) 
0.06 
(-.47±01.66) 
0.52 * 
(0.27±0.11) 
0.22 
(0.49±0.05) 
0.55 * 
(0.92±0.33) 
0.55 ** 
(0.31±0.29) 
E/A 
0.36 * 
(-1.25±0.72) 
0.45 * 
(-0.73±0.32) 
0.14 
(1.25±1.92) 
0.52 * 
(-0.32±0.12) 
0.12 
(-0.31±0.60) 
0.53 * 
(-1.05±0.38) 
-0.46 ** 
(-0.31±0.13) 
DCT 
0.10 
(0.40±0.88) 
0.05 
(0.09±0.72) 
0.20 
(2±2.17) 
0.06 
(-0.04±0.16) 
0.29 * 
(0.88±0.46) 
0.08 
(0.18±51) 
-0.05 
(-0.03±0.17) 
IVRT 
0.15 
(0.52±0.77) 
0.23 * 
(0.37±0.36) 
0.19 
(-1.63±1.95) 
0.28 * 
(0.16±0.13) 
0.03 
(-0.08±0.59) 
0.25 * 
(0.46±0.43) 
0.39 ** 
(0.25±0.14) 
* P < 0.05. E; early diastolic inflow velocity, A; late (atrial phase) diastolic inflow velocity, DCT; deceleration time, IVRT; isovolumetric 
relaxation time. 
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Table 4. 9 The allometric correlations (r) and allometric power exponents (b ± 95% confidence intervals) for TDI-derived LV 
diastolic function and indices of body size and composition 
 BSA BM HT FM FFM WC EFT 
Em 
0.28 * 
(-0.61±0.5) 
0.36 * 
(-0.37±0.27) 
0.11 
(0.55±1.36) 
0.44 * 
(-0.16±0.09) 
0.00 
(-0.01±0.45) 
0.47 * 
(-0.64±0.33) 
-0.36 ** 
(-0.16±0.12) 
Am 
0.25 * 
(0.56±0.6) 
0.31 * 
(0.33±0.28) 
0.07 
(-0.36±1.39) 
0.33 * 
(0.12±0.1) 
0.02 
(0.03±0.46) 
0.53 * 
(0.72±0.33) 
0.25 † 
(0.11±0.22) 
Em/Am 
0.31 * 
(-1.16±1.01) 
0.40 * 
(-0.70±0.46) 
0.13 
(1.04±2.3) 
0.47 * 
(-0.28±0.16) 
0.01 
(0.03±0.79) 
0.61 * 
(-1.35±0.52) 
-0.37 ** 
(-0.27±0.2) 
E/Em 
0.13 
(0.33±0.7) 
0.13 
(0.14±0.32) 
0.06 
(0.33±1.66) 
0.12 
(0.05±0.12 
0.05 
(0.1±0.58) 
0.19 
(0.28±0.42) 
0.17 
(0.08±0.13) 
* P < 0.05. A; late (atrial phase) diastolic inflow velocity, Em; early diastolic myocardial velocity, Am; late (atrial phase) diastolic myocardial 
velocity, E; early diastolic inflow velocity. 
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Table 4. 10 The allometric correlations (r) and allometric power exponents (b ± 95% confidence intervals) for 2DST-derived 
LV diastolic function and indices of body size and composition 
 BSA BM HT FM FFM WC EFT 
LongSRe 
0.09 
(-0.24±0.73) 
0.09 
(-0.11±0.35) 
0.03 
(-0.18±1.65) 
0.16 
(-0.07±0.12) 
0.05 
(0.09±0.55) 
0.10 
(-0.16±0.46) 
-0.31 * 
(-0.16±0.14) 
CircSRe 
0.32 * 
(1.17±0.97) 
0.42 * 
(0.72±0.44) 
0.17 
(-1.43±2.41) 
0.49 * 
(0.29±0.15) 
0.05 
(0.13±0.77) 
0.41 * 
(0.94±0.59) 
0.44 ** 
(0.32±0.18) 
RadSRe 
0.25 
(0.96±1.07) 
0.32 * 
(0.62±0.52) 
0.08 
(-0.67±2.38) 
0.35 * 
(0.27±0.19) 
0.00 
(0.01±0.79) 
0.32 * 
(0.74±0.63) 
0.17 
(0.13±0.22) 
LongSRa 
0.31 * 
(0.68±0.59) 
0.47 * 
(0.49±0.26) 
0.35 * 
(-1.7±1.32) 
0.59 * 
(0.21±0.08) 
0.09 
(-0.14±0.47) 
0.52 * 
(0.71±0.33) 
0.34 * 
(0.15±0.12) 
CircSRa 
0.40 * 
(1.86±1.23) 
0.41 * 
(0.89±0.58) 
0.12 
(1.32±3.17) 
0.29 * 
(0.23±0.22) 
0.38 * 
(1.38±0.98) 
0.40 * 
(1.11±0.75) 
0.14 
(0.14±0.28) 
RadSRa 
0.07 
(-0.31±1.47) 
0.10 
(-0.23±0.71) 
0.06 
(0.62±3.14) 
0.04 
(-0.04±0.27) 
0.04 
(-0.15±1.14) 
0.05 
(-0.12±0.78) 
0.03 
(0.02±0.32) 
* P < 0.05. LongSRe; longitudinal early diastolic strain rate, CircSRe; circumferential early diastolic strain rate, RadSRe; radial early diastolic strain rate, LongSRa: longitudinal 
late (atrial phase) diastolic strain rate, CircSRa; circumferential late (atrial phase) diastolic strain rate, RadSRa: radial late (atrial phase) diastolic strain rate. 
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4.3.7 LV diastolic function: is there a difference between normal 
weight, overweight and obese participants? 
Tables 4.11 and 4.12 present the values (mean ± SD) of absolute and 
allometrically scaled LV diastolic function in normal weight, overweight and 
obese subjects. Both overweight and obese subjects exhibited poorer LV 
diastolic function compared to their normal-weight counterparts. This was 
demonstrated by significantly higher A, IVRT, Am (obese group only) and 
LongSRa and lower E/A, Em/Am and longSRe/a. However, both overweight 
and obese subjects had significantly higher CircSRe, RadSRe and 
RadSRe/a than normal-weight women. The only variable that was 
significantly higher in the obese compared to the overweight group was 
RadSRe. Interestingly, all these measures became non-significantly different 
between the 3 groups after they were allometrically scaled to BSA and BM. 
Finally, E velocity, DCT and E/Em were similar in the 3 groups. 
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Table 4. 11 Standard PW- and TDI-derived echocardiographic 
measures of LV diastolic function in normal weight, overweight 
and obese women before and after allometric scaling for body 
size 
 Normal Overweight Obese 
E (ms) 
A (ms) 
A/BSA
1.29
 
A/BM
0.69
 
E/A 
DcT (ms) 
IVRT (ms) 
IVRT/BM
0.37 
Em (ms) 
Em/BSA
-0.61
 
Em/BM
-0.37
 
Am (ms) 
Am/BSA
0.56
 
Am/BM
0.33 
Em/Am 
E/Em 
94.1 ± 18.3 
45.6 ± 13.1 
23.4 ± 5.2 
2.67 ± 0.58 
2.11 ± 0.66 
198.3 ± 70.2 
79.5 ± 8.3 
17.7 ± 1.9 
8.83 ± 0.96 
11.8 ± 1.5 
39.6 ± 4.7 
6.31 ± 1.16 
4.58 ± 0.99 
1.56 ± 0.34 
1.42 ± 0.37 
10.4 ± 3.6 
87.7 ± 14.5 
56.9 ± 11.7 * 
24.8 ± 6.8 
2.77 ± 0.74 
1.61 ± 0.43 * 
172.1 ± 52.1 
115.4 ± 53 * 
18.3 ± 4.4 
7.55 ± 1.19 * 
11.7 ± 2.4 
39.2 ± 7.5 
6.99 ± 1.31 
5.07 ± 0.95 
1.74 ± 0.33 
1.13 ± 0.27 * 
11.5 ± 2.1 
87 ± 14.7 
61.3 ± 14.3 * 
22.4 ± 5.7 
2.53 ± 0.65 
1.48 ± 0.51 * 
191.3 ± 67 
104.2 ± 39.9 * 
18 ± 3.4 
7.25 ± 1.6 * 
12.2 ± 1.6 
40.9 ± 4.7 
7.68 ± 1.26 * 
4.68 ± 0.92 
1.6 ± 0.31 
1.02 ± 0.43 * 
12.3 ± 2.9 
* indicates significantly different from Normal (P < 0.05). † significantly 
different from Overweight (P < 0.05). E, early diastolic inflow velocity; A, late 
(atrial phase) diastolic inflow velocity; DCT, deceleration time; IVRT, 
isovolumetric relaxation time; Em, early diastolic myocardial velocity; Am, 
late (atrial phase) diastolic myocardial velocity. 
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Table 4. 12 2DST-derived longitudinal, circumferential and radial 
diastolic strain rate in normal weight, overweight and obese women 
before and after allometric scaling for body size 
 Normal Overweight Obese 
LongSRe (sec
-1
) 
CircSRe (sec
-1
) 
CircSRe/BSA
1.17
 
CircSRe/BM
0.72 
RadSRe (sec
-1
) 
RadSRe/BM
0.62 
LongSRa (sec
-1
) 
LongSRa/BSA
0.31
 
Long SRa/BM
0.47 
CircSRa (sec
-1
) 
CircSRa/BSA
1.86
 
CircSRa/BM
0.89 
RadSRa (sec
-1
) 
LongSRe/a 
CircSRe/a 
RadSRe/a 
1.54 ± 0.35 
1.00 ± 0.35 
0.55 ± 0.15 
0.05 ± 0.01 
1.19 ± 0.32 
0.12 ± 0.03 
0.72 ± 0.1 
0.62 ± 0.07 
0.10 ± 0.01 
0.49 ± 0.13 
0.17 ± 0.03 
0.01 ± 0.00 
1.33 ± 0.84 
2.21 ± 0.69 
2.06 ± 0.82 
0.97 ± 0.31 
1.41 ± 0.35 
1.35 ± 0.4 * 
0.66 ± 0.21 
0.06 ± 0.02 
1.79 ± 0.64 * 
0.10 ± 0.03 
0.89 ± 0.16 * 
0.72 ± 0.16 
0.12 ± 0.02 
0.57 ± 0.27 * 
0.21 ± 0.09 
0.01 ± 0.01 
1.37 ± 0.73 
1.63 ± 0.46 * 
2.65 ± 1.11 
1.76 ± 1.1 * 
1.42 ± 0.32 
1.42 ± 0.33 * 
0.56 ± 0.16 
0.05 ± 0.01 
2.35 ± 0.76 *† 
0.11 ± 0.04 
0.95 ± 0.17 * 
0.63 ± 0.10 
0.10 ± 0.02 
0.68 ± 0.35 * 
0.20 ± 0.07 
0.01 ± 0.00 
1.12 ± 0.67 
1.55 ± 0.47 * 
2.61 ± 0.72 
1.74 ± 0.63 * 
* significantly different from Normal (P < 0.05). † significantly different from 
Overweight (P < 0.05). LongSRe, early diastolic longitudinal strain rate; 
CircSRe, early diastolic circumferential strain rate; RadSRe, early diastolic 
radial strain rate; LongSRa, late (atrial phase) diastolic longitudinal strain 
rate; CircSRa, late (atrial phase) diastolic circumferential strain rate; 
RadSRa, late (atrial phase) diastolic radial strain rate; BSA, body surface 
area; BM, body mass. 
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4.4 Discussion 
The principal findings of this study were that LV size and morphology relate 
to overall body size and composition in a non-linear fashion. Furthermore, 
scaling LVM to BSA or BM, even allometrically, results in over-correction for 
body size as it removes the impact of adipose as well as non-adipose tissue, 
leading to the underestimation of LVM in overweight and obese subjects. 
Scaling to FFM successfully partitions out individual differences in non-
adipose tissue size and allows the identification of the impact of excess 
adipose tissue on LV size. This study also shows that excess visceral fat is 
associated with concentric as opposed to eccentric LV hypertrophy. 
Moreover, LV functional indices did not correlate with FFM, ruling out the 
need for normalisation prior to comparison between groups. This study 
shows that obesity is associated with more pronounced diastolic than 
systolic dysfunction, the latter being fairly subtle and only detected by novel 
2DST echocardiography. Finally, this study identified for the first time an 
association between excess epicardial fat thickness and reduced LV systolic 
myocardial deformation in healthy obese women, not associated with 
excess body fat or abdominal visceral fat, pointing to a possible mechanical 
impact of epicardial fat on LV systolic function.  
4.4.1 Impact of body size and composition and excess adiposity 
on LV size and morphology 
Generally, a positive correlation was found between overall LV size and 
body size confirming the already established notion that obesity is 
associated with LV hypertrophy. However, this relationship was non-linear 
as indicated by the absence of Tanner’s special circumstance between each 
pair of LV size vs. body size. Allometric scaling was therefore used as 
adopting the ratio scaling technique to compare individuals of different sizes 
would have been inappropriate.  
The generated allometric power exponents for LVM scaled to body size and 
composition further confirmed the non-linear association and were similar to 
values previously reported by Batterham (Batterham and George, 1998, 
Batterham et al., 1997). As explained by Batterham, theoretically the 
relationship between LV and body dimensions should follow the theory of 
geometric similarity, ie. LVM (3-dimensional) should scale to BM (3-
dimensional) to the power of 1.0, to height (1-dimensional) to the power of 
3.0 and to BSA (2-dimensional) to the power of 1.5. Similarly, LVID (1-
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dimensional) should scale to BM (3-dimensional) to the power of 0.33, to 
height to the first power and to BSA (2-dimensional) to the power of 0.5 
(Batterham et al., 1999). In this study, the theory of geometric similarity did 
not apply with all body size and composition variables.  
With regards to body size variables (ie. BM, height and BSA), the generated 
allometric exponent for LVM scaled to BSA followed the dimensionality 
theory. However this was not the case when scaled to BM or height. Indeed, 
LVM scaled to BSA to a power exponent of 1.3 (P < 0.05) which is not 
significantly different from 1.5 and included it in the 95% CI. When LVM was 
scaled to BM, the generated allometric exponent was 0.64 (P < 0.05) which 
is significantly lower than 1.0 and not within the 95%CI. This finding is in line 
with a previous study by (Batterham et al., 1997) reporting an allometric 
exponent of 0.78. This appears to be secondary to the adipose tissue 
component of BM as we show that the allometric exponent for LVM scaled 
to FM  is 0.19 (P < 0.05) which is significantly lower than 1.0 and does not 
include it in the 95%CI. In contrast, the allometric exponent for LVM scaled 
to FFM was 0.92 (P < 0.05) which is not significantly different from 1.0 and 
included it in the 95% CI. This indicates that LVM increases with increasing 
adipose tissue to a lesser rate than it does with muscle tissue. Therefore, 
the scaling exponent of LVM to BM will reduce with increasing adipose 
tissue content. This is in contrast to previous reports by (Batterham and 
George, 1998) showing no significant correlation between LVM and FM and 
suggested that the influence of fat on LV hypertrophy is negligible. However, 
their studies consisted of young healthy non-obese men and women with an 
average body fat content of ~22% as opposed to our cohort which included 
overweight and obese subjects with body fat of up to ~45%. In the Strong 
Heart Study, a significant correlation between LVM and FM was reported in 
a population of healthy obese men and women which is in line with our 
findings (Bella et al., 1998). Interestingly, we did not observe any 
significantly correlation between HT and both LVM or LVIDd (P > 0.05) and 
the generated allometric exponents were not significantly different from zero. 
This may be due to the limited range of heights in our cohort. Previous 
studies showed a significant correlation between HT and both LVM and 
LVIDd with allometric exponents not significantly different from predicted 
values by the dimensionality theory. Batterham reported an allometric 
exponent of 0.63 for LVIDd scaled to HT, and 1.0 was included in the 95%CI 
(Batterham and George, 1998). However the allometric power exponent for 
LVM scaled to HT reported by different studies has been variable. (de 
Simone et al., 1992) reported a value 2.7, whereas (Chirinos et al., 2010, 
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Daniels et al., 1995) reported values of 1.7 and 3.0 respectively. This 
indicates the necessity of using sample-specific allometric power exponents 
in all studies where scaling is needed, as was suggested by Batterham 
(Batterham et al., 1997). In this study we show that LVIDd does not correlate 
with BM or BSA which contradicts reports by (Batterham et al., 1998). This 
appears to be due to the observed opposite influences of both adipose and 
non-adipose tissue on LVIDd, as will be explained below.  
With regards to body composition, the theory of geometric similarity applied 
only with FFM as the allometric exponents for LVM and LVIDd scaled to 
FFM were 0.92 and 0.23 respectively (P < 0.05). These values are fairly 
close to the values predicted by the dimensionality theory (1.0 and 0.33 
respectively) both of which were included in the 95% CI. Similar values were 
previously reported by (Batterham et al., 1997) and (Batterham and George, 
1998). However, as mentioned above the allometric exponent for LVM 
scaled to FM was 0.19 (P < 0.05). LVIDd negatively correlated with FFM and 
the generated allometric exponent was -0.05 (P < 0.05) and zero was not 
included in the 95% CI. The fact that LVIDd correlated positively with FM 
and negatively with FFM could explain the lack of correlation with BM and 
BSA as the two opposite impacts of adipose and muscle mass would have 
eliminated one another when combined into one body size variable. This 
contradicts previous reports by (Bella et al., 1998) showing a positive 
correlation between LVIDd and FM. 
On group comparison, normalizing LVM for FFM
0.92
, appropriately 
partitioned out the individual differences in non-adipose tissue content and 
strictly identified the impact of obesity on LV size by showing significantly 
larger LVM/FFM
0.92
 in the overweight and obese females. However, 
normalising for BM
0.64
 or BSA
1.3
 resulted in all 3 groups having non-
significantly different LVM/BM
0.64
 and LVM/BSA
1.3
. Therefore, when 
comparisons between subjects of different body sizes is to be carried out, 
LV size should be allometrically scaled to FFM and not BM or BSA in order 
not to mask the influence of adipose tissue, as was previously suggested 
(Batterham et al., 1999, De Simone et al., 2011, George et al., 2009). 
Finally, with regards to the impact of obesity on LV morphology, our study 
shows that obesity is associated with LV concentric remodelling and 
hypertrophy. This has been previously shown by several studies (Gutin et 
al., 1998, Peterson et al., 2004, Wong et al., 2004, Woodiwiss et al., 2008) 
and is in contrast with the classic predominant notion that obesity is rather 
associated with LV eccentric hypertrophy (Nakajima et al., 1985, Smith HL, 
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1933). Our results suggest that visceral adiposity is the key mediator of this 
concentric morphology as both WC and EFT, which is the visceral fat depot 
of the heart, both strongly correlated with RWT. In fact, EFT displayed the 
strongest correlations with all the measures of LV size and morphology. 
Hence, as suggested by (Iacobellis et al., 2004) EFT is a better surrogate 
marker for visceral adiposity than WC. Several mechanisms have been 
proposed for LV hypertrophy in obesity including haemodynamic changes, 
neurohormonal factors including insulin, Angiotensin II, cathecholamines, 
oxidative stress and nitric oxide synthase (Garcia and Incerpi, 2008, Wong 
and Marwick, 2007b). Insulin-resistance and hyperinsulinemia, are believed 
to be responsible for the concentric morphology as several studies reported 
a strong association between markers of insulin resistance and fasting 
insulin levels and concentric LV morphology (Lind et al., 1995, Ohya et al., 
1996, Sundstrom et al., 2000). 
4.4.2 The allometric relationship between body size on LV 
function 
Measures of LV function have not been routinely scaled to body size in 
cardiac research. Nevertheless, stroke volume index (SVI) and cardiac index 
(CI) are fairly popular and traditionally used measures of LV systolic function 
(Schuster et al., 2012, Vella et al., 2009). They consist of ratio-scaling SV 
and CO to BSA and are considered size independent measures of LV pump 
function. However, in a population of 970 normotensive individuals, (De 
Simone et al.,1997) showed that the relationship between SV and CO and 
body size is non-linear and that both SVI and CI underestimated LV function 
in overweight and obese subjects. The reported allometric exponents for CO 
scaled to BSA, BM and height were 0.62, 0.41 and 1.16 respectively and for 
SV scaled to the same variables were 0.93, 0.62 and 1.78 respectively. Our 
results are not very far from these values as the allometric exponents for SV 
scaled to BSA, BM and height we reported were 0.75, 0.34 and 0.97 
respectively, though height did not reach statistical significance (P > 0.05). 
Furthermore, we report a significant correlation between SV and both BSA 
and BM, which is mediated by FFM, as SV did not correlate with FM. FFM 
was previously shown to be the strongest independent correlate of SV in the 
Strong Heart Study cohort (Bella et al., 1998, Collis et al., 2001) and an 
allometric exponent of 0.73 was previously reported by (Turley et al., 2007) 
for submaximal SV scaled to FFM in women, which is not far from our value 
(0.67). In our subjects, SV did not significantly differ between the normal-
weight, overweight and obese groups, which is probably due to the small 
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differences in FFM between the 3 groups (48.7 ± 7.65 vs 47.8 ± 6.26 vs 52.1 
± 4.98 g) respectively. With regards to diastolic function, DCT was the only 
variable to show a significant correlation with FFM with an allometric 
exponent of 0.88, however it did not correlate with BSA or BM. This 
relationship is fairly weak (r = 29) and requires further confirmation in larger 
population samples. 
To the best of our knowledge, the need to scale measures of LV myocardial 
velocity and deformation to body size has not been previously investigated. 
The interest in previous studies has rather been on whether or not these 
measures needed to be scaled to LV chamber size. Indeed, (Batterham et 
al., 2008) reported a close to linear correlation between LVL and both peak 
Sm and Em, suggesting that these two variables should be normalised to 
LVL. However, (Oxborough et al., 2009) reported no relationship between 
LV dimensions and both global LV strain and strain rate ruling out the need 
to normalise measures of myocardial deformation to chamber size. Our 
results show that myocardial velocity and strain are not influenced by overall 
body size or FFM. There is no need to normalise for body size prior to 
comparison between groups in order to explore the influence of obesity on 
these measures. This is not surprising given that myocardial strain is a size-
independent variable as it represents the magnitude of change in length 
relative to the original length. 
4.4.3 Impact of excess body fat on LV function 
Our results indicate that, in healthy overweight and mildly obese women, 
excess adipose tissue is associated with a reduction in both systolic and 
diastolic function, the latter being more pronounced than the former.  
Indeed, standard echocardiographic and tissue Doppler-derived measures 
of systolic function including SV, CO, EF and peak Sm were preserved in 
overweight and obese women. A significant reduction in longitudinal strain 
was observed in the obese group compared to overweight and lean 
counterparts. This has previously been reported by several studies (Di Salvo 
et al., 2006, Kuznetsova et al., 2008, Tumuklu et al., 2007, Wong et al., 
2004). Log-linear correlation analysis showed a significant inverse 
correlation between LongS and FM, WC and EFT. There was no difference 
between the 3 groups in SRs in all three directions or circumferential and 
radial S. Interestingly, we show that LongS inversely correlated with EFT 
more than WC (r = -0.33 vs -0.29 respectively), and in addition, Long SRs 
and CircS also displayed a significant negative correlation with EFT, though 
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this was not the case with FM or WC. This suggests an independent 
negative impact of excess EFT on LV systolic strain rate, possibly indicating 
a mechanical influence rather than an influence of general increase in body 
fat. EFT was previously shown to be related to subclinical dysfunction in 
right ventricular strain and strain rate in patients with metabolic syndrome 
(Gokdeniz et al., 2014). To the best of our knowledge, this is the first 
reported independent association between EFT and reduced LV 
deformation in healthy overweight/obese females. 
As for diastolic function, changes were more pronounced. A reduction in 
mitral annular IVRT was detected in the obese group in addition to a 
reversal in the ratio of early-to-late diastolic filling velocities, myocardial 
velocities and longitudinal SR. It was observed that the reversal in the early-
to-late ratio of diastolic function was a result of increased late diastolic 
phase with little or no change in the early phase. This pattern was previously 
reported in healthy overweight/obese subjects (Di Bello et al., 2006, 
Koopman et al., 2012, Orhan et al., 2010, Wierzbowska-Drabik et al., 2013) 
and possibly reflects a very early sign of LV diastolic dysfunction since the 
increase in the late phase, which indicates increased left atrial contraction 
and/or increased LV compliance, could be compensatory to a subtle 
reduction in early myocardial diastolic relaxation. We also reported a 
paradoxical increase in CircSRe and RadSRe, possibly compensatory to the 
reduction in longitudinal diastolic deformation. Log-linear correlation 
confirmed the significant association between excess adiposity including 
FM, WC and EFT and LV diastolic dysfunction represented in LV diastolic 
filling velocities, myocardial velocity and deformation. Finally, measures of 
preload and afterload were all preserved in our subjects including LV end-
diastolic volume, left atrial diameter and volume, E/Em ratio and LV SWS, 
indicating that systolic and diastolic functional changes were not a reflection 
of changes in pre-load or after-load. Several mechanisms have been 
proposed to explain the adverse LV systolic and diastolic functional changes 
associated with obesity. The most well-recognised mechanism of LV 
dysfunction is the haemodynamic mechanism (Alpert, 2001, Wong et al., 
2004). The high metabolic demands associated with obesity result in a high 
intravascular blood volume. This results in increased preload with 
subsequent increased stroke volume by the Frank-Starling mechanism. LV 
chamber dilatation and stretching of the walls of the LV with the increased 
wall stress, induce LV remodelling and hypertrophy to reduce wall stress. 
This pathological hypertrophy results in myocardial fibrosis and reduced LV 
compliance leading to diastolic function. Eventually, afterload also develops 
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and LV systolic dysfunction occurs. However, recent evidence suggest that 
other mechanisms play important roles in LV dysfunction including insulin-
resistance induced metabolic changes in glucose vs fatty acid utilisation, 
myocardial fatty infiltration and steatosis, pro-inflammatory cytokine release 
and reactive oxygen species, leptin-insensitivity and reduced adiponectin 
expression, all of which result in contractile dysfunction and subsequent 
systolic and diastolic failure. 
4.4.4 Conclusions 
This study has several outcomes: (1) It confirms the strong impact of body 
size and composition on LV size and the importance of normalising LV size 
variables to body size, particularly FFM, using allometric scaling before the 
comparison between subjects is to be carried out. Furthermore, If the impact 
of excess body fat is to be studied, especially in mild obesity, scaling for 
BSA, even using allometric procedures, may underestimate LV size and 
mask the influence of adipose tissue. Therefore FFM should be used 
instead using sample-specific allometric power exponents. (2) This study 
highlights the importance of novel TDI and 2DST echocardiographic 
techniques and their higher sensitivity in detecting subclinical and subtle 
systolic and diastolic dysfunction in mild obesity compared to standard 
echocardiography. Indeed, we show that, in healthy overweight and obese 
women, visceral adiposity is associated with concentric LV morphology, 
decreased LV longS, Em and LongSRe with compensatory increase in 
CircSRe and ʀadSRe despite normal standard echocardiographic measures 
of systolic and diastolic function. (3) Epicardial fat thickness is strongly 
associated with obesity-mediated LV structural and functional changes and 
appears to have an independent negative mechanical impact on LV systolic 
deformation, not mediated through general adiposity. 
4.4.5 Study limitations 
This study included women only and does not take into account other 
physiologically relevant factors such as race or age. Furthermore, the 
number of participants is relatively small, which would have affected the 
strength of our observations. Finally, this is a cross-sectional observational 
study performed at one point in time and hence does not give information on 
cause and effect. Bigger-sized longitudinal studies, supported by cellular 
and molecular techniques are needed in order to determine explanatory 
mechanisms of the observed findings, follow their change over time at both 
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the population and individual levels and increase the statistical strength of 
the observations. 
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Chapter 5 The assessment of left ventricular response to 
heavy-intensity exercise in obese women 
5.1 Introduction 
Overweight and obesity are important independent risk factors for the 
development of heart failure in women (Dagenais et al., 2005). They 
mediate subtle LV morphological and functional changes in otherwise 
healthy individuals, that can remain silent for years and undetectable by 
standard echocardiography. In the previous chapter excess body fat, 
particularly visceral adipose tissue, was associated with concentric LV 
remodelling and reduced systolic and diastolic myocardial deformation 
despite normal EF, SV and CO in healthy normotensive overweight/obese 
women. Weight loss can be a challenging task for obese women, and its 
maintenance remains extremely difficult. Furthermore, the worldwide 
prevalence of obesity is on the rise (Rennie and Jebb, 2005). Recent 
evidence suggest that exercise alone can improve and restore cardiac 
function in obese individuals without the need for dietary modification and 
weight loss (Ingul et al., 2010, Schuster et al., 2012). Indeed, Ingul et al. 
showed that, in obese adolescents, LV systolic and diastolic function both at 
rest and during exercise, improved to levels comparable to non-obese 
controls after 3 months of aerobic training, without any accompanying weight 
loss (Ingul et al., 2010). Despite the large body of evidence on the LV 
structural and functional adaptations to short and long periods of aerobic 
exercise training in healthy mild-moderately obese individuals (Baynard et 
al., 2008, Eriksson et al., 2010, Humphries et al., 2002, Ingul et al., 2010, 
Millen et al., 2014, Mitchell et al., 2002, Schrauwen-Hinderling et al., 2010, 
Schuster et al., 2009, Sijie et al., 2012, Stewart et al., 2006, Vogelsang et 
al., 2008, Weiner and Baggish, 2012), very little is known about LV systolic 
and diastolic functional changes during acute exercise in this population, 
particularly women. Older studies tended to assess morbidly obese subjects 
(Alexander and Peterson, 1972, Alpert et al., 1989, Ferraro et al., 1996, 
Salvadori et al., 1999) and to date, most studies have predominantly 
focused on CO, SV and/or EF during exercise (Alpert et al., 1989, Ferraro et 
al., 1996, Licata et al., 1992, Rowland et al., 2003, Sasso et al., 2005, Vella 
et al., 2009). These measures are strongly influenced by changes in preload 
and afterload and are not sensitive enough to detect subtle changes in 
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myocardial contractility during exercise. Only two studies have assessed LV 
myocardial velocity during exercise in obese children (Ingul et al., 2010, 
Schuster et al., 2012) and of these two studies, only one study assessed 
longitudinal deformation (Ingul et al 2010). Schuster demonstrated that 
moderately obese children, despite having similar peak Sm to lean controls 
at rest and throughout incremental exercise, they reached significantly lower 
levels at submaximal and maximal exercise. This was not the case for 
overweight children that displayed similar LV systolic function to lean 
controls both at rest and during all exercise intensities. This may indicate 
that LV systolic function is preserved in mild degrees of obesity and that as 
the degree of obesity increases, subtle reductions in LV systolic function 
may occur (Schuster et al., 2012). Ingul  reported lower LV systolic and 
diastolic myocardial velocity and deformation both at rest and during cycling 
at a workload of 100 W in obese adolescents compared to lean 
counterparts. However, this technique of using an absolute rather than 
relative workload does not account for individual differences in cardio-
pulmonary fitness and hence may result in discrepancies between subjects. 
Furthermore, this study did not assess the amount of exercise-induced 
change in LV function between both groups (Ingul et al., 2010). 
LV function during exercise has been predominantly assessed during 
incremental exercise test until exhaustion (Licata et al., 1992, Rowland et 
al., 2003, Schuster et al., 2012) or during steady cycling at fixed work rates 
of 40-50 W, 70-75 W and/or 100 W (Salvadori et al., 1999, Vella et al., 
2009, Ingul et al., 2010). This does not accurately normalise the exercise 
intensity between subjects as it does not account for individual differences in 
cardiorespiratory fitness. Participants exercising at these fixed work rates 
may be at different exercise intensities above or below their lactate 
threshold depending on their level of cardiorespiratory fitness. Thus, the 
physiological stimulus for LV response to exercise may vary between 
participants which may lead to disparity in results between studies or 
between participants of the same study. 
To date, the assessment of LV function during acute heavy-intensity 
exercise, determined based on individual lactate thresholds, in healthy 
overweight/obese women has not been studied. Furthermore, no information 
is available in the literature on LV systolic and diastolic function during 
recovery from acute heavy-intensity exercise in healthy overweight/obese 
women or indeed in obese subjects in general. 
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Therefore, the aims of this chapter were to compare between healthy 
overweight/obese and non-obese women with regards to LV systolic and 
diastolic function during, and after 5 minutes of recovery from,  heavy-
intensity exercise using standard and novel echocardiographic techniques. 
This will potentially allow the identification of the presence or absence of 
subtle LV  systolic and/or diastolic dysfunction in overweight/obese women 
not detected at rest and only revealed under the additional exercise-induced 
stress. Furthermore, it will allow the potential identification of beneficial 
exercise-induced alterations in LV function, which would help expand our 
understanding of LV adaptation to aerobic exercise training. Finally, it will 
allow the potential identification of differences between overweight/obese 
and non-obese women in LV response to exercise secondary to excess 
body fat. It was hypothesised that healthy overweight/mildly obese women 
would display subtle exercise-induced reduction in LV function not detected 
at rest and would manifest greater benefit than non-obese women from 
heavy-intensity exercise on LV function. 
5.2 Methods 
5.2.1 Participants 
Sixteen healthy women (age 33.4 ± 3.9 years) were recruited for the study 
through local poster advertisements across the University of Leeds campus. 
All volunteers confirmed being healthy and free of known cardiovascular 
disease and were not on any form of prescribed medication. Exclusion 
criteria other than specified in the general methods included involvement in 
regular and/or heavy physical exercise more than twice weekly. A 12-lead 
ECG was carried out at rest prior to testing and throughout the 
cardiopulmonary exercise test to rule out ECG abnormalities. 
5.2.2 Experimental protocol 
Participants were invited to attend the University of Leeds exercise 
physiology laboratory on two occasions. On the first visit, participants were 
first given a chance to familiarise themselves with the equipment and ask 
questions. Then, after recording their anthropometric measurements, 
participants completed a cardiopulmonary fitness test for the assessment of 
VO2max and LT, in order to be used for the calculation of the work-rates to be 
used for the subsequent exercise sessions. The second visit was at least 
one week after the first one and consisted of a 10-minute heavy-intensity 
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exercise on a semi-supine bicycle ergometer (Lode BV Medical Technology, 
Groningen, Netherlands). The echocardiographic assessment of LV function 
was carried out at rest, 8 min after the start of cycling and 5 min after the 
end of the exercise session (Figure 5.1). The control factors for the two 
sessions are detailed in the general methods chapter. 
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Figure 5. 1 Schematic representation of the heavy-intensity exercise 
session. Echocardiographic imaging was carried out at 3 time points, 
(1) after 5 min of rest, (2) after 8 min of heavy-intensity exercise in the 
form of semi-supine cycling at 120%LY and (3) after 5 min recovery. 
5.2.3 Measured variables 
5.2.3.1 Anthropometric variables  
Anthropometric measurements included body mass (BM), height (HT), waist 
circumference (WC), hip circumference (HC) and waist to hip ratio (W:H 
ratio). Body mass index (BMI) and body surface area (BSA) were calculated 
as explained in the general methods chapter. 
5.2.3.2 Echocardiographic variables 
Echocardiographic techniques are explained in details in the General 
Methods chapter (Chapter 3, section 3.4). Echocardiography was completed 
at rest, after 8 min of the start of the exercise session and 5 min after the 
end of the session and included standard 2D, PWD, TDI and 2DST 
echocardiography. Standard 2D measurements included IVSTd, PWTd, 
LVIDd, LVM, RWT, LAD, EDV, ESV, SV, EF and LAV. PWD 
echocardiographic variables included E, A, E:A, IVRT and DCT.  TDI 
echocardiographic variables included Em, Am, Em:Am and E/Em. Finally, 
2DST echocardiographic variables included LongS, LongSRs, LongSRe, 
LongSRa, LongSRe/a, CircS, CircSRs, CircSRe, CircSRa, CircSRe/a, RadS, 
RadSRs, RadSRe, RadSRa, RadSRe/a and LVTor. 
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5.2.3.3 Cardiopulmonary fitness 
An incremental ramp test was performed on a semi-supine cycle ergometer 
at 12 W/min to determine maximal oxygen uptake (VO2peak) and WRpeak. 
This was followed by a step exercise at 105% WRpeak to determine a second 
VO2peak, and the average of both were used as VO2max as explained in the 
general methods (Chapter 3, section 3.5). Lactate threshold (LT) and its 
corresponding WR (WRLT) were then determined for the calculation of 120% 
WRLT to be exercised at in the subsequent exercise session.  
5.2.4 Exercise session protocol 
All participants refrained from vigorous exercise for 24 hours and avoided 
alcohol and caffeine for 4 hours prior to exercise session. Participants 
completed a 10-min heavy-intensity exercise session on a semi supine cycle 
ergometer. The exercise session consisted of cycling in the semi-supine 
position at 120% WRLT, which falls in the heavy intensity domain (Rossiter, 
2011). Prior to commencement of the session, participants were seated on 
the semi-supine cycle ergometer for a 5-min rest period followed by a 2-min 
warm-up period of unloaded cycling at 20 W. During the rest period, 
baseline echocardiographic assessment of LV function was carried out. 
After 8 min of cycling at 120% WRLT, the cycle ergometer was tilted slightly 
to the left, a second echocardiographic assessment of LV function was 
performed during exercise and then the cycle ergometer was tilted back to 
its original position. Participants were instructed to maintain a cadence of > 
60 rpm throughout the session which was stopped after 10 min of cycling. 
Finally, a third echocardiographic assessment of LV function was carried out 
after 5 min of recovery. A schematic representation of the exercise session 
protocol is presented in Figure 5.1. 
5.2.5 Statistical analysis 
Data were checked for normality of distribution using a Kolmogorov-Smirnov 
test. Both groups’ resting anthropometric, blood pressure, cardiorespiratory 
and echocardiographic parameters were compared using independent t-
tests. The effect of exercise and recovery were analysed using a mixed 
mode ANOVA with repeated measures for time (rest vs. exercise vs. 
recovery) as the within subjects factor and group (obese vs. non-obese) as 
the between-subjects factor. At rest, HR, IVRT and Em/Am were 
significantly different between the two groups (P < 0.05), therefore resting 
values of these variables were added as covariate to the ANOVA. Post-hoc 
analysis was carried out using paired t-tests in the presence of significant 
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time by group interaction to identify which variables changed significantly. 
Student’s independent t-tests were performed to compare between both 
groups’ percentage change from rest to exercise.   
5.3 Results 
5.3.1 Participant and exercise session characteristics 
The anthropometric, BP and cardio-respiratory fitness characteristics of the 
obese and non-obese groups are displayed in Table 5.1. The total number 
of participants was 16, consisting of 8 obese and 8 non-obese females. The 
obese group had a significantly higher average weight, BMI, BSA, WC and 
W:H ratio than the non-obese group (P < 0.05). Both groups had similar BP 
readings. With regards to cardio-respiratory fitness, absolute VO2max, LT, 
LT% and WRLT did not differ between groups (P > 0.05) However the obese 
group had a significantly lower relative VO2max (P < 0.05)  and a trend for a 
lower average WR120%LT than the non-obese group (P = 0.08). All 16 
participants completed the exercise sessions. Groups did not differ in LV 
size and morphology including LVM, LVIDd, PWT, IVSTd and RWT (P > 
0.05). 
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Table 5. 1 Anthropometric, body composition, BP and cardio-
respiratory fitness measurements (mean ± SD) of the obese and non-
obese women 
 Obese Non-Obese 
Weight (kg) 
Height (m) 
BMI (kg/m
2
) 
BSA (m
2
) 
Waist (cm) 
W:H ratio 
SBP (mmHg) 
DBP (mmHg) 
Absolute VO2max (L/min) 
Relative VO2max (ml/kg/min) 
LT (L) 
LT (%)  
WRLT (W) 
WR120%LT (W) 
LVM (g) 
LVIDd (cm) 
PWTd (cm) 
IVSTd (cm) 
RWT 
93.8 ± 11.2 * 
1.63 ± 0.17 
32.9 ± 3.5 * 
1.99 ± 0.18 * 
100.6 ± 12.4 * 
0.87 ± 0.09 * 
122.5 ± 7.1 
81.3 ± 2.3 
2.09 ± 0.56 
22.6 ± 6.35 * 
1.08 ± 0.18 
53.2 ± 11.2 
64.4 ± 8.5 
75.5 ± 11.03 † 
133.8 ± 27.2 
4.21 ± 0.51 
0.94 ± 0.2 
1.01 ± 0.18 
0.47 ± 0.09 
67.3 ± 7.2 
1.71 ± 0.08 
22.9 ± 1.1 
1.79 ± 0.14 
74.6 ± 5.1 
0.77 ± 0.03 
120 ± 9.3 
79.4 ± 6.8 
2.53 ± 0.83 
37.0 ± 8.04 
1.19 ± 0.31 
48.4 ± 10.2 
77.4 ± 19.1 
92.8 ± 23.1 
129.9 ± 18.4 
4.51 ± 0.49 
0.93 ± 0.12 
0.96 ± 0.18 
0.42 ± 0.07 
BMI = body mass index, BSA = body surface area, W:H ratio = waist to hip 
ratio, SBP = systolic blood pressure, DBP = diastolic blood pressure, LT = 
lactate threshold, WRmax = work rate at VO2max, WR120%LT = work rate at 
120% of lactate threshold. LVM = left ventricular mass, LVIDd = LV diastolic 
internal diameter, PWTd = diastolic posterior wall thickness, IVSTd = 
diastolic inter-ventricular septum thickness, RWT = relative wall thickness.  * 
= significant difference (P < 0.05) between obese and non-obese groups. † 
= close to significant difference (P < 0.09) between obese and non-obese 
groups. 
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5.3.2 Haemodynamic parameters and internal dimensions 
At baseline, obese participants had significantly higher resting HR compared 
to the non-obese group (P < 0.05) and a trend for a greater CO than their 
non-obese counterparts (P = 0.08). All the remaining resting haemodynamic 
parameters did not differ between the two groups (Table 5.2). 
Table 5. 2 Left ventricular haemodynamic parameters (mean ± SD) 
during heavy-intensity exercise at 120%LT and at 5-min recovery 
in obese and non-obese women 
 Obese 
   Baseline         120%LT       Recovery 
Non-Obese 
  Baseline         120%LT       Recovery 
HR (bpm) 
SBP (mmHg) 
EDV (ml) 
ESV (ml) 
SV (ml) 
EF (%) 
CO (L) 
LAV (ml) 
69±7 
123±7 
105.3±24.4 
30.9±4.1 
73.8±22.6 
69.5±6.3 
5.12±1.65 
38.5±7.6 
127±12 
166±11 
121.3±34.8 
23.8±5.9 
97.6±31.7 
79.8±5.23 
12.25±3.78 
45.7±13.7 
78±6 § 
126±9 
107±25 
27.9±2.53 
79.1±24.9§ 
72.8±6.5§ 
6.12±1.8§ 
36.8±10 
59±9* 
120±9 
108.4±27.3 
34±14.4 
74.3±15.7 
69.4±5.9 
4.32±0.52† 
38.6±11.2 
119±12 
150±8* 
117.8±29.4 
26.9±13.9 
90.9±17.2 
78.6±6.19 
10.69±1.49 
46.4±13.2 
62±10* 
123±9 
112±25.2 
32.3±12.4 
79.6±15.2§ 
72±5.4§ 
4.86±0.7†§ 
36.6±9.9 
HR = heart rate, EDV = end diastolic volume, ESV = end systolic volume, 
SV = stroke volume, LAV = left atrial volume, EF = ejection fraction, COP = 
cardiac output. * indicates significant difference from the obese group at the 
same time point (P < 0.05). † indicates a trend for difference from the obese 
group at the same time point. § indicates significant difference from baseline 
(time effect P < 0.05). All variables at 120%LT were significantly higher than 
baseline (Time effect P < 0.05) 
During heavy-intensity exercise, both groups showed a significant increase 
in all haemodynamic parameters (Time effect, P < 0.05; Table 5.3). Heart 
rate and SV increased by ~90% and ~27% respectively resulting in a ~140% 
increase in CO. The exercise-induced increase in SV (~30%) was driven by 
a ~22% decrease in ESV and a ~12% increase in EDV. Left atrial volume 
increased during exercise by ~16%. Finally, EF increased by ~ 14% during 
exercise. A significant time by group interaction (P < 0.05) was observed for 
SBP with post-hoc analysis revealing a significantly higher SBP during 
exercise in the obese compared to the non-obese group (26% vs 20% 
respectively; Figure 5.2). No other time by group interactions were observed. 
119 
 
S
y
s
to
li
c
 B
P
 (
m
m
H
g
)
R e s t 1 2 0 %  L T R e c o v e r y
1 0 0
1 2 0
1 4 0
1 6 0
1 8 0
2 0 0
O be se
N o n -o b e se
*
T im e  b y  G ro u p
P   <  0 .0 5
 
Figure 5. 2 Heavy-intensity exercise-induced increase in systolic blood 
pressure (SBP) in obese and non-obese women. * indicates significant 
difference between the two groups (P < 0.05). Time by group interaction, P < 
0.05 
At 5-min recovery, SBP, EDV, ESV and LAV returned to resting levels in 
both groups whereas HR, SV, CO and EF were significantly higher than at 
rest (Time effect; P < 0.05). A significant time by group interaction was 
observed for HR with post-hoc analysis revealing that only the obese group 
had a significantly higher HR at 5-min recovery than baseline (P < 0.05) 
whereas the non-obese group’s HR at recovery did not differ from rest as 
shown in Figure 5.3. This time by group interaction remained significant 
even after correcting for baseline HR. No other time by group interactions 
were observed.  
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Figure 5. 3 Heart rate at baseline and after 5 min recovery following 10 min 
of heavy-intensity exercise in obese and non-obese women. * indicate 
significant difference between baseline and recovery (P < 0.05). Time by 
group interaction, P < 0.05. 
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5.3.3 Left ventricular mitral inflow and tissue Doppler parameters 
At baseline, obese participants displayed significantly longer IVRT than their 
non-obese counterparts (P < 0.05). Also, obese subjects showed a trend for 
higher Am velocity (P = 0.08) and significantly lower Em/Am ratio than non-
obese participants (P < 0.05). No other differences were detected between 
the 2 groups at baseline (Table 5.3). 
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Table 5. 3 Changes in mitral inflow and tissue Doppler velocities (mean 
± SD) during exercise at 120%LT and after 5-min recovery in obese 
and non-obese women 
 Obese 
   Baseline         120%LT       Recovery 
Non-Obese 
  Baseline         120%LT       Recovery 
E (ms) 
A (ms) 
E/A 
DCT (ms) 
IVRT (ms) 
Sm 
Em 
Am 
Em/Am 
E/Em 
0.94±0.18 
0.53±0.14 
1.93±0.8 
181.6±40.4 
67.9±12.8 
7.18±0.5 
10.45±1.66 
6.08±0.77 
1.75±0.39 
9.12±2.45 
1.44±0.27 
N/A 
N/A 
83.7±25.2 
36.6±16.2 
10±0.93 
14.55±1.87 
N/A 
N/A 
10.14±2.97 
0.9±0.09 
0.52±0.06 
1.75±0.27 
140.7±59.4‡  
66.1±19.7 
7±1.6 
11.39±0.99 
6.25±2.34 
2.12±0.94§   
7.93±2.63 
0.93±0.1 
0.52±0.15 
1.96±0.61 
183.1±36.3 
85.3±16.1* 
6.84±1.74 
11.32±2.96 
4.88±1.72† 
2.39±0.36* 
8.85±2.8 
1.54±0.33 
N/A 
N/A 
109.7±31.8† 
36.5±11.9 
10.1±2.22 
12.76±3.17 
N/A 
N/A 
11.08±2.57 
0.97±0.13 
0.44±0.14 
2.28±0.44 
162±33.7‡  
87.3±19.8* 
6.7±1.9 
11.25±1.87 
4.47±1.72 
2.72±0.65§  
8.83±1.81 
E = early diastolic mitral inflow velocity, A = late diastolic mitral inflow 
velocity, DCT = deceleration time, IVRT = isovolumic relaxation time, Sm = 
systolic myocardial velocity, Em = early diastolic myocardial velocity, Am = 
late diastolic myocardial velocity. * indicates significant difference from the 
obese group at the same time point (P < 0.05). † indicates a trend for 
difference from the obese group at the same time point. § indicates 
significant difference from baseline (time effect P < 0.05). ‡ indicates close 
to significant difference from baseline (time effect P < 0.09). All variables at 
120%LT were significantly higher than baseline (Time effect P < 0.05) 
 
As shown in Table 5.3, all indices of mitral inflow and tissue Doppler 
velocities changed significantly during heavy-intensity exercise in both 
groups, with a ~38% increase in E velocity, a ~48% decrease in DCT, a 
~54% decrease in IVRT, a ~40% increase in Sm, a ~27% increase in Em 
and a ~20% increase in E/Em (Time effect; P < 0.05). A significant time by 
group interaction was detected for IVRT (P < 0.05) but disappeared after 
correcting for baseline differences between both groups. No difference was 
detected between both groups’ exercise-delta IVRT (P > 0.05). During 
heavy-intensity exercise, a trend for a greater reduction in DCT was 
observed in the obese compared to the non-obese group (exercise-delta 
DCT = ~58% vs 40% respectively, P = 0.09, time by group interaction P > 
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0.05; Figure 5.4). Furthermore, both BMI and WC displayed significant 
negative correlations with exercise-delta DCT (r = -0.53 and -0.56 
respectively, P < 0.05; Figure 5.5a and 5.5b). A significant time by group 
interaction was observed for Em and post-hoc analysis revealed that the 
exercise-induced increase in Em in the obese group was significantly 
greater than the lean counterparts (41% vs. 14% respectively, time by group 
interaction P < 0.05; Figure 5.6). Additionally, BMI and WC showed 
significant positive correlations with exercise delta Em (r = 0.61 and r = 0.63 
respectively, P < 0.05; Figure 5.7a and 5.7b). 
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Figure 5. 4 Heavy-intensity exercise-induced decrease in early 
diastolic filling deceleration time (DCT) in obese and non-obese 
women. † indicates a close to significant difference between the two 
groups (P = 0.09). Time by group interaction, P > 0.05. 
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Figure 5. 5 Relationship between high-intensity exercise-induced 
decrease in deceleration time (DCT) and obesity in women. (a) a 
significant negative correlation was observed between exercise-
induced decrease in DCT (delta-exercise DCT) and (a) waist 
circumference (r = 0.56, P < 0.05) and (b) BMI (r = 0.53, P < 0.05). 
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Figure 5. 6 Heavy-intensity exercise-induced increase in early diastolic 
myocardial velocity (Em) in obese and non-obese women. * indicates a 
significant difference between the two groups (P < 0.05). Time by group 
interaction, P < 0.05. 
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Figure 5. 7 Relationship between high-intensity exercise-induced increase 
in Em and obesity in women. (a) a significant positive correlation was 
observed between exercise-induced increase in Em (delta-exercise Em) and 
(a) waist circumference (r = 0.63, P < 0.05) and (b) BMI (r = 0.61, P < 0.05). 
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At 5-min recovery both groups’ E, A, E/A, IVRT, Sm, Em, Am and E/Em 
returned to their baseline levels (Time effect, P > 0.05) whereas Em/Am was 
higher and DCT was lower than baseline in both groups (Time effect; P < 
0.05 and 0.08 respectively, time by group interaction P > 0.05 for both). A 
trend for time by group interaction was observed for E/A (time by group 
interaction, P = 0.09) with post-hoc analysis revealing a E/A at 5-min 
recovery higher than rest in the non-obese group with strong effect size(P > 
0.05, d = 0.6) whereas it was lower than rest in the obese group with mild 
effect size (P > 0.05, d = 0.3; Figure 5.8). 
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Figure 5. 8 E/A ratio at baseline and after 5 min recovery following 10 
min of heavy-intensity exercise in obese and non-obese women. 
Obese women had a lower E/A ratio at 5 min recovery than rest 
whereas the opposite was observed in non-obese women (time by 
group interaction, P < 0.05). d indicates Cohen’s effect size. 
5.3.4 Left ventricular myocardial deformation and torsion  
Baseline measures of myocardial deformation and torsion were similar in 
both groups (P > 0.05). Table 5.4 displays the changes in myocardial 
deformation and torsion during heavy-intensity exercise and 5-min recovery 
in obese and non-obese subjects.  
During heavy-intensity exercise, all measures of myocardial deformation and 
torsion increased significantly in all 3 planes of motion (Time effect, P < 
0.05). Exercise-induced increase in LV strain was ~20%  in the longitudinal, 
~29% in the circumferential and ~39% in the radial directions with no 
difference between groups (time by group interaction, P > 0.05). The 
exercise-induced increase in SRs was ~77% in the longitudinal, ~85% in the 
circumferential and ~50% in the radial directions. No time by group 
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interactions were detected for LongSRs or CircSRs, however a trend was 
detected for RadSRs with post-hoc analysis showing a significantly higher 
exercise-induced increase in RadSRs in the obese group (~80%, P < 0.05) 
compared to the non-obese group (~19%, P = 0.07; Figure 5.9a). 
Furthermore, a close to significant direct correlation was observed between 
exercise-induced increase in RadSRs and BMI (r = 0.48, P = 0.08; Figure 
5.9b)  During heavy-intensity exercise, SRe increased by ~42% in the 
longitudinal, ~65% in the circumferential and ~96% in the radial directions 
with no differences between groups (Time effect, P < 0.05; Time by group 
interaction, P > 0.05). Finally, LVTor only increased by ~4% during heavy-
intensity with no difference between groups (Time effect, P < 0.05; Time by 
group interaction, P > 0.05). 
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Table 5. 4 Changes in LV myocardial deformation and torsion (mean 
± SD) during heavy-intensity exercise (120% LT) and after 5-min 
recovery in obese and non-obese women 
 Obese 
   Baseline         120%LT       Recovery 
Non-Obese 
  Baseline         120%LT       Recovery 
Strain (%) 
LongS 
CircS 
RadS 
SRs (ms) 
LongSRs 
CircSRs 
RadSRs 
SRe (ms) 
LongSRe 
CircSRe 
RadSRe 
SRa (ms) 
LongSRa 
CircSRa 
RadSRa 
SRe/a 
LongSRe/a 
CircSRe/a 
RadSRe/a 
Torsion 
 
16.8±2.69 
15.8±2.87 
15.1±2.41 
 
0.88±0.25 
0.97±0.27 
1.33±0.3 
 
1.4±0.3 
1.42±0.45 
1.25±0.58 
 
0.6±0.14 
0.4±0.26 
0.71±0.19 
 
2.51±0.88 
5.4±3.95 
1.58±0.54 
10.2±2.55 
 
19.6±2.1 
19.7±3.36 
20.9±7.42 
 
1.44±0.26 
1.8±0.37 
2.33±0.46 
 
1.89±0.46 
2.13±0.76 
2.36±0.71 
 
N/A 
N/A 
N/A 
 
N/A 
N/A 
N/A 
14.2±3.03 
 
15.7±2.32 
17±3.46 
15.2±5.48 
 
0.88±0.23 
1.1±0.24 
1.6±0.47 
 
1.22±0.23 
1.59±0.18 
1.6±0.58 
 
0.6±0.2 
0.56±0.34 
0.79±0.21 
 
2.27±1.0 
4.03±2.74 
2.01±0.72 
10.3±3.12 
 
18.3±3.22 
17.9±3.4 
16.7±2.9 
 
0.96±0.23 
1.05±0.28 
1.47±0.42 
 
1.71±0.42 
1.53±0.5 
1.18±0.23 
 
0.54±0.19 
0.33±0.22 
0.59±0.32 
 
3.28±0.57† 
5.87±3.27 
2.47±1.21† 
8.9±4.38 
 
22.34±5.33 
22.8±4.01 
22.3±10.7 
 
1.75±0.54 
1.8±0.5 
1.99±0.66 
 
2.31±0.37† 
2.25±0.86 
2.41±1.03 
 
N/A 
N/A 
N/A 
 
N/A 
N/A 
N/A 
12.4±5.03 
 
17.9±2.67 
16.7±3.02 
14.5±3.18 
 
0.93±0.19 
1.02±0.17 
1.1±0.42* 
 
1.72±0.41* 
1.27±0.3* 
1.42±0.45 
 
0.47±0.17 
0.35±0.17 
0.42±0.12* 
 
3.97±1.22* 
4.28±1.62 
3.17±0.89* 
8.5±4.38 
SRs= systolic strain rate, SRe = early diastolic strain rate, SRa = late 
diastolic strain rate. * indicates significant difference from baseline (P < 
0.05). All variables at 120%LT were significantly different from baseline 
(time effect, P < 0.05). 
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Figure 5. 9 Impact of heavy-intensity exercise on radial systolic strain 
rate (RadSRs) in obese and non-obese women. (a) Obese women  
had a significantly greater increase in RadSRs at 120%LT and 5-min 
recovery compared to non-obese women (time by group interaction, P 
< 0.05). (b) Relationship between heavy-intensity exercise-induced 
increase in RadSRs and obesity, a significant positive correlation was 
observed between exercise-induced increase in RadSRs (delta-
exercise RadSRs) and BMI (r = 0.48, P = 0.08). * indicates a significant 
difference between the two groups (P < 0.05) 
 
At 5-min recovery, LV strain, strain rate and torsion returned to their 
baseline levels (Time effect, P > 0.05; Table 5.4). A significant time by group 
interaction was observed for RadSRs with post-hoc analysis showing 
significantly lower RadSRs at recovery than rest in the non-obese group, 
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whereas the obese group’s RadSRs returned to resting level (Figure 5.9a). 
A trend for time by group interaction was observed for RadSRa with post-
hoc analysis showing a higher RadSRa at 5-min recovery than rest in the 
non-obese group (P > 0.05, cohen’s d = 0.7) whereas it was lower than rest 
in the obese group (P > 0.05, cohen’s d = 0.4; time by group interaction, P = 
0.06; Figure 5.10a). Despite a lack of significant time by group interaction for 
RadSRe/a (P > 0.05), a higher value than rest was noticed in the non-obese 
group at 5-min recovery with strong effect size (P > 0.05, d = 0.6), however 
this was not observed in the obese group (Figure 5.10b). 
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Figure 5. 10 Radial diastolic strain rate after 5-min recovery following 
heavy intensity exercise in obese and non-obese women. (a) At 5-
min recovery, RadSRa was lower than rest in non-obese woman 
whereas it was higher than rest in obese women. (b) RadSRe/a was 
higher than rest in the non-obese women with no change in the obese 
women. d indicates Cohen’s effect size. 
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Despite the absence of a significant time by group interaction for LongSRe, 
LongSRa and LongSRe/a (P > 0.05), it was observed that, at 5-min 
recovery, LongSRe was lower than baseline in the obese group (P > 0.05, 
cohen’s d = 0.7; Figure 5.11), LongSRa was higher than baseline in the non-
obese group (P = 0.08; Figure 5.12) and LongSRe/a was higher than 
baseline in the non-obese group (P < 0.05; Figure 5.13).  
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Figure 5. 11 Longitudinal SRe after 5-min recovery following heavy intensity 
exercise in obese and non-obese women. At 5-min recovery, LongSRe 
was lower than rest in the obese group with no change in the non-obese 
group. Time by group interaction, P > 0.05. d indicates Cohen’s effect size.  
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Figure 5. 12 Longitudinal SRa after 5-min recovery following heavy intensity 
exercise in obese and non-obese women. At 5-min recovery, LongSRa 
was lower than rest in the non-obese group with no change in the obese 
group. Time by group interaction, P > 0.05. † indicates a close to significant 
difference (P < 0.08). 
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Figure 5. 13 Longitudinal SRe/a after 5-min recovery following heavy 
intensity exercise in obese and non-obese women. At 5-min recovery, 
LongSRe/a was higher than rest in the non-obese group with no change in 
the obese group. Time by group interaction, P > 0.05. * indicates a significant 
difference (P < 0.05). 
5.4 Discussion 
To the best of our knowledge, this is the first study to explore the LV systolic 
and diastolic functional responses to heavy-intensity exercise in healthy 
obese women using standard, TDI and 2DST echocardiography. It is also 
the first study to assess cardiac function during an exercise session defined 
according to LT as opposed to VO2max or HRmax. The principal findings were 
that, during heavy-intensity exercise: (1) Obese women displayed  a 
significantly higher systolic BP during exercise than non-obese women, but 
both groups showed similar changes in HR, SV and CO. (2) Obese women 
displayed significantly higher exercise-induced increase in diastolic 
myocardial velocity and systolic radial strain rate than non-obese women. 
Additionally, at 5-min recovery following heavy-intensity exercise: (1) Obese 
women displayed a slower HR recovery than non-obese counterparts. (2) 
Non-obese women displayed a post-exercise increase in diastolic function, 
not observed in obese women. 
5.4.1 LV haemodynamic response to high-intensity exercise 
During aerobic exercise, the intravascular blood volume increases in order 
to meet the metabolic demands of the exercising muscles. This occurs 
through arteriolar vasodilataion and decrease in peripheral vascular 
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resistance with a subsequent increase in systemic venous return to the heart 
(Rowland, 2008).  The LV haemodynamic response to exercise generally 
mirrors these intravascular haemodynamic changes showing a parallel 
increase in heart rate, stroke volume, cardiac output and ejection fraction 
(Rowland, 2008). 
In this study, we showed similar LV haemodynamic response in obese and 
non-obese women during heavy-intensity supine cycling at 120% LT except 
for SBP. Despite having similar resting SBP, a significantly higher exercise-
SBP was observed in obese compared to non-obese women. High SBP 
during exercise has been shown to be is a strong predictor of hypertension 
and a stronger predictor of cardiovascular mortality than resting SBP in 
adults (Goble and Schieken, 1991, Mundal et al., 1994). This manifestation 
confirms that exercise reveals subtle unfavourable changes in 
cardiovascular function, not detected at rest. However, both groups 
displayed a similar exercise-induced increase in HR, SV, CO and EF. This is 
in line with previous reports showing similar exercise-induced increase in 
CO, SV and HR during incremental (Giordano et al., 2003) and steady 
(Salvadori et al., 1999, Vella et al., 2009) exercise in obese and non-obese 
individuals. However, this is in contrast to previous reports by (Rowland et 
al., 2003) showing higher CO during exercise in obese than non-obese girls. 
These girls however had higher resting CO than lean counterparts, which is 
in contrast to our participants who had similar haemodynamic parameters at 
rest. Reports on LV EF response to exercise thus far have been disparate. 
According to (Sasso et al., 2005) overweight and obese adults had a smaller 
increase in EF than lean controls during exercise, despite having higher EF 
at rest. However, (Ferraro et al., 1996) reported no change in EF in severely 
obese adults during submaximal exercise. Interestingly, (Alpert et al., 1989) 
showed that, in morbidly obese adults, only those who had normal LVM 
displayed an 11% increase in EF during exercise as opposed to those with 
LVH that showed no change in EF during exercise. Several factors may 
influence EF during exercise including preload, afterload and state of 
myocardial contractility. However, EF is known to be strongly influenced by 
haemodynamic changes and therefore it is not a reliable indicator of 
myocardial contractile response to exercise. 
At 5 min post-exercise, a delay in heart rate recovery (HRR) was observed 
in obese compared to non-obese women. HRR is believed to be associated 
with vagal tone reactivation post-exercise (Arena et al., 2010) and a delayed 
HRR following strenuous exercise is a sign of impaired vagal reactivation 
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and has been shown to be strongly related cardiovascular risk factors in 
obesity (Mora et al., 2005). Impaired vagal reactivation is a manifestation of 
autonomic dysfunction resulting from insulin resistance and 
hyperinsulinemia associated with obesity (Carroll et al., 2012).  Therefore, in 
our group of obese women, with high visceral adipose tissue content, the 
delay in HRR at 5 min post heavy-intensity exercise, compared to non-
obese subject may be an early sign of insulin resistance. 
5.4.2 Left ventricular systolic myocardial velocity, deformation 
and torsion during heavy-intensity exercise 
Healthy obese women showed a similar exercise-induced increase in Sm as 
non-obese women. This is in line with reports by (Schuster et al., 2012) 
showing similar Sm in obese and non-obese children during an incremental 
exercise test. However, this is in contrast to reports by (Ingul et al., 2010) 
showing significantly lower Sm at rest and during exercise in obese 
compared to non-obese adolescents. The difference in the magnitude of 
change in Sm during exercise between both groups was not reported. 
Systolic myocardial velocity is generally dependent on both myocardial 
contractility and heart rate. Both these measures increase during exercise in 
response to sympathetic stimulation (Quintana et al., 2005). Therefore, 
impaired LV systolic myocardial velocity during exercise in obese subjects 
may be a reflection of contractile or autonomic dysfunction. 
To the best of our knowledge, this is the first study to explore the changes in 
LV deformation in all 3 directions; longitudinal, circumferential and radial, 
and  torsion during heavy intensity exercise in healthy obese women. We 
report a similar increase in global LV longitudinal, circumferential and radial 
strain in obese and non-obese women. However, higher RadSRs was 
observed during exercise in obese women, whereas LongSRs and CircSRs 
were similar in both groups. This was still manifested at 5 min recovery post-
exercise. Additionally, a positive correlation was observed between both BMI 
and WC and the magnitude of increase in RadSRs during exercise. This 
possibly reflects an enhanced LV systolic function as a means of optimising 
adequate SV and CO for muscle perfusion and to overcome the high SBP 
during exercise. This is in line with previous reports by (Schuster et al. 2012) 
showing higher Sm in mildly obese compared to lean children at submaximal 
and maximal exercise despite both groups displaying similar Sm at rest and 
lower exercise intensities during an incremental exercise test. Interestingly, 
this was not observed in more severely obese children, indicating that only 
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mild degree of obesity is associated with a compensatory increase in LV 
systolic function during heavy-intensity exercise.  
Strain is defined as the degree of deformation (ie. change in length) of a 
given myocardial segment compared to its end-diastolic length, and strain 
rate is the rate of this deformation (Dandel et al., 2009). The myocardium is 
made up of a complex network of helically-orientated longitudinal and 
circumferential myocardial fibrils (Nakajima et al., 1985, Torrent-Guasp et 
al., 2001). Therefore, the deformation of each fibril during systole will result 
in shortening in the longitudinal and circumferential directions and thickening 
in the transmural or radial direction of an entire segment of myocardium 
(Dandel et al., 2009). Since the myocardium is incompressible, the 
thickening of the wall occurs as a result of shortening in order to maintain 
volume (Kato et al., 2010). Hence radial strain represents the magnitude of 
systolic thickening resulting from longitudinal and circumferential shortening 
of the overlapping myocardial fibrils. Weidemann showed that radial strain 
correlates with inotropic stimulation (Weidemann et al., 2002), however it 
does not take into account the temporal dimension ie. how long it takes for 
the myocardium to reach a particular magnitude of thickening. Furthermore, 
(Weidemann et al., 2002) reported a strong direct correlation between peak 
RadSRs and change in LV pressure (dP/dtime) which is the gold standard 
measure of global LV function. Additionally, RadSRs was constant despite 
the increasing HR on inotropic stimulation, indicating that it is HR 
independent and only reflects myocardial inotropic state. Therefore, 
Weidemann argued that radial strain rate is better and more reliable 
measure of contractile function than radial strain.  
Surprisingly, although radial thickening represents the outcome of 
longitudinal and circumferential shortening, our results show that the change 
in RadSRs in the obese women does not parallel any changes in LongSRs 
and CircSRs. This can be explained by either the possibility that changes in 
LongSRs and CircSRs were too subtle to be detected by echocardiography. 
However, there is always a possibility of measurement error. Nevertheless, 
this has previously been reported in the literature. Indeed, (Nottin et al., 
2008) reported lower RadSRs but similar LongSRs and CircSRs in athletes 
compared to sedentary controls. Furthermore, (Pons, 2014) reported lower 
LV radial strain despite higher circumferential and longitudinal strain in long-
distance runners compared to sedentary controls. It was suggested that, the 
lower radial strain at rest represents a myocardial contractile reserve in 
135 
 
radial deformation which can be utilised during exercise to maximise LV 
response to exercise (Pons,  2014).  
5.4.3 LV diastolic inflow and myocardial velocity and deformation 
during high-intensity exercise 
Normally, during exercise LA pressure does not change; therefore the rate 
of LV filling is determined by both the suction effect of LV end systolic 
pressure and the rate of diastolic myocardial relaxation (Rowland, 2008). 
Hence, increased early diastolic filling velocity will compensate for the 
shortened diastolic filling time during exercise as heart rate increases. We 
show for the first time that healthy obese women display a greater increase 
in Em during heavy-intensity exercise compared to lean controls. We also 
report a greater decrease in DCT during exercise in obese women 
compared to lean counterparts. Interestingly, this persisted after exercise 
cessation as shown by the slightly reduced DCT at 5-min recovery in obese 
women. This possibly reflects an enhanced LV diastolic filling during heavy-
exercise to optimise adequate CO and SV for muscle perfusion during 
heavy-intensity exercise in addition to excess adipose tissue. This is further 
supported by the significant positive correlation observed between exercise-
delta Em and both WC and BMI and the negative correlation observed 
between exercise-delta DCT and BMI. Previous reports by (Schuster et al., 
2012) showed that obese children had significantly higher Em during 
exercise than non-obese controls. However, this was also observed at rest, 
indicating that it was not an influence of exercise, but rather a manifestation 
of excess adipose tissue in this cohort.  
Interestingly, at 5-min recovery, non-obese women were found to have 
higher E/A ratio, LongSRe/a and RadSRe/a than resting values, whereas 
this was not observed in the obese group. The exact explanation of this 
observation is not clear, however it reflects a slight improvement in diastolic 
function after heavy exercise in non-obese women that is absent in obese 
ones. These changes were not strongly significant and further tests on 
larger cohorts are needed to confirm this finding. 
5.4.4 Conclusions 
This study shows for the first time that overweight/obese women have an 
accentuated LV systolic and diastolic response to heavy-intensity exercise 
compared to non-obese women. Obesity, particularly visceral adiposity, was 
found to be associated with a greater increase in both RadSRs and Em and 
decrease in DCT during heavy-intensity exercise reflecting higher systolic 
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and diastolic function, possibly as a means of optimising an adequate 
cardiac output for muscle perfusion. Additionally, obese women displayed a 
significantly higher SBP during exercise, indicating a high risk of developing 
hypertension and an increased risk of cardiovascular mortality. Furthermore, 
a delayed HRR was observed in obese women following heavy-intensity 
exercise, possibly reflecting an impaired post-exercise vagal reactivation 
and autonomic dysfunction. Finally, this study reports for the first time 
evidence of enhanced LV diastolic function immediately following heavy-
intensity exercise in non-obese women, which was absent in obese women. 
In conclusion, despite evidence of subclinical LV systolic and diastolic 
dysfunction in mild obesity, heavy-intensity exercise provides an effective 
method of enhancing cardiac function in overweight/mildly obese women, 
particularly in individuals struggling to reduce their weights and/or maintain 
their weight loss. 
5.4.5 Limitations and future work 
This study included a small number of participants, affecting the ability to 
draw firm conclusions from it. Further studies involving large cohorts are 
needed to validate the above findings. Additionally, this study is 
observational and does not give information on molecular mechanisms. 
Future animal studies or studies involving human tissue biopsies for the 
biochemical assessment of cardiac myocyte signaling pathways and 
electorphysiology during and immediately following exercise would give 
valuable information to support our observations. Moreover, this study only 
includes women and does not take into consideration other potentially 
relevant factors such as age, race and genetic factors. 
With regards to echocardiographic limitations, this study involved the 
assessment of obese women, which can result in suboptimal image quality 
and affect the analysis of data. Additionally, exercise can affect image 
quality and result in insufficient visualisation of the LV walls. It can also 
affect probe positioning resulting in inadequate image planes. Finally, 
exercise echocardiography has to be performed in a narrow time-window 
due to the time-consuming nature of serial acquisition of different image 
planes (Eroglu et al., 2006). MRI can potentially overcome these obstacles 
and give higher degrees of sensitivity and accuracy. 
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Chapter 6 The impact of heavy-intensity interval and 
continuous aerobic training on left ventricular structure and 
function in overweight/obese women 
 
6.1 Introduction 
Long-term aerobic training and its benefits on cardiovascular function are 
well-established (Blomqvist and Saltin, 1983). Evidence has shown that 
aerobic exercise training induces favourable LV structural and functional 
adaptations in healthy non-obese subjects (Baggish et al., 2008, D'Andrea 
et al., 2007). As it was observed in Chapter 4, excess adipose tissue, 
particularly visceral fat, is associated with concentric LV pathological 
remodelling and reduced LV myocardial velocity and deformation in both 
systole and diastole. Unfortunately, weight loss represents a difficult 
challenge in many obese women and the maintenance of weight loss can 
also be an even bigger problem that weight loss itself. Protecting the heart 
from the detrimental effects of obesity does not solely depend on weight 
reduction. Long-term exercise alone, particularly at heavy-intensity, has 
been shown to be an effective means of protecting and even improving 
cardiac function in obese individuals without accompanying weight loss. 
Indeed, in the previous chapter, we have demonstrated that heavy-intensity 
exercise enhances LV systolic and diastolic function in obese women. 
Additionally, evidence has shown that aerobic exercise mediates favourable 
LV structural and functional adaptations in obese individuals without the 
need to reduce body weight through dietary modifications (Vogelsang et al., 
2008, Schuster et al., 2012, Sijie et al., 2012, Schrauwen-Hinderling et al., 
2010). Exercise intensity appears to be a strong contributing factor to the 
magnitude of exercise-induced benefit on the heart (Swain and Franklin, 
2006) and protection against developing heart disease (Wisloff et al., 2006). 
Additionally, (Wisloff et al., 2007) demonstrated that 12 weeks of heavy-
intensity interval training resulted in LV reverse remodelling and significant 
improvements in LV systolic and diastolic function, which moderate-intensity 
continuous training had failed to achieve, in heart failure patients. With 
regards to obesity, (Ingul et al., 2010) showed that, 13 weeks of Heavy-
intensity interval training were able to restore LV systolic and diastolic 
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function in obese adolescents to levels comparable to non-obese controls. 
However, other interventional studies involving low- (Eriksson et al., 2010) or 
moderate-intensity training (Millen et al., 2014) have failed to detect any 
change in LV structure or function in healthy obese individuals. From these 
observations, it seems that interval training may provide more beneficial 
outcomes on LV structure and function than continuous training because of 
the high-intensities achieved during the exercise intervals. It was observed 
in Chapter 5 that LV systolic and diastolic response to heavy-intensity 
exercise is higher in obese than non-obese women, suggesting a greater 
cardiac effort to optimise adequate cardiac output for muscle perfusion. This 
also suggests that heavy-intensity training maximises the cardiac benefit 
from exercise in obese individuals. It is not clear, however, whether the 
repetitive pattern of interval training provides any additional benefit on LV 
structural and functional adaptations to exercise training. To date, a 
comparison between work- and intensity-matched interval and continuous 
training on LV structure and function has not been studied. Therefore, the 
aim of this study is to compare work- and intensity-matched interval and 
continuous training on LV structural and functional adaptations in 
overweight/obese women. It is hypothesised that heavy-intensity continuous 
training will provide similar LV structural and functional adaptations to high-
intensity interval training. 
6.2 Methods 
6.2.1 Participants 
Twenty healthy overweight/obese females (age: 42 ± 5 yrs; BMI ≥ 27 kg/m
2
 
and/or WHR > 0.8) participated in the study. Recruitment was carried out 
through local poster advertisements in the University of Leeds campus and 
by contacting participants from previous studies, who had given permission 
to be contacted for further studies. All participants demonstrated low risk of 
subclinical coronary heart disease; they were non-smokers with no history of 
hypertension and were not utilising any form of prescribed medication. The 
nature and purpose of the study were explained to each participant and 
written informed consent was provided prior to their participation. All 
participants met the inclusion criteria outlined in the general methods 
chapter.  
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6.2.2 Experimental protocol 
Initially, participants were invited to attend the exercise physiology laboratory 
at the University of Leeds on two occasions. During the first visit, the 
assessment of body composition was carried out and participants were 
given a chance to familiarize themselves with the study equipment. On the 
second visit, baseline echocardiography was performed followed by a 
cardiopulmonary fitness test for the assessment of maximal aerobic capacity 
(VO2max) and the lactate threshold (LT) in order to calculate the appropriate 
work rates (WR) for the subsequent exercise sessions. Control factors for 
these two visits are detailed in the general methods (Chapter 3, section 3.2). 
Participants were then matched for age and BMI and randomly assigned to 
either an interval (INT, n = 10) or continuous (CON, n = 10) heavy-intensity 
exercise training group. Participants attended the University of Leeds 
exercise physiology laboratory twice per week for supervised exercise 
sessions, in addition to one home-based unsupervised exercise session 
once per week. At mid-point (ie. 6 weeks) in the exercise training 
programme, a training session was replaced by a cardiopulmonary fitness 
test in order to assess any change in VO2max and LT and adjust exercise 
session work-rates accordingly. Following 12 weeks of training, 
echocardiography and cardiopulmonary fitness tests were completed within 
one week of the last training session. 
6.2.3 Measured variables pre and post-training 
The protocols for the following variables are described in detail in the 
general methods chapter. 
6.2.3.1 Anthropometric variables  
Anthropometric measurements were taken pre and post-training and 
included body mass (BM), height (HT), waist circumference (WC), hip 
circumference (HC), waist to hip ratio (WHR), fat mass (FM), fat percent 
(FP) and fat-free mass (FFM). 
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6.2.3.2 Echocardiographic variables 
Echocardiographic assessment of LV structure and function is explained in 
detail in the general methods (Chapter 3, section 3.4). Echocardiography 
was completed at pre and post-training and included standard 2-D, PW, TDI 
and 2D-speckle tracking echocardiography. Standard 2D echocardiographic 
measurements included left ventricular internal diastolic diameter during 
systole and diastole (LVIDds and LVIDd respectively), posterior wall 
thickness during systole and diastole (PWTs and PWTd respectively), 
interventricular septal thickness during systole and diastole (IVSTs and 
IVSTd respectively), relative wall thickness (RWT), left ventricular mass 
(LVM), ejection fraction (EF), end-systolic, end-diastolic and stroke volumes 
(ESV, EDV and SV respectively). Doppler echocardiographic variables 
included early diastolic inflow velocity (E), late diastolic inflow velocity (A), 
E:A ratio (E/A), isovolumic relaxation time (IVRT), deceleration time (DcT), 
early diastolic myocardial velocity (Em), late diastolic myocardial velocity 
(Am), Em:Am ratio, E/Em ratio and myocardial performance index (MPI). 
Finally, 2-D speckle tracking echocardiographic variables included 
longitudinal strain (LongS), longitudinal systolic, early and late diastolic 
strain rates (LongSRs, LongSRe and LongSRa respectively), circumferential 
strain (CircS), circumferential systolic, early and late diastolic strain rates 
(CircSRs, CircSRe and CircSRa respectively), radial strain (RadS), radial 
systolic, early and late diastolic strain rates (RadSRs, RadSRe and RadSRa 
respectively), and torsion (LVtor). 
6.2.3.3 Cardiopulmonary fitness 
An incremental cycle ergometer ramp test in the seated position was 
performed at pre and post-training to determine peak oxygen uptake 
(VO2peak),LT, their corresponding work-rates (WRpeak and WRLT) and the 
individual work-rates for the subsequent exercise training sessions (Chapter 
3, section 3.5). 
6.2.4 Exercise training protocol 
Both groups completed 12 weeks of work-matched heavy intensity exercise 
training consisting of cycling on a cycle ergometer (Lode BV, Excalibur Sport 
V2.0, the Netherlands) twice weekly under supervision at the University of 
Leeds exercise physiology laboratory. Additionally, participants were 
instructed to carry out one additional exercise session once weekly 
consisting of 30 min of unsupervised brisk walking. To ensure participants 
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trained at the intended intensity, first training sessions were monitored for 
VO2 and blood lactate levels throughout the session. VO2 levels were 
obtained by breath by breath data collection. Blood lactate levels were 
obtained by capillary blood sample collection using an automated blood 
lactate analyser (Lactate Pro, Arkray, Japan). Capillary blood samples were 
taken twice at rest, separated by a 5 min interval, for calculating the 
average, and every 5 min for the INT group and 4 min for the CON group as 
session duration was shorter as will be explained in detail below. After 6 
weeks of training, cardiopulmonary exercise tests were performed on all 
participants and the work rates at which they cycled were adjusted to ensure 
they trained at the desired intensity as training adaptations occurred. An 
additional non-exercising control group was not included as the primary aim 
of this study was to compare the influence of two different exercise 
interventions (interval and continuous) on cardiac structure and function in 
obese women as opposed to the impact of exercise alone. 
6.2.4.1 Interval training sessions 
Interval training sessions consisted of a modification of the 1:2 
(work:recovery) duty cycles first developed by (Turner et al., 2006). In this 
study, Turner et al. compared the physiological responses to 4 different duty 
cycles at work:recovery ratios of 10:20, 30:60, 60:120 and 90:180s by 
monitoring VO2 and blood lactate levels throughout each session. All 4 
sessions were work matched and consisted of 30 min of cycling on a cycle 
ergometer at 120% WRpeak with recovery periods at 20 W. The results 
showed that the 30:60s duty cycle corresponded to the heavy-intensity 
domain as demonstrated by a rising VO2 level reaching a plateau above the 
LT at ~10-15 min and a rising blood lactate level reaching a plateau from 
~10 min. In our study, the interval training sessions were modified and 
consisted of 40:80s duty cycles of cycling at 70% delta work-rate (70% 
ΔWR) for 40s followed by active recovery at 20 W for 80s. 70% ΔWR is 
70% of the difference between WRpeak and WRLT and is calculated as: 
70% ΔWR = 0.7(WRpeak - WRLT) + WRLT 
The reason for normalising to ΔWR rather than WRpeak or VO2max, as done 
by most exercise training studies, is that normalising for ΔWR takes into 
account individual differences in LT whereas normalising to WRpeak or 
VO2max can put individuals at different points above or below LT. The WR of 
70% ΔWR was chosen as it is above critical power ie. in the very heavy 
intensity domain (Cannon et al., 2011). Finally, the work:recovery ratio of 
142 
 
40:80s was chosen as it was confirmed in a pilot session to be in the heavy 
intensity domain and with a slightly higher VO2-time integral and average 
VO2 than 30:60s, hence maximising the influence of exercise training 
(Figure 6.1). The duration of the interval sessions in the first week was 20 
min, increased to 25 min in week 2, 30 min in week 3, 35 min in week 7 and 
40 min in week 10. 
 
Figure 6. 1 Schematic representation of the heavy-intensity interval 
training session. Interval training sessions consisted of 40:80 s duty 
cycles at 70%WRdelta which was above lactate threshold (LT; red 
shaded line), followed by 20W active recovery for a duration of 20 min. 
6.2.4.2 Continuous training sessions 
The CON training sessions consisted of continuous steady cycling at 20% 
ΔWR for a pre-calculated duration that would give the same total amount of 
work achieved if the individual was to perform an INT session (Figure 6.2). 
This was done by calculating the total amount of work (J) that would be 
achieved by this individual if they were to perform an INT session at 70% 
ΔWR for 40s and 20W for 80s for the duration of 20 – 40 min depending on 
the time point of the training. Then this total amount of work was divided by 
this individual’s work rate (20% ΔWR). This was to ensure both groups were 
matched for the amount of work and both fell in the heavy intensity domain.  
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Figure 6. 2 Schematic representation of the heavy-intensity 
continuous training exercise session. Continuous training sessions 
consisted of continuous cycling at 20%WRdelta which was above lactate 
threshold (LT; red shaded line) for a pre-calculated period of time that 
would result in a total amount of work equivalent to an interval training 
session. 
6.2.5 Statistical analysis 
All data were normally distributed and were presented as mean ± SD. The 
effects of training were analysed using ANOVA with repeated measures with 
time (pre and post) entered as the within subjects factor and training group 
(INT and CON) as the in-between subjects factor. At baseline, a significant 
difference was observed between both groups’ LVPWd, Am and CircSRs. 
Therefore, baseline values for these variables were entered as covariates to 
the ANOVA test. Where significant time by group interaction was found, a 
paired t-test was performed to assess the significance of change in each 
group. The percentage change from pre- to post-training was assessed for 
group differences using a Student’s independent t-test. Significance was 
accepted if P < 0.05. 
6.3 Results 
6.3.1 Exercise session characteristics 
The exercise session characteristics for both groups are presented in Table 
6.1. The INT group exercised at higher WR than CON group for a longer 
period of time per session. However the total amount of work per session 
was similar between both groups. 
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Table 6. 1 First session characteristics (mean ± SD) for interval and 
continuous exercise training 
 Interval Continuous 
WRLT (W) 
Session WR (W) 
Work/session (KJ) 
Session durations (min) 
57 ± 15 
124 ± 25 
66 ± 10 
20 
68 ± 14 
85 ± 16 * 
67 ± 9 
13.3 ± 1.3 * 
* indicates a significant difference between both groups ( P < 0.01) 
6.3.2 Participants’ characteristics 
Two participants only completed 10 weeks of training; one from the INT 
group due to injury not related to training and one from the CON group due 
to unavailability. In these two participants, the sessions’ durations were 
adjusted to give a total amount of work equal to 12 weeks of training. All 
other participants completed the 12 weeks of training. The anthropometric, 
BP and HR characteristics of the 2 groups are presented in table 6.2. There 
was no significant difference between both groups’ baseline anthropometric 
measurements, cardio-respiratory fitness and BP before and after training. 
Twelve weeks of training did not have any significant effect on participants’ 
anthropometric characteristics in either groups. With regards to BP, there 
was a trend for a decrease in SBP post-training in both groups (time effect P 
= 0.08, time by group interaction P > 0.05). 
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Table 6. 2 Anthropometric, BP, HR and cardiopulmonary fitness 
measurements (mean ± SD) of the interval and continuous training 
groups before and after 12 weeks of training 
 Interval 
Pre                    Post 
Continuous 
  Pre                   Post 
Weight (kg) 
Height (m) 
BMI (kg/m
2
) 
Waist (cm) 
WHR 
Fat mass (kg) 
Fat-free mass (kg) 
SBP (mmHg) 
DBP (mmHg) 
MAP (mmHg) 
Resting HR (bpm) 
VO2max (ml/kg/min) 
LT (ml) 
88.5 ± 15 
1.64 ± 0.1 
32.6 ± 3.3 
106.2 ± 7.3 
0.90 ± 0.1 
39 ± 7.9 
49.3 ± 7 
124 ± 11 
81 ± 9 
96 ± 10 
68 ± 6 
24.1 ± 2.9 
1077 ± 187 
86.9 ± 16 
1.64 ± 0.1 
32 ± 3.6 
103.7 ± 10.6 
0.89 ± 0.1 
38.4 ± 9.5 
48.5 ± 7 
119 ± 7 
79 ± 8 
92 ± 8 
68 ± 11 
25.3 ± 3.3 
1169 ± 247 
85.3 ± 12 
1.66 ± 0.1 
30.9 ± 3.7 
101.4 ± 9.5 
0.90 ± 0.1 
35.3 ± 8.5 
49.8 ± 5.1 
125 ± 15 
82 ± 10 
96 ± 11 
66 ± 10 
24.6 ± 2.7 
1181 ± 239 
85.7 (12.6) 
1.66 (0.1) 
31 (3.7) 
101.9 (10.6) 
0.90 ± 0.1 
36.1 (8.3) 
49.5 (5.2) 
124 ± 15 
82 ± 10 
96 ± 11 
68 ± 7 
25.7 ± 2.3 
1181 ± 183 
BMI = body mass index, SBP = systolic blood pressure, DBP = diastolic 
blood pressure, HR = heart rate, VO2max = maximal oxygen uptake, LT = 
lactate threshold.. No significant time effect (P > 0.05) on anthropometric, 
BP and HR measurements after 12 weeks of training. A trend for a reduction 
in SBP was noticed in both groups (time effect P = 0.08) 
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6.3.3 Left ventricular structure 
Table 6.3 displays both groups’ measures of LV structure before and after 
12 weeks of training. At baseline, the CON group displayed significantly 
higher PWTd, being compared to the INT group (P < 0.05). No significant 
difference was observed between both groups’ IVSTd, LVIDd, LVM and 
RWT (P > 0.05), however the CON group displayed higher mean LVM and 
RWT than the INT group with large effect sizes (d = 0.5 and 0.6 
respectively). Moreover, the CON group’s mean LVM and PWTd exceeded 
the limits for normality (LVM > 162 g, PWTd > 0.9 cm) as per the American 
Society of Echocardiography guidelines (Lang et al., 2005), whereas the INT 
groups’ mean LVM and PWTd were within normal limits. Finally, both groups 
showed evidence of concentric remodelling (RWT > 0.42) at baseline, being 
more marked in the CON compared to the INT group though not significantly 
different (P > 0.05; effect size d = 0.6).  
 
Table 6. 3 LV structure (mean ± SD) after 12 weeks of either interval 
or continuous training in overweight/obese women 
 Interval 
Pre                       Post 
Continuous 
Pre                      Post 
LVM (g) 
LVID (cm) 
IVS (cm) 
PWT (cm) 
RWT 
146.5 ± 35.7 
4.35 ± 0.49 
1.08 ± 0.19 
0.90 ± 0.15 
0.46 ± 0.1 
154.8 ± 40.1 
4.33 ± 0.62 
1.09 ± 0.18 
0.99 ± 0.25 
0.49 ± 0.12 
166.6 ± 43.5 
4.28 ± 0.51 
1.02 ± 0.13 
1.18 ± 0.24 † 
0.52 ± 0.09 
151.5 ± 32.7 
4.44 ± 0.36 
1.0 ± 0.09 
0.99 ± 0.16 * 
0.45 ± 0.08 * 
LVM = Left ventricular mass, LVID = LV internal diameter, IVS = inter-
ventricular septal thickness, PWT = posterior wall thickness, RWT = relative 
wall thickness. No significant main time effect in LV structure after 12 weeks 
of training. † = significantly different from the other group at the same time 
point. * = significantly different from pre-training in the same group.  
 
After 12 weeks of training, opposite changes were observed in both groups’ 
PWTd (time effect P > 0.05, time by group interaction P < 0.05), LVM and 
RWT (both, time effect P > 0.05, time by group interaction P = 0.06). Post-
hoc analysis revealed ~16%, ~6% and ~12% decreases in PWT, LVM and 
RWT respectively in the CON group post-training (P < 0.05, except for LVM; 
effect size d = 0.4). As for the INT group, a 10% increase in PWTd (P > 
0.05, d = 0.4) and a 6% increase in LVM and RWT (both P > 0.05, d = 0.3) 
were observed with no change in RWT (Figure 6.3a, c and e). Furthermore, 
significant inverse correlations were observed between baseline PWT, LVM 
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and RWT and their respective changes pre to post-training (r = -0.64 P < 
0.05, -0.54 P < 0.05 and -0.40 P = 0.09 respectively; Figure 6.3b, d and f). It 
was noted that participants with baseline PWTd and LVM above normal 
almost invariably increased in these measures post-training and vice versa. 
Interestingly, after 12 weeks of training, the CON group’s mean LVM and 
PWTd were no longer above normal limits according to ASE guidelines 
(Lang et al., 2005). Finally, there was no significant change in LVID in either 
group after 12 weeks of training (time effect P > 0.05, time by group 
interaction P > 0.05). 
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Figure 6. 3 Figure 5. 1 Changes in LV posterior wall thickness (PWTd), mass 
(LVM) and relative wall thickness (RWT) after 12 weeks of interval (INT) or 
continuous (CON) heavy-intensity training in obese women. (a) PWTd increased 
in the INT group whereas and decreased in the CON group post-training (time by 
group interaction P < 0.05). (b) LVM decreased in the CON group post-training 
whereas it did not change in the INT group (time by group interaction P = 0.06) (c) 
RWT decreased in the CON group post-training whereas it did not change in the INT 
group (time by group interaction P = 0.06). Inverse correlations were observed 
between (c) baseline PWT and pre to post delta-PWT (P < 0.05), (d) baseline LVM 
and pre to post delta-LVM (P < 0.05) and (e) baseline RWT and pre to post delta-
RWT (P = 0.09). The red dotted lines represent the cut-offs for normality according to 
the ASE guidelines (Lang et al., 2005). 
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6.3.4 Left ventricular systolic function 
At baseline, All measures of systolic function were not different between 
both groups (P > 0.05; Table 6.4). Twelve weeks of heavy-intensity interval 
and continuous training resulted in a 30% and 11% increase in CircS and 
LongSRs respectively and a 7% decrease in MPI (Time effect P < 0.05; 
Table 6.4) with no difference between both groups (time by group interaction 
P > 0.05). the percentage change in these variables in each group did not 
differ from the other group (P > 0.05). No change was observed in the 
remaining measures of systolic function in both groups (Time effect P > 
0.05).  
As shown in Figure 5.2a and c, trends for significant time by group 
interactions were detected for RadS (P = 0.09) and RadSRs ( P = 0.05) with 
post-hoc analysis revealing a respective ~25% (P = 0.07) and ~19% (P > 
0.05, effect size d = 0.6) post-training reductions in these variables in the 
CON group. As for the INT group, no change was observed in RadS, 
however RadSRs increased by ~11% (P > 0.05, effect size d = 0.5) post-
training. Interestingly, significant correlations were found between the pre to 
post-training delta-PWTd and both delta-RadS and delta-RadSRs (r = 0.55 
and 0.66 respectively, P < 0.05; Figure 5.2b and d). 
 
150 
 
 
Table 6. 4 LV systolic function (mean ± SD) before and after 12 
weeks of heavy intensity training in obese females 
 Interval 
Pre                 Post 
Continuous 
Pre                  Post 
SV (ml 
EF (%) 
HR (bpm) 
CO (L) 
FS 
Sm (ms) 
LongS (%) 
CircS (%) 
RadS (%) 
LongSRs (s
-1
) 
CircSRs (s
-1
) 
RadSRs (s
-1
) 
Torsion (%) 
MPI 
69.5 ± 11.4 
79.7 ± 9.95 
71.3 ± 10.3 
4.7 ± 0.63 
0.39 ± 0.08 
6.66 ± 2.24 
20.4 ± 1.28 
14.7 ± 2.21 
54 ± 17.4 
1.02 ± 0.1 
1.24 ± 0.14 
2.15 ± 0.4 
14.2 ± 5.59 
0.34 ± 0.04 
69 ± 9.9 
77.4 ± 7.66 
72.3 ± 11.9 
4.89 ± 0.46 
0.38 ± 0.08 
7.47 ± 2.17 
20.7 ± 3.75 
27.8 ± 4.35* 
54 ± 21 
1.14 ± 0.21* 
1.22 ± 0.19 
2.33 ± 0.33 
15.1 ± 7.36 
0.31 ± 0.05* 
69.7 ± 7.06 
80.1 ± 5.9 
71.9 ± 9.54 
4.96 ± 0.44 
0.38 ± 0.08 
6.89 ± 1.82 
18.8 ± 3.02 
15.4 ± 3.85 
45.2 ± 17.7 
0.98 ± 0.13 
1.29 ± 0.25 
2.04 ± 0.54 
15.4 ± 6.04 
0.33 ± 0.04 
74.7 ± 8.61 
80.8 ± 6.14 
66.7 ± 7.3 
4.93 ± 0.44 
0.41 ± 0.08 
7.46 ± 2.13 
19.2 ± 2.96 
21.5 ± 6.84* 
31.4 ± 16.6† 
1.09 ± 0.28* 
1.23 ± 0.34 
1.64 ± 0.74 
14.1 ± 6.75 
0.31 ± 0.02* 
SV = stroke volume, EF = ejection fraction, HR = heart rate, COP = cardiac output, 
FS = fractional shortening, S’ = systolic myocardial velocity, LS = longitudinal 
strain, CS = circumferential strain, RS = radial strain, LSRs = longitudinal systolic 
strain rate, CSRs = circumferential systolic strain rate, RSRs = radial systolic strain 
rate, MPI = myocardial performance index. * indicates significant difference from 
pre-training in the same group (P < 0.05). † indicates close to significant difference 
from pre-training in the same group. 
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Figure 5. 14 Changes in left ventricular posterior radial strain and systolic 
strain rate after 12 weeks of interval (INT) or continuous (CON) heavy-intensity 
training in obese females. (a) Radial strain decreased in the CON group post-
training with no change in the INT group (time by group interaction P = 0.09). (b) 
Radial SRs decreased in the CON group and increased in the INT group post-
training (time by group interaction P = 0.05). Significant positive correlations were 
observed between pre to post-training delta-PWT and (c) delta-radial strain (P < 
0.05) and (d) delta-radial SRs (P < 0.05). d indicates cohen’s effect size. 
 
6.3.4 Left ventricular diastolic function 
At baseline, both groups had similar measures of LV diastolic function (P > 
0.05; Table 6.5). After 12 weeks of training, both groups demonstrated a 
general improvement in diastolic function represented by an increase in Em 
by ~30%, Em/Am by ~86%, CircSRe by 18% and CircSRa by 45% and a 
decrease in Am by ~26% (time effect P < 0.05, except CircSRe P = 0.07; 
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time by group interaction > 0.05). A significant time by group interaction was 
observed for RadSRe (P < 0.05) with post-hoc analysis showing a ~15% 
decrease in the CON group (P = 0.08) and a ~12% increase in the INT 
group post training (P > 0.05, d = 0.5) (table 5.4). No other time by group 
interactions were observed in the rest of the diastolic measures (P > 0.05). 
Interestingly, a significant correlation was observed between pre to post 
delta-RadSRe and delta-PWTd (r = 0.49, P < 0.05). 
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Table 6. 5 Changes in LV diastolic function (mean ± SD) after 12 
weeks of heavy intensity training in obese females 
 Interval 
Pre                Post 
Continuous 
Pre            Post 
E (ms) 
A (ms) 
E/A ratio 
DCT (ms) 
IVRT (ms) 
Em (ms) 
Am (ms) 
Em/Am ratio 
E/Em 
LSRe (s
-1
) 
CSRe (s
-1
) 
RSRe (s
-1
) 
LSRa (s
-1
) 
CSRa (s
-1
) 
RSRa (s
-1
) 
0.89 ± 0.15 
0.57 ± 0.12 
1.69 ± 0.63 
184 ± 45 
93.1 ± 11.7 
6.99 ± 0.68 
9.23 ± 0.82 
0.76 ± 0.12 
0.13 ± 0.03 
1.43 ± 0.19 
1.17 ± 0.35 
1.71 ± 0.26 
0.86 ± 0.14 
0.41 ± 0.19 
1.31 ± 0.62 
0.95 ± 0.16 
0.60 ± 0.13 
1.65 ± 0.46 
193 ± 32 
87.9 ± 15.8 
8.77 ± 2.4* 
6.84 ± 2.84* 
1.37 ± 0.31* 
0.12 ± 0.05 
1.5 ± 0.38 
1.33 ± 0.36† 
1.89 ± 0.46 
0.88 ± 0.33 
0.65 ± 0.29* 
1.5 ± 0.36 
0.85 ± 0.22 
0.63 ± 0.13 
1.37 v 0.33 
189 ±40 
113.6 ± 7.7 
6.35 ± 0.85 
8.63 ± 1.07 
0.74 ± 0.06 
0.13 ± 0.03 
1.32 ± 0.31 
1.18 ± 0.31 
2.09 ± 0.73 
0.85 ± 0.18 
0.46 ± 0.19 
1.13 ± 0.34 
0.87 ± 0.16 
0.61 ± 0.11 
1.48 ± 0.50 
196 ± 20 
91.9 ± 9.0 
7.8 ± 1.91* 
6.41 ± 2.52* 
1.41 ± 0.67* 
0.12 ± 0.04 
1.34 ± 0.3 
1.44 ± 0.47† 
1.67 ± 0.37† 
0.86 ± 0.3 
0.62 ± 0.26* 
1.22 ± 0.46 
E, early mitral inflow velocity; A, late mitral inflow velocity; DCT, early inflow velocity 
deceleration time; IVRT, isovolumetric relaxation time; Em, early diastolic 
myocardial velocity; Am, late diastolic myocardial velocity; LongSRe, CircSRe and 
RadSRe, early diastolic strain rate in the longitudinal, circumferential and radial 
directions respectively; LongSRa, CircSRa and CircSRa, late diastolic strain rate in 
in the longitudinal, circumferential and radial directions respectively. * indicates a 
significant difference from pre-training in the same group (P < 0.05). † indicates a 
close to significant difference from pre-training in the same group (P < 0.09). 
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Figure 5. 15 Changes in early diastolic radial strain rate after 12 weeks 
of interval or continuous heavy-intensity training in obese females. (a) 
Radial SRe decreased by ~15% (P = 0.08) in the CON group, whereas it 
increased by ~12% (P > 0.05) in the INT group post-training (time by group 
interaction P < 0.05). (b) A significant direct correlation was observed 
between pre to post delta Radial SRe and delta PWTd (P < 0.05). d 
indicates Cohen’s effect size. †indicates close to significance (P  < 0.09). 
 
6.4 Discussion 
To the best of our knowledge, this is the first study to compare the effects of 
work-matched heavy-intensity continuous and interval exercise training on 
LV structure and function in overweight/obese women. The principal findings 
were that both exercise types induced similar improvements in LV systolic 
and diastolic function only detected by novel TDI and 2DST 
echocardiography however their impact on LV structure differed according to 
baseline LV size and morphology in each group. 
6.4.1 Impact of aerobic exercise training on LV structure  
Twelve weeks of heavy-intensity interval and continuous training induced 
opposite outcomes on LV structure. The continuous training group which 
displayed characteristics of pathological LV concentric hypertrophy at 
baseline, demonstrated a training-induced reverse remodelling following 
training, evidenced by a significant reduction in posterior wall thickness with 
subsequent reduction in LVM and RWT resulting in a non-hypertrophic LV 
with a significantly less concentric morphology. The interval training group, 
which had normal mean LVM at baseline, demonstrated a slight increase in 
posterior wall thickness, LVM and RWT after training with mild to moderate 
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effect size, though not reaching statistical significance. This could possibly 
indicate early signs of exercise-induced LV remodelling, represented in 
increased wall thickness preceding chamber dilatation. Aerobic exercise is 
known to induce eccentric LV hypertrophy ie. increase in both LV mass and 
internal diameter (Weiner and Baggish 2012). No change in LVIDd was 
observed in either groups, probably due to the short duration of training as it 
appears wall thickness changes precede diameter changes. Shuster et al. 
(2011) reported a significant reduction in LV wall thickness and mass 
following 8 weeks of low intensity aerobic training in obese men that had 
severe LV hypertrophy at baseline, whereas Vogelsang et al. (2008) 
reported a post-training increase in LVM after 4 months of moderate-
intensity aerobic training in mild to moderately obese adults with normal pre-
training LVM. Hence, it appears that the nature of morphological alterations 
in response to aerobic training vary according to the state of LV structure at 
baseline and how severe (if any) LV pathological remodelling is manifested. 
Other studies reported no change in LV structure following different aerobic 
training in healthy obese subjects with normal pre-training LVM. These 
training programmes included 6 months low-intensity training (Eriksson 
2010), 8 months and 6 months moderate-intensity training programmes 
(Mitchell et al. 2002 and Stewart et al. 2005 respectively). Therefore, the 
heavy-intensity used in our study possibly explains the favourable changes, 
albeit small, in LV structure in the INT group despite having normal baseline 
LVM. Hence, the training intensity as well as the pathological state of the 
myocardium at baseline appear to be strong determinant of training-induced 
LV structural adaptations. Other factors include participants’ state of 
physical fitness, gender, race and genetic factors (Weiner and Baggish 
2012). 
It is not possible to conclude from our results whether interval training is 
superior to continuous training or vice versa in improving LV structure 
because of the baseline structural differences between both groups. 
Matching subjects for LV size and morphology was not possible in this study 
due to the blinded nature of the analysis.  A comparison between work-
matched heavy-intensity interval and continuous training after matching 
subjects for LV size and morphology is necessary. Nonetheless, our results 
suggest that both exercise types resulted in favourable changes in LV 
structure after 12 weeks of heavy-intensity training.  
Suggested mechanisms for exercise-induced LV remodelling and 
hypertrophy include increased insulin-like growth factor-1 (IGF-1) 
expression, activation of phosphoinositide-3 kinase (PI3K), down-regulation 
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of microRNAs with subsequent reduction in collagen and myocardial fibrosis, 
reduction of cardiac myocyte apoptosis and induction of cellular 
regeneration (Ellison 2012, Gielen 2010). Furthermore, exercise has been 
shown to enhance insulin sensitivity through activation of monophosphate-
activated kinase (AMPK) which suppressed triglyceride and fatty acid 
synthesis and activates glucose uptake and glycogenolysis. Indeed, Stewart 
et al. (2005) reported a negative correlation between markers of insulin 
resistance and increase in LV size following 6 months of moderate intensity 
training in overweight and moderately obese healthy adults. In the context of 
obesity, all these mechanisms would counteract and reverse the 
mechanisms involved in pathological remodelling which would result 
predominantly in a reduction in LV wall thickness. In subjects without 
pathological remodelling, the predominant outcome of exercise on LV 
structure would be manifested as an increase in wall thickness and 
physiological hypertrophy. Both outcomes were manifested in our study by 
both interval and continuous heavy-intensity exercise training. 
6.4.2 Impact of heavy-intensity interval or continuous training on 
standard echocardiographic measures of LV systolic and 
diastolic function  
Twelve weeks of interval and continuous heavy-intensity training did not 
have any impact on standard echocardiographic measures of measures of 
LV systolic function including SV, EF and FS and diastolic function including 
E, A, E/A, IVRT and DCT in overweight and obese healthy women. Reports 
from the literature with regards to the influence of aerobic training on 
standard echocardiographic variables in obese healthy subjects have been 
variable. With regards to systolic function, Sijie et al. (2012) reported a 
significant increase in SV and EF in overweight young women following 12 
weeks of either moderate/heavy-intensity aerobic training. Shrauwen et al. 
(2010) reported a significant increase in EF and SV following 12 weeks of 
moderate-intensity mixed endurance and resistance training in overweight 
and obese adult males, however these measures were assessed by MRI 
which is more sensitive and accurate than echocardiography (Greenberg 
1997). As for diastolic function, Ingul et al. (2010) reported decrease in DCT 
and IVRT with no change in E, A and E/A ratio following 13 weeks of heavy-
intensity interval training in 10 obese adolescents. Schuster et al. (2011) 
reported similar findings in 10 mildly obese adults after 8 weeks of low-
intensity training. Several studies, however failed to detect any change in 
standard and/or TDI-derived echocardiographic measures of systolic and/or 
157 
 
diastolic function after aerobic training of a wide range of durations and 
intensities including 10 days moderate-intensity training in obese men and 
women (Baynard et al. 2008), 6 weeks of moderate intensity continuous or 
heavy-intensity interval training in obese adults (Millen et al. 2014), 8 months 
of moderate or heavy-intensity training in obese adolescents (Mitchell et al. 
2014) and 4 months aerobic training at an average HR of 157 bpm in obese 
children (Humphries et al. 2002). As mentioned in previous chapters, 
standard echocardiography is highly dependent on preload and afterload 
and has a low sensitivity in detecting subclinical contractile dysfunction. 
6.4.3 Impact of heavy-intensity interval or continuous training on 
TDI-derived myocardial systolic and diastolic velocity and 
myocardial performance index  
Twelve weeks of heavy-intensity interval and continuous training resulted in 
an increase in Em, Em/Am and decrease in Am and MPI with no change in 
Sm in healthy overweight/obese women. Ingul et al. (2010) and Schuster et 
al. (2011) both reported increased Em following 13 weeks of heavy-intensity 
interval training in 10 obese adolescents and 8 weeks of low-intensity 
training in 10 mildly obese men respectively. Millen et al. (2014) did not 
observe any change in Em after 6 weeks of moderate intensity continuous 
or heavy-intensity interval training in obese men and women. Myocardial 
performance index is a fairly new load-independent TDI-derived measure of 
combined systolic and diastolic function that has been shown to be highly 
sensitive measure of cardiac dysfunction (Brush 200), strongly correlate with 
LV function derived from cardiac catheterization (dP/dt; Tei et al. 1997) and 
an independent predictor of congestive cardiac failure (Arnlov et al 2004). 
MPI has been shown to decrease following aerobic training in healthy non-
obese subjects indicating an improvement in systolic and diastolic contractile 
performance (Tuzun 2014) however it has never been investigated in obese 
individuals. This is the first study to assess and report a positive impact of 
aerobic training on MPI in healthy overweight/obese women reflecting an 
improvement in intrinsic systolic and diastolic contractile performance. 
6.4.4 Impact of heavy-intensity interval or continuous training on 
myocardial systolic and diastolic deformation and torsion 
This is the first study to examine the impact of aerobic training on all 3 
planes of motion (longitudinal, circumferential and radial) using 2DST 
echocardiography in healthy obese subjects. Twelve weeks of both heavy-
intensity interval and continuous training resulted in an increase in global LV 
158 
 
longitudinal SRs, circumferential systolic strain and circumferential diastolic 
SRe and SRa. Schuster et al. (2011) previously reported an increase in 
global 2DST-derived longitudinal strain and SRs and SRe in mild to 
moderately obese men after 8 weeks of low-intensity continuous training. It 
was observed that, at baseline, the men involved in this study had severe LV 
hypertrophy (LVM = 234.6 ± 16.9 g) and lower longitudinal strain values 
compared to our values (15.9 ± 0.8 vs. 19.7 ± 2.3%) however, the 
longitudinal SRs were similar to our values. Ingul et al. (2010) also reported 
an increase in global longitudinal strain, SRs and SRe after 10 weeks of 
heavy-intensity interval training in mild to moderately obese adolescents. 
These two studies did not assess circumferential or radial deformation. 
Several factors can influence strain and strain rate, including preload, 
afterload, heart rate and cardiac myocyte contractility (Becker et al. 2007). In 
this study we report no change in EDV, E/Em ratio or SWS following training 
reflecting no change in preload or LV filling pressure or afterload 
respectively. Also, resting heart rate did not change following training. 
Therefore, the improved global longitudinal systolic and circumferential 
systolic and diastolic deformation are most likely reflections of improvement 
in cardiac myocyte contractility after training.  
With regards to radial strain, SRs and SRe, only the continuous training 
group displayed a reduction in these measures post-training. As explained in 
the previous chapter, radial strain and strain rate represent the magnitude 
and rate of change in thickening or thinning of the myocardium in response 
to the longitudinal and circumferential shortening or lengthening of its 
helically oriented fibres during systole or diastole. This change in thickness 
occurs in order to maintain cardiomyocyte volume as the myocardium is 
incompressible in nature (Dandel 2009). Theoretically, this applies when 
cardiac myocyte length and width is constant. Hence, if the myocardium 
decreases in thickness, it would be reasonable to expect a parallel reduction 
in the degree of radial thickening or thinning in response to shortening or 
lengthening during systole or diastole. Our observation that the reduction in 
radial strain, SRs and SRe significantly correlated with the reduction in LV 
posterior wall thickness is consistent with the notion that the reduction in 
radial strain and strain rate in the continuous training group is a due to the 
reduction in thickness and not a reflection of contractility. Furthermore, with 
the reported increase in circumferential strain, an increase rather than a 
decrease in radial strain should be expected. The absence of increased 
radial strain possibly reflects a training-induced change in myocardial fibre 
orientation.  
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From these data, it is shown that both continuous and interval heavy-
intensity training induce similar improvements in LV systolic and diastolic 
function in healthy overweight/obese women that can only be detected by 
novel TDI and 2DST echocardiography. Aerobic exercise enhances 
myocardial contractile function through several mechanisms including 
increased IGF-1 expression with subsequent activation of AKT leading to 
improvement in Ca
2+
 handling through phosphoilamban phosphorylation and 
disinhibition of sarcoplasmic reticulum Ca
2+
 ATPas pump (Gielen 2013). 
Furthermore, IGF-1 expression results in improved myocardial repair and 
function and the increase in the number of newly formed myocytes (Ellison 
2012). It was also shown that exercise intensity is directly related to 
exercise-induced influence on cell length, myocardial relaxation and calcium 
decay, being more beneficial with high intensities (Gielen 2013). 
Additionally, exercise is a powerful regulator of endothelial nitric oxide 
synthase- (eNOS-) mediated release of nitric oxide (NO). The exercise-
induced enhancement in Ca
2+
 handling and length-dependent increase in 
myocardial contraction is regulated by eNOS (Ellison 2012). Furthermore, 
aerobic exercise results in up-regulation of anti-oxidative enzymes and 
reduction in ROS release, as well as enhance mitochondrial function and 
reduces ROS generation from the mitochondria (Gielen 2013), all of which 
are mechanisms contributing to obesity cardiomyopathy as explained in the 
literature review chapter. 
6.4.5 Conclusions 
In conclusion, both interval and continuous heavy-intensity training induced 
favourable LV structural changes that differed in nature according to 
baseline LV size and morphology in each groups. Continuous training 
induced reverse remodelling of obesity-mediated concentric hypertrophy by 
reducing LV posterior wall thickness, mass and relative wall thickness. 
Interval training slightly increased LV wall thickness and mass, contributing 
to an early exercise-induced LV remodelling. Changes in wall thickness 
following aerobic training precedes diameter changes as both training types 
did not lead to any change in LVIDd, possibly due to the short duration of 
the exercise programme. With regards to function, both interval and 
continuous heavy-intensity training resulted in equal improvements in both 
systolic and diastolic function. These improvements were only detected by 
TDI and 2DST echocardiography as no change was observed in standard 
echocardiography. A significant increase in 2DST-derived global longitudinal 
SRs, systolic circumferential strain, circumferential SRe and SRa was 
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observed in both groups in addition to an increase in TDI-derived Em and 
Em/Am and a decrease in Am and MPI. These changes are most likely 
secondary to improvement in myocardial contractility as no changes in 
preload, afterload or resting heart rate were detected. Finally, global LV 
radial strain, SRs and SRe followed the changes in wall thickness, 
decreased in the continuous group and slightly increased in the interval 
group. This is believed to be secondary to changes in thickness rather than 
contractility. This study confirms that exercise alone, without dietary 
modification, is an effective measure of improving LV structure and function 
in healthy overweight and obese women, protecting against the 
development of obesity cardiomyopathy. Furthermore, this study suggests 
that interval training is not superior to continuous exercise in improving 
cardiac function when both are in the heavy-intensity domain and that no 
additional benefit is observed from the repetitive nature of interval exercise. 
Since both training types were matched for work, the session durations of 
continuous training were much shorter than interval training. This could offer 
overweight and obese individuals the option of training for shorter durations 
and obtain similar benefits as longer interval training sessions when time 
constraints is a hindrance to training. 
6.4.6 Limitations and future work 
This study includes a small number of participants, making it difficult to draw 
strong conclusions from it. Results from this study require validation through 
future studies including large numbers of participants. Before the training 
intervention, both groups included in this study were matched for age, BMI 
and cardio-respiratory fitness, but not for LV size and morphology and due 
to the significant differences between both groups in LV structure, it was 
impossible to compare the impact of both types of exercise on LV structure. 
Future studies are required comparing both types of exercise after matching 
participants for LV size, morphology and function. This study is 
observational and does not provide information on molecular mechanisms. 
Future longitudinal studies supported by cellular/molecular techniques are 
required. This study lacks a non-obese control group, as the aim was to 
compare the effects of both types of exercise on LV structure and function in 
obese women. Future studies including a non-obese control group are 
required in order to confirm the findings were exclusively attributed to 
training and not to other potential external factors. Finally, this study is a 
women-only study and does not account for other potentially influencing 
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factors such as age, gender, race and genetic factors. Large-scale studies 
including a mixture of age groups, genders and races are required. 
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Chapter 7 General discussion 
The aim of this chapter is to tie together the key findings presented in the 
thesis, discuss their clinical and research implications as well as their 
implications on the community, highlight the potential limitations of each 
study and provide suggestions for future direction and research. 
7.1 Summary of findings 
This study was set out to address the following aims: (1) To explore  the 
physiological relationship between LV size and morphology, and body size 
and composition in a population of healthy women. (2) To assess the 
independent influence of excess body fat, particularly visceral adiposity, on 
LV size, morphology and function in healthy mild-moderately obese women. 
(3) To investigate the LV systolic and diastolic functional alterations during 
and immediately following heavy-intensity exercise in healthy obese women. 
(4) To explore the LV structural and functional adaptations to heavy-intensity 
interval and continuous exercise training in healthy overweight/obese 
women. (4) To determine whether interval exercise training provides any 
additional benefit over continuous exercise training on LV adaptations to 
aerobic training in healthy overweight/obese women. 
Chapter 4 explored the impact of body size and composition on LV structure 
and function in healthy women. The principal findings were that, LV size was 
related to body size in a non-linear fashion and that body composition 
determined the pattern of LV morphology. Increased muscle mass was 
accompanied by a parallel increase in LVM following an eccentric 
morphology, whereas increased fat mass, particularly visceral fat, caused 
LVM to increase at a slower rate and in a concentric morphological pattern. 
Furthermore, normalising LVM for BM or BSA using allometric scaling 
techniques, masked the influence of excess body fat on LV size, which was 
avoided by normalising to FFM. With regards to LV function, this study 
provided evidence of reduced both systolic and diastolic function in healthy 
overweight/moderately obese women, which appeared to be mediated 
exclusively by excess body fat, particularly visceral adipose tissue. There 
was no evidence suggesting a need to normalise measures of LV function to 
FFM. Finally, this study showed for the first time that excess epicardial 
adipose tissue is independently associated with reduced LV systolic 
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myocardial deformation, suggesting a possibility of a local mechanical 
influence of epicardial fat on LV systolic performance. 
Chapter 5 compared the LV systolic and diastolic functional response to 
heavy-intensity exercise in healthy obese and non-obese women. The 
primary findings were that, obese women displayed higher SBP than non-
obese women during exercise indicating a high risk of developing 
hypertension. Furthermore, despite having similar systolic and lower 
diastolic LV function at rest, obese women displayed higher LV systolic and 
diastolic function during and following heavy-intensity exercise compared to 
non-obese women. This is possibly a compensatory means of optimising 
adequate cardiac output for the perfusion of exercising muscles. However,  
obese women displayed evidence of delayed HRR post-exercise, which may 
reflect impaired vagal reactivation possibly secondary to insulin resistance. 
Finally, this study reports for the first time a post-exercise improvement in LV 
diastolic filling and myocardial deformation in non-obese women only. The 
absence of this manifestation in obese women may reflect a subtle exercise-
induced cardiac fatigue. 
Chapter 6 assessed the long-term LV structural and functional adaptations 
to heavy-intensity interval and continuous exercise training in 
overweight/moderately obese women. The principal findings were that both 
types of exercise resulted in favourable alterations in LV structure and 
improvements in both systolic and diastolic function. Additionally, there was 
no evidence to suggest that interval exercise provides additional benefits 
over continuous exercise when both types of exercise are matched for work 
and exercise intensity domain. Finally, this study shows that exercise 
intensity and total amount of work per session rather than session duration 
and work-rate determine the training-induced improvements in LV function. 
7.2 Practical implications 
This section will discuss the practical implications of the key findings of this 
thesis. These will be broken down into clinical, research and implications on 
obese women. 
7.2.1 Clinical implications  
Chapter 4 highlights the importance of normalising LV size to the right body 
size variable before comparisons between individuals is to be carried out, 
particularly when it involves overweight/obese subjects. This is of significant 
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clinical  importance because of the detrimental impact of LV hypertrophy on 
cardiovascular morbidity and mortality (Levy et al., 1990). To date, LVM is 
typically normalised to either BSA, HT or HT
2.7
 both in the clinical and 
research settings. The reported allometric exponents for HT relative to LVM 
have been disparate, and we have failed to detect a significant relationship 
between HT and LVM. Additionally, we have shown that scaling LVM to 
BSA, even allometrically, underestimates LVM in overweight and moderately 
obese women and masks the impact of excess body fat. This was avoided 
when LVM was scaled to FFM. Therefore, using FFM as a scaling variable 
provides an accurate interpretation of LV size and is more sensitive for the 
identification of LV hypertrophy in mild degrees of obesity. To date, cut-off 
values for LVM scaled to FFM have not yet been developed and large 
epidemiological studies are required for this purpose. 
Chapter 5 draws the attention to the importance of exercise stress testing for 
the detection of subtle cardiovascular dysfunction not apparent at rest. 
Obese women were shown to have high SBP during exercise and delayed 
HRR following exercise, despite having normal HR and SBP at rest. Both 
these manifestations reflect underlying cardiovascular and metabolic 
abnormalities. Therefore, high risk individuals, notably obese subjects, 
should have regular exercise stress tests to allow the early detection of 
subclinical abnormalities in cardiovascular function and the early 
implementation of appropriate treatment and follow up.  
This thesis also underscores the importance of using novel 
echocardiographic techniques in the assessment of LV function in obese 
individuals both in clinical and research settings. In Chapters 4, 5 and 6, TDI 
and 2DST echocardiography revealed systolic and diastolic functional 
abnormalities that were not detected by standard 2D and PWD 
echocardiography. This was particularly evident with LV systolic function. To 
date, EF remains the most widely used indicator of LV systolic performance 
in clinical setting due to its ease of measurement. Although the routine use 
of TDI and 2DST-echocardiography can be more time consuming than 
standard echocardiography, they can potentially detect subtle LV systolic 
dysfunction in apparently healthy obese individuals allowing for early 
interventional measures to be initiated and the potential avoidance of 
eventual cardiac failure. 
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7.2.2 Research implications 
To date, studies exploring the long-term cardiac adaptations to exercise or 
functional response during exercise, have predominantly defined the 
exercise intensity as a percentage of HRmax, VO2max or designed fixed WR 
exercise sessions (Ingul et al., 2010, Salvadori et al., 1999, Schrauwen-
Hinderling et al., 2010). This method does not control for individual 
differences in metabolic activity. Indeed, participants exercising at fixed WRs 
or at particular percentages of HRmax or VO2max may be exercising above or 
below their individual lactate threshold ie. at different training intensities 
relative to one another (Rossiter, 2011). Consequently, the physiological 
stimulus will be different between participants and hence, may explain the 
high discrepancy in LV response to exercise and long-term adaptation to 
exercise training between studies. In chapters 5 and 6, we have 
demonstrated that heavy-intensity exercise, a defined according to individual 
lactate thresholds, resulted in significant improvements in LV systolic 
function during exercise and after long-term training.  
7.2.3 Implications on obese women 
Obesity represents a major cardiovascular risk factor for women. Exercise 
training provides overweight and obese women with a means of protecting 
themselves against heart disease, and indeed improve their cardiac 
structure and function, particularly if they are struggling to reduce weight 
and/or maintain weight loss. The UK government recommends that adults 
exercise for ≥ 30 min moderate-intensity exercise on 5 days/week. However, 
the number of women who adhere to exercise is very small and was mainly 
attributed to lack of time and motivation (BHF, 2012). Recent evidence 
suggests that heavy-intensity interval exercise provides higher cardiac 
benefits than moderate-intensity continuous exercise (Wisloff et al., 2007). 
Additionally, we have demonstrated that heavy-intensity exercise, regardless 
of exercise type and session duration, provides significant improvements in 
LV systolic and diastolic function in obese women. Indeed, continuous 
exercise for significantly shorter session durations than interval exercise 
(approximately 13 – 25 min vs 20 – 40 min respectively) resulted in similar 
improvements in LV function. This was provided it fell within the heavy-
intensity domain and resulted in equivalent total amount of work as an 
interval training session. Hence, this may address the issue of lack of 
adherence because of lack of motivation and/or time. Women who lack 
motivation may find interval training more enjoyable, whereas women who 
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lack time may find continuous exercise for shorter duration more convenient 
and practical.  
7.3 Limitations and future work 
The main limitation in this thesis is the small number of participants included 
in each study which makes it difficult to draw firm conclusions from these 
studies. Therefore, the reported findings require validation by studies on 
larger population samples. Moreover, Chapters 4 and 5 are cross-sectional 
studies and do not take into account individual differences in the duration of 
obesity. Therefore, they do not provide information on mechanisms, causes, 
trends and changes over time and effects. Future longitudinal studies are 
required to explore the influence of time and duration of obesity on the 
obesity-mediated LV structural and functional alterations both at rest and 
during exercise by frequent follow up assessments at different time points. 
Additionally, Chapter 5 assessed LV function at a single time point during 
heavy-intensity exercise. This does not provide information on the pattern of 
change in LV function throughout the exercise session. Continuing is 
required to assess LV function during heavy intensity exercise at multiple 
time points covering the beginning, middle and end of exercise. 
Furthermore, in chapter 6, both groups had significantly different baseline 
LV size and morphology which has made it impossible to compare between 
both types of exercise with regards to their impact on LV structure. 
Continuing work is required to compare the impact of work- and intensity-
matched interval and continuous exercise training on LV structure after 
matching participants for LV size and morphology before training. Moreover, 
this work does not control for potentially relevant factors such as race and 
genetic factors as it involved women only. 
There are a number of limitations related to the echocardiographic technique 
employed in this thesis. Firstly, this thesis included overweight and obese 
women, which poses an important limitation to echocardiography. Excess 
adipose tissue can compromise image quality which can potentially affect 
the analysis of data. Therefore, tissue harmonic imaging was used in order 
to improve image quality and images were optimised to maximise spatial 
and temporal resolution. Additionally, physical limitations have been 
encountered in Chapter 5 during the echocardiographic assessment during 
exercise. Exercise results in a significant amount of motion, both through the 
exercising muscles and faster breathing. This can affect image quality and 
result in insufficient visualisation of the LV walls. Furthermore, it can affect 
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the positioning of the echocardiographic probe on the chest was of the 
exercising participant, resulting in inadequate image planes. Finally, the 
serial acquisition of different image planes is time consuming and during 
exercise, echocardiographic assessment has to be performed in a narrow 
time-window, which also affects imaging quality. Future studies exploring the 
LV functional alterations during exercise overcome using cardiac MRI can 
overcome these limitations and validate our findings. 
Finally, one of the principal limitations of this work is the difficulty to translate 
the concept of exercise intensity to the public. The definition exercise 
intensity according to lactate threshold and the calculation of appropriate 
exercise work-rates that would fall in the heavy-intensity domain require 
specialised equipment and the performance of a maximal cardio-pulmonary 
exercise test. Future studies are required to develop alternative methods 
allowing the easy and quick estimation of individual lactate thresholds and 
subsequent calculation of work-rates corresponding to the heavy-intensity 
domain in order for healthcare professionals to be able to prescribe exercise 
interventions for obese individuals.  
7.4 Conclusion 
In summary, excess visceral adipose tissue is associated with subclinical LV 
concentric hypertrophy and subtle LV systolic and diastolic dysfunction in 
otherwise healthy overweight/moderately obese women. Furthermore, 
allometric scaling of LVM for FFM allows the detection of LV hypertrophy in 
obese women, whereas normalising for BSA or BM underestimates of LV 
size in these women by overcorrecting for body size. Additionally, novel TDI 
and 2DST echocardiography are more sensitive than standard 
echocardiography in detecting subtle LV systolic and diastolic dysfunction in 
overweight/obese women. Heavy-intensity exercise induces beneficial LV 
structural and functional adaptations, both during exercise and following 
long-term training in overweight and obese women. Finally, interval training 
does not seem to provide any additional benefits over continuous training on 
LV structural and functional adaptations to exercise after both types of 
exercise were matched for total amount of work and intensity domain. 
However, further studies are required to explore the influence of obesity 
duration on LV structure and function and the pattern of change in LV 
function during heavy-intensity exercise.  
. 
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